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SUMMARY
The gene coding for staphylococcal protein A has been cloned and the nucleotide 
sequence coding for the structural gene and its 5'flanking region determined. The DNA 
sequence showed the gene to be composed of a series of repetitive sequences, with five 
120 nucleotide repeats comprising the 5 'part of the structural gene and ten 24 
nucleotide repeats in a continous sequence at the 3’terminus. Analysis of codon usage 
of the gene and comparison with other S. aureus genes revealed that spa showed a 
higher degree of homology with S. aureus plasmid genes than with chromosomally- 
located genes. Comparison with the reported codon preference in E.coli showed spa to 
have a similar bias, except for the leu codon.
An open reading frame o f the spa structural gene showed 508 a.a residues, with a 
predicted protein molecular weight of 55,426. The N-terminal signal peptide comprised 
the first 36 amino acids. A fifth N-terminal domain (E) was shown to be homologous to 
the four IgG-binding domains previously reported to constitute the N-terminal portion 
of SpA.
The C-terminal part o f SpA was shown to consist of two structurally different regions: 
an N-terminal repetitive region (Xr) composed of ten octapeptide repeats which are 
hydrophilic and have been proposed to span the Gram-positive cell wall, followed by a 
single domain (X c), 58 a.a in length, whose C-terminal portion contains 20 
hydrophobic residues, suggesting anchorage on the cell membrane.
Enhanced production of SpA in E. coli has been achieved by placing the E. coli lac 
promoter immediately upstream of the spa gene. This has allowed yields as high as 1.5g 
of SpA per litre o f culture to be obtained from 150-litre batch fermenters. Problems 
were encountered during large-scale fermentation, as the recombinant clones were 
found to be extremely fragile when producing high levels of SpA.
Characterisation of the recombinant SpA indicated a molecular weight of 54,000 for the 
full length protein, compared with 56,000 for SpA produced in S. aureus. SDS-PAGE 
analysis of the IgG-binding proteins revealed extensive proteolysis of the recombinant 
SpA. Comparitive analysis of the IgG-binding polypeptides encoded by a truncated spa 
gene (lacking 69 a.a residues from the C-terminus), together with the determination of 
the N-terminal amino acid sequence, indicated that proteolysis occurred at the N- 
terminal portion  o f  the Xc region . Cell fractionation studies and 
immunoelectronmicroscopy localised the SpA to the periplasm in E. coli. A possible 
regulatory control region for the spa gene has been localised upstream of the structural 
gene.
The E.coli alkaline phosphatase gene was isolated, cloned and its sequence determined 
to facilitate the production of SpA-alkaline phosphatase fusion proteins.

1.1 STAPHYLOCOCCUS AUREUS PROTEIN A
1.1.1 Background
Staphylococcus aureus is a Gram-positive, facultatively anaerobic, non-motile 
bacterium of the Micrococcaceae family. The term "staphylococcus" reflects the 
characteristic grouping of the organism in irregular cell clusters (Greek staphyle, bunch 
of grapes), an individual coccus is 0.7 pm - 1.2 pm in diameter. Staphylococci are 
among the hardiest of the non-spore-forming bacteria. They can withstand dehydration 
for many weeks, many strains can survive temperatures as high as 60°C for 30 mins, 
they are more resistant to disinfectants (such as mercuric chloride and phenol) than 
most bacteria and also have a very high salt tolerance. Of the three staphylococcal, 
species S. aureus is the most pathogenic and can cause a wide variety of suppurative 
diseases such as, superficial and deep abscesses, wound infections, septicaemia, 
endocarditis including metastatic abscesses, osteomylitis, pneumonia and emphysema, 
meningitis, and purulent arthritis; it also causes two forms of toxinoses: exfoliative 
skin disease and food poisoning (Davis el al., 1980). Before the advent of antibiotics, 
staphylococcal bacteraemia resulted in an 80% mortality rate ( Sheagren, 1984a). Since 
the 1950s, plasmid coded antibiotic resistance has increased, until now, 60%-90% of 
strains are res is tan t to two or m ore o f the commonly used antibiotics and 
staphylococcal bacteraemia is once again one of the most common nosocomial 
infections (Sheagren 1984a, 1984b).
The Gram-positive cocci were first differentiated by Koch in 1878, and S. aureus as a 
species by Rosenbach in 1884 on the basis of colonial pigmentation (a golden yellow 
colouration, hence the name, "aureus"). In 1940 Verwey, using a serological test 
system to classify different strains developed an extraction procedure which resulted in 
five cellular fractions. Of these fractions, B was found to be highly antigenic, type 
specific and of a protein nature. In 1958 Jensen, classifying organisms using a gel 
precipitation method, found three antigens common to most strains of 5. aureus. Of 
these, antigen A (classified as a polysaccharide) had strong antigenic properties and 
later experiments showed antibodies that reacted with antigen A to be present in normal
human serum, and in several samples of human colostrum and milk (Jensen, 1938a, 
1958b, 1959). Lofkvist and Sjoquist (1962, 1963) and Grov et al., (1964) showed that 
Jensen’s antigen A was a protein, not a polysaccharide, and was in fact identical to the 
major component of Verwey’s fraction B and the name protein A (SpA) was adopted. 
It was Forsgren and Sjoquist (1966) who first concluded that the reactivity of SpA to 
immunoglobulins was unusual in that it was directed against the Fc region of IgG as 
opposed to the normal binding of antigen to the antibody Fab sites.
1.1.2 Occurrence and production of protein A
Since the classification o f SpA as a cell wall protein, several hundred strains of 
staphylococci and related organisms have been tested for the production of SpA 
(review by Langone, 1982a). SpA appears to be restricted almost entirely to S. aureus, 
exceptions being some strains of S.hyicus (Muller eta l., 1981) and S.intermedius 
(Lachia et al., 1979) which also possess some immunoglobulin binding activity. 
Although no direct correlation between the production o f SpA and the degree of 
pathogenicity of S. aureus has been shown to exist in vivo (Jonsson et al., 1985), it has 
been shown to activate the complement system through the classical pathway. This 
may have implications for pathogenesis. It is also reported to cause histamine release, 
inhibit phagocytosis, inhibit antibody dependent cellular cytotoxicity (ADCC) and 
interact with the activation of B and T cells (reviews Langone, 1982b; Forsgren et al., 
1983). However, many of the reported results appear contradictory and may be caused 
by the dissimilar methodologies employed by different investigators. SpA has been 
found in 98.9% of 5. aureus strains known to produce coagulase and DNase, the 
production of which is often correlated to pathogenicity (Forsgren, 1970, 1972). SpA 
has been shown to be produced in varying amounts by 95% of human S. aureus strains 
and 95% of animal S. aureus strains, the only exception being S. aureus isolated from 
bovine chronic mastitis where only 5% were SpA positive (Langone, 1982b). Sjoquist 
et al. (1972a) showed cell-bound SpA to be covalently linked to the peptidoglycan 
chains of the cell wall. Only 5% of the SpA positive strains produce predominantly
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extracellular SpA, the majority of methicillin resistant strains have been shown to 
produce extracellular SpA (Lind, 1972; Winblad and Ericson, 1973; Movitz, 1976 and 
Lindmark et al., 1977). Most of the strains producing cell-wall-bound SpA are also 
found to produce a small amount of extracellular SpA, up to 9% from exponentially 
growing S. aureus Cowan I, though higher yields are seen in the medium of stationary 
cultures. SpA has been shown to be produced during the exponential phase of cell 
growth and rapidly incorporated into the cell wall after synthesis, with production 
ceasing shortly after stationary phase is reached, followed by a significant fall in the 
amount of cell-bound SpA (Movitz, 1974). Therefore, high yields of extracellular SpA 
in predominantly cell-bound SpA strains during stationary phase have been attributed to 
autolysis rather than excretion. Although Forsgren (1969) found that as much as 10% 
of the total SpA was cytoplasmic, other investigators, (Movitz, 1974; 1976; Lindmark 
et al., 1977) found only trace amounts in the cytoplasm (1%). Movitz (1976) showed 
that protoplasts from Cowan I produced the same total amount of SpA as intact 
bacteria, with 1% in the cytoplasm and 97% extracellular and therefore concluded that 
the bacterial cell wall was not necessary for de novo SpA synthesis. On the basis of 
SpA distribution, he also concluded that there may be no cytoplasmic stage involved in 
the production of SpA, i.e., SpA synthesised on membrane-bound ribosomes is direcdy 
incorporated into the cell wall.
1.1.3. Structure of protein A
To examine the structure of SpA it was first necessary to formulate reliable procedures 
for the isolation of the protein in a homogeneous and fully active form. The earliest 
attempts to isolate SpA involved boiling cells in various buffers, followed by 
precipitation with acid o r high salt (Grov et al., 1964; Grov, 1967; Lofkvist and 
Sjoquist, 1962; Forsgren and Sjoquist, 1969). Later attempts relied on enzymatic 
extraction using either lysozyme (Forsgren, 1969; Sjoquist et al., 1972b) or lysostaphin 
(Sjoquist et al., 1972a; Bjorck et al., 1972). However, the majority of extraction 
procedures resulted in preparations exhibiting low SpA activity and which were 
composed of a heterogeneous collection of polypeptides, with molecular weights
3
ranging between 12 and 32 kDa and sedimentation coefficients between 1.26 and 2.6 
(Langone, 1982b). Even with the homogeneous and fully active form of SpA produced 
using a lysostaphin extraction method, it was found that the molecular weight of the 
protein varied according to the determination method used. Thus, SDS-polyacrylamide 
gel electrophoresis gave values of 55 to 56 kDa, whereas chromatography and 
sedimentation techniques gave values of 41 to 42 kDa. The latter set of values are 
generally accepted as correct. This discrepancy in size determination may be caused by 
the unusual configuration of SpA. This was first alluded to by Bjorck (1972) whose 
hydrodynamic studies of SpA, released from Cowan I using lysostaphin, revealed a 
fractional ratio of 2.1 and 2.2 and an intrinsic viscosity of 29 ml/g. These parameters 
were interpreted as indicating an extended shape rather than a typical globular protein. 
Circular dichroism studies by Sjoholm (1975) were consistent with the proposed 
extended shape and indicated an ordered structure composed of 50% right-handed 
helical regions and 10% to 20% (5-structure.
Amino acid analysis of intact Cowan I SpA isolated by lysostaphin treatment, indicated 
that it comprised some 378 amino acids, but contained no tryptophan or cysteine 
residues (Sjoquist et al., 1972b). Further analysis o f lysostaphin isolated Cowan I SpA 
by Movitz (1976) and Lindmark et al. (1977) also showed no tryptophan or cysteine 
residues to be present, however, the total number of amino acids were slightly different, 
381 and 395 respectively.
Sjoquist et al. (1972b) also analysed the precipitation reaction between SpA and human 
IgG. They concluded that one molecule of SpA was able to bind two molecules of IgG, 
and suggested that SpA might consist, in part, of repeating units. The existence of the 
SpAI-IgG2 complex was confirmed by Mota et al. (1978), who went on to suggest, on 
the basis of further precipitation reactions of SpA 1-rabbit IgG2 complex with rabbit 
IgG, sheep erythrocytes and human IgG, that the SpA molecule may contain four 
combining sites with different affinities for IgG. Hjelm et al. (1975) confirmed the
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repetitive structure of SpA, following the amino acid analysis and mapping of purified 
SpA fragments generated by partial tryptic digestion, capable of binding to the Fc 
region of human IgG. Their results suggested the presence of at least three similar 
regions in SpA. A similar series of studies were undertaken by Sjodahl (1976; 1977a; 
1977b). SpA fragments, derived by both lysostaphin and trypsin digestion, were 
purified by affinity chromatography on IgG Sepharose and their amino acid sequence 
determined using manual Edman degradation. On the basis of this data, a model for the 
structure of SpA was proposed, suggesting that the molecule is composed of two 
structurally and functionally different regions, (i) an N-terminal immunoglobulin­
binding region, with a molecular weight of 27 kDa, composed of four consecutive 
units, D, A, B, and C, and; (ii) a C-terminal region which exhibited no immunoglobulin 
binding abilities.
A partial amino acid sequence of the C-terminal region, designated X, revealed that it 
consisted of an octapeptide sequence repeated several times. The inability of trypsin to 
generate region C material when used on intact, rather than on lysostaphin treated cells 
may be explained by the region X being buried in the cell wall, making the trypsin site 
separating region C from region X inaccessible. Amino acid sequence of the N- 
terminal immunoglobulin-binding units showed them to be between 58 to 60 amino 
acids in length with an 80% homology level between the repeat units, as well as internal 
homology within each unit. Sjoquist et al. (1972a) had showed that region D was 
preceded by another region, but a blocked N-terminus made amino acid analysis 
difficult. The subsequent determination of the nucleotide sequence of the N-terminal 
region of the spa gene of strain 8325-4 (Lofdahl et al., 1983) confirmed the presence of 
a coding region 5 ' to that encoding region D. The predicted amino acid sequence of 
the SpA N-terminus was characterised by the presence of an atypically long signal 
peptide, followed by 50 amino acids highly homologous to those of the four previously 
characterised immunoglobulin regions. This new domain was designated region E. 
Lofdahl et al. (1983) also noted the presence of a possible promoter region and 
ribosomal binding sequence upstream of the initiation codon.
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The structure of SpA, in particular the nucleotide sequence, has been further elaborated 
upon within this thesis (strain Cowan I, NCTC8S30) and also in a series of papers 
(strain 8325-4) published during the course of the practical experimentation work and 
writing of this thesis. These papers are discussed in Chapter 3, where comparison of 
the nucleotide sequences is undertaken.
1.1.4 The interaction between protein A and immunoglobulins
The early studies of Forsgren and Sjoquist (1966) had shown that the immune 
interaction between IgG and protein A was non-specific, with the protein A binding to 
the Fc-region of the IgG molecule and not the Fab-region. A more precise localisation 
of the protein A reactivity was subsequendy obtained by Kronvall and Frommel (1970), 
when examination of isolated F(ab’)2» Fab, Fc and Fc’ fragments, along with pepsin 
component II and III (see Figure 1.1), showed the binding site for SpA to be located on 
pepsin component II; this corresponds mainly to the C „2  domain of IgG.
Attempts to further identify the exact region of the Fc fragment involved in the binding 
reaction between IgG and SpA, and the amino acid residues involved have been carried 
out using chemical modification techniques, but with only a limited amount of success. 
Results did, however, suggest that the presence of covalently linked CH2 and CH3 
were necessary for protein A binding (Endrescn and Grov, 1976; Stewart et al., 1978; 
Tarkhanova et al., 1980). X-ray crystallographic investigations carried out by 
Deisenhofer et al. (1978) and Deisenhofer (1981), have defined both the secondary 
structure o f a purified fragment B of protein A and the Fc fragment of IgG and the 
nature of the interaction between these two fragments. The Cpj2 and Cpj3 domains of 
the Fc fragment of IgG consists of 2 layers of anti-parallel ^-pleated sheets, enclosing a 
mainly non-polar interior. The Cjj2 chains are more disordered than the Cjj3 chains as 
they do not form a lateral contact. This dissimilarity between CH2 and Cjj3 gives a 
flexible interface between the two regions.
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Figure 1.1 Diagrammatic representation o f  the structure of human IgGl
This figure was adapted from Edelmann et al., (1969) and shows the different domains of the heavy (H) and light (L) chains; 
the variable  regions (V) and the constant regions (C). The intrachain and interchain disulphide bonds are shown. The 
cleavage sites for the proteolytic enzymes papain and pepsin are indicated; the various peptide fragments produced and their 
nomenclature are marked.
Fragment B of protein A is a small globular protein consisting of three helices which 
form a regular triangular array. There are two antiparallel a  helices consisting of three 
turns each, and a C-terminal helix consisting of two turns, with the remainder of the 
molecule being elongated.
The data of Deisenhofer (1981) indicated two contacts between fragment B and Fc, 
however, it is thought that only one is normally formed under physiological conditions 
and the other is a crystal contact only. The former contact, which is predominantly 
hydrophobic, involves residues from both the N-terminal helices and the Cpj2 and Cjj3 
domains of Fc. Investigations by Mota et al. (1978) and Langone et al. (1978 a&b), 
have shown that a complete protein A molecule, containing IgG binding regions E, A, 
B, C and D, can bind two IgG molecules. More recent studies (Hanson and Schumaker, 
1984; Moks et al., 1986) indicate that IgG is functionally bivalent for SpA, which itself 
is at least tetravalent and possibly even pentavalent. Hanson and Schumaker propose 
that the composition of the IgG-SpA complex varies according to the ratio of IgG and 
SpA molecules present, with an IgG j-SpA j, and IgG2-SpA2 complex being favoured 
at high SpA ratios (4:1 and above) and a IgG4-SpA2 complex being favoured at higher 
IgG to SpA ratio (1.7:1) to (4:1).
In addition to an Fc binding ability, SpA also exhibits a weak reactivity to the Fab 
fragment of many classes of immunoglobulins (Endresen, 1979; Inganas et al., 1980). 
This interaction does not involve the antigen combining site and is also able to act 
independently of the Fc activity of a single IgG-SpA domain (Inganas et al., 1981). It 
has been shown that in order to precipitate SpA, and for complement activation by 
SpA, the IgG involved must have both Fc and Fab reactivities, (Endresen, 1979; 
Inganas and Nilsson, 1981).
The binding specificities o f protein A for the Fc fragment of the different types of 
immunoglobulin and their sub-classes are summarised in Table 1.1. With few 
exceptions SpA reacts strongly with the IgG of almost all mammals. Notable
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TABLE 1.]
Binding Specifities of Protein A to the Fc Fragment of the Immunoglobulin
Species Type of Immunoglobulin Subgroup
Man IgG 1,2.4,
(3 variable)
IgA 2
IgM 2
Rabbit IgG (Soluble complex) •
Mouse IgM (weakly) -
IgG 1 (weakly) 
2a, 2b, 3
Rat IgG 1.2c
Guinea pig IgG 1.2
Cow IgG 2 (weakly)
Sheep IgG 2 (weakly)
Goat IgG 2 (weakly)
Horse IgG a, b, c (T)
Dog IgG
IgA (some) 
IgM (some)
a, b, c, d
Protein A does not bind Avian IgG, though it has been reported to bind to small 
amounts of chicken IgM (3%).
The table was adapted from review articles by Langone (1982a) and Surolia et al., 
(1982).
exceptions are ruminant IgG and subclass 3 of human IgG (Langone, 1982a). The 
failure of most human IgG 3 immunoglobulins to bind to SpA is attributed to the 
presence of an amino acid change at position 435 in the Fc fragment, where arginine 
has been substituted for histidine. When the substitution was included in the models of 
Deisenhofer (1981) it was shown that arginine would considerably affect the normal 
Fc-SpA complex as the arginine side chain could form additional contacts with other 
amino acids of the complex, while its positive charge would also remain unbalanced. 
Such major affects would prevent arginine fitting into the normal Fc-SpA complex. 
Other studies have shown that SpA can bind to certain human IgA’s and IgM’s, Table
1.1 (reviewed by Langone, 1982a). SpA also binds to some IgA and IgM groups in 
some mammalian species.
Initial reports on the binding of SpA to the immunoglobulins of non-mammalian 
species (Kronvall et al., 1970; 1974) indicated that only the serum from two primative 
flightless birds (Rhea americana and Pterocnemia pennata) showed positive reactions. 
No reactions were recorded among Amphibian, Reptilian, Fish or among all other birds 
tested. However, Zikan et al. (1980) reported that small amounts of non-mammalian 
serum IgM of chicken, clawed toad and carp bound to SpA. Subsequent tests on 
purified carp IgM appeared to locate the majority of the binding activity to the Fab 
region. Although protein A has been reported to bind weakly to the Fab fragments of 
some IgG and IgE globulins. These particular IgM and Fab-SpA binding results were 
considered dubious by Langone (1982a) who concluded that the binding seen may have 
been due to Fab antibody activity against SpA.
1.1.5 Uses of protein A
The ability of protein A to bind to immunoglobulins without inhibiting the antigen- 
antibody reaction has resulted in its use in a wide range of analytical and preparative 
immunological techniques, and a more limited number of therapeutic applications 
(reviews: Goding, 1978; Langone, 1982a, 1982b).
1.1.5.1 Analytical and preparative immunological techniques
One of the most significant advances in immunological techniques was the formulation 
by Hjelm el al. (1972) of a reliable, low cost method for purifying immunoglobulins 
from serum and ascites fluid, using affinity chromatography on protein A Sepharose. 
In this simple one step procedure, immunoglobulin can be recovered from the column 
using a variety of techniques including; lowering or raising the pH (Hjelm et al., 1972); 
the use of chaotropic buffers such as KSCN, (Kronvall, 1973), or electrophoretic 
elution (Morgan et al., 1978). The use of SpA-Sepharose columns provides not only 
rapid high performance affinity purification of IgG immunoglobulins per se, but also 
facilitates the isolation of immunoglobulins for the subsequent purification of 
antigens. Furthermore, they may be employed in the analysis of crude biological 
samples for the presence of monoclonal antibodies.
SpA has been labelled with many types of tracer, including radionucleotides, enzymes 
fluorescent probes and metals (Langone, 1982b). Labelled SpA is often used in direct 
binding assays where it replaces the second antibody. Examples of some of the uses of 
labelled SpA are listed below:
(A) The study of surface antigens on intact cells is greatly enhanced by the use of 
labelled SpA as an anti-5 reagent in place of the normal second antibody (anti-receptor 
antibody) (Goding, 1978). Its use avoids the problems of lack of specificity of antisera 
and the non-specific binding of the anti-receptor antibodies to the cells via Fc receptors, 
observed by Warner (1974).
(B) The quantitative determination of antibodies and antigens either on the cell 
surface or in solution, for a wide variety of purposes:
(i) Monitoring the production o f monoclonal antibodies by lymphocyte 
hybridomas. In particular SpA labelled with * ^ I  followed by autoradiography allows 
a rapid and inexpensive screening procedure for several hundred hybridoma cells
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(Brown et al., 1979).
(ii) Evaluation of polyclonal B cell activation by various stimulatory substances 
using the haemolytic plaque assay developed by Gronowicz et al. (1976).
(iii) The detection and quantification of antigens and IgG antibodies on human 
lymphoid cells, following rosette formation between these cells and SpA (labelled with 
glutaraldehyde) coated erythrocytes (Ghetie et al., 1984).
(iv) Labelled SpA either in the form of l^2]p labelled S. aureus or H25]j can 
be used in an assay for the quantitation of circulating immune complexes (CIC). The 
CIC are precipitated from serum using polyethyleneglycol and the washed precipitate 
either incubated with labelled SpA (Stevens and Bridts, 1981) or the CIC precipitated, 
redissolved and absorbed to S. aureus (via SpA receptors) and stimulated by incubation 
with I125]j SpA, (Barkas, 1981). The latter method relies on the availability of 
multiple SpA binding sites. This type of approach will not detect all complexes, but is 
superior to the alternative platelet aggregation test as it can be carried out accurately on 
older serum samples whereas stored platelets do not aggregate.
(C) SpA labelled with a heavy metal tracer (i.e. gold) can be used in conjunction 
with electron microscopy to visualise the localisation of a protein to a particular cellular 
compartment within sectioned cells (Bendayan, 1984; Baron, etal., 1989).
The use of SpA in place of a second antibody offers several advantages; it requires only 
one tracer regardless of the antigen used, non-specific binding is lower, it is as sensitive 
as the classical assay method while having a quicker reaction time, it can be used in 
situations where the conditions necessary to introduce other forms of tracer may prove 
harmful to labile substances, and unlike many second antibodies whose activity is often 
severely affected by the different methods of labelling, SpA retains a high degree of 
functional activity when labelled with a variety o f reagents.
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The utility of SpA as an immunological tool has been considerably enhanced by the 
application of recombinant techniques. Using such technology gene fusions may be 
made composed of DNA encoding SpA and sequences specifying the enzyme 
conjugate to act as the tracer. In vivo translation of the constructed hybrid "gene" by a 
bacterial cell results in a multifunctional chimaeric protein, containing the SpA IgG 
binding regions and the desired enzyme activity. Fusion proteins produced in this 
manner have several advantages over SpA-enzyme conjugates made by chemical 
means. Most notably a gene fusion system will yield a defined conjugate in terms of 
attachment site and molar ratio between carrier and peptide. The loss of enzyme 
activity often associated with the process of chemical conjugation will be avoided. 
Furthermore, when a synthetic peptide is being used as a tracer, it is easier to 
manufacture using oligodeoxynucleotide synthesis (which allows for rapid and efficient 
production of up to 150 bp, 50 a.a) than by peptide synthesis. The latter route relies on 
more complex methodology, which is both time consuming, and often fails as some 
peptide sequences are inherently difficult to synthesise.
The subsequent purification of the recombinant SpA fusion proteins is readily achieved 
in a single affinity chromatographic step by capitalising on the IgG binding properties 
of the SpA moiety (Uhlen et al., 1984a). For some immunological procedures, such as 
acting as an antigen for antibody generation the eluted fusion protein is suitable for 
immediate use. Further processing may be required for direct structural or functional 
studies. In the former case, the SpA region does not interfere with the immune 
response. Indeed, Lowenadler et al. (1986; 1987), describes a novel method for 
obtaining specific antibodies against short peptides in which the repetitive structure of 
SpA acted as an adjuvant enhancing the immune response against the attached short 
peptide. The system described by Lowenadler et al. (1986; 1987) has also been used to 
express longer synthetic genes from which antibodies were successfully prepared. This 
should allow for the development of antibodies directed against both linear and 
discontinuous epitopes, the latter accounting for a substantial fraction of the antibodies 
produced against a variety of native proteins (Berzofsky, 1985). It should also be noted
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that the SpA- fusion protein used to induce the production of polyclonal and monoclonal 
antibodies can also be used for the screening of the resulting hybridoma (Valerie et al., 
1987).
The use of the purified fusion protein in structural and functional studies often requires 
the separation of the SpA affinity tail from the protein of interest. This separation can 
be achieved by introducing a specific chemical o r enzymatic cleavage site at the 
junction between the two proteins. Nilsson et al. (1985b), used such a system to 
facilitate the production and purification of native human insulin-like growth factor 
(IGF-1). A synthetic IGF-1 gene was fused to SpA and then, using site directed 
mutagenesis, an acid labile Asp-Pro cleavage site introduced at the fusion point. 
Following recombinant production, the fusion protein was eluted from an affinity 
column and treated with 70% formic acid to cleave the Asp-Pro peptide bond. The 
mixture of the two cleaved proteins was then passed through another affinity column, 
where the SpA portion of the fusion and the non-cleaved materials bound to the IgG 
ligand and were retained, leaving the desired protein to be collected in the eluate.
To further enhance the use of spa in gene fusions a number of protein fusion vectors 
have been developed by Nilsson et al. (1985a, 1985b). These vectors contain DNA 
encoding the IgG binding region of SpA followed by a multiple cloning site containing 
5 unique restriction sites for insertion of a foreign gene, allowing for rapid construction 
of the required gene fusion.
1.1.5.2 Therapeutic applications
The anti-tumour effects of some Gram-positive microorganism extracts were reported 
as early as 1906 (Coley, 1906). In more recent years it was observed that after surgery 
to remove lung cancer, patients who had a staphylococcal emphysema had a better 
survival rate than those who had an uncomplicated post-surgical period (Ruckdeschel et 
al., 1972, Takita, 1970). A potential role for SpA became more apparent when it was
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demonstrated that circulating immunoglobulins appeared to act as blocking factors, 
inhibiting cell-mediated cytotoxicity against tumour cells (Baldwin et al., 1973; 
Hellstrom et al., 1969; Hellstrom and Hellstrom, 1970; Sjorgren et a l., 1971). 
Circulating immunoglobulin was also found in abnormally high levels in patients with 
acute immune diseases (Jones et al., 1986; Steel et al., 1974). Therefore, SpA appeared 
a logical host reagent for removing immune complexes from tumour-bearing serum by 
affinity binding extracorporeally, allowing the later return of the plasma to the patient. 
The only other method of removing the circulating immune complexes would be the 
removal of the plasma, followed by return of donor plasma, with the associated risk of 
contaminated blood products, or the use of a plasma replacement solution of albumin 
and saline, which lacks essential plasma components. The fact that SpA has been 
shown to have a higher affinity for immunocomplexes than for free IgG allows for 
removal of the damaging immunocomplexes while allowing the plasma to retain a 
reasonable level of free IgG (Kessler, 1975). However, it soon became apparent that 
the immunological consequences of plasma therapy were far more complex, with many 
researchers noting the occurrence of tumour regression following the passage of plasma 
volumes too small to achieve significant blocking factor removal (reviews: Fer and 
Oldham, 1985; Mackintosh et al., 1985; Jones et al., 1986 and Solal-Celigny, 1985). 
Romagnani et al. (1980), observed that serum CIC levels showed a similar decrease in 
dogs with mammary carcinoma (in both those exhibiting tumour regression and those 
not). Therefore, the removal of a significant portion of circulating CICS did not appear 
to be essential for tumouricidal effects; although there was no doubt that perfusion of 
patient serum over protein A bearing S. aureus, and over purified SpA, resulted in 
clinically significant responses. The possibility of direct activation of hormonal 
antitumour effects through SpA interactions with sera from tumour bearing animals was 
suggested by Steele etal. (1974). Further experiments then ensued, which although 
supporting the activation of hormonal antitumour effects, cast doubt on the role of SpA 
in the interaction. These often contradict one another. For instance in in vitro 
experiments with SpA treated plasma used against acute myeloid leukeamia blast cells 
(AML), it has been shown that (i) the plasma must come from AML patients to obtain
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cytotoxicity and (ii) the treated sera is non-toxic to normal cells and that SAW (S. 
aureus, Wood 46) not bearing SpA did not induce toxicity (Miller et al., 1982). 
However, in in vivo studies on dogs undertaken by Gordon et al. (1983) on canine 
spontaneous tumour systems, it was shown that perfusion of plasma over SpA 
producing S. aureus cells, or over non-SpA bearing SAW, was equaily effective in 
causing regression of tumours in 6 out of 9 dogs. If SpA is the active agent, direct 
infusion might elicit similar tumouricidal effects. While such cases have been reported 
(Ray and Bandyopadhyay, 1983) using relatively pure SpA, a series of animal studies 
by Cohen et al., (1984) showed no tumouricidal effects and it is generally accepted that 
the interaction of SpA with plasma in vivo results in no antitumour effects.
The role of SpA has been further questioned by the work of Sukumar et al. (1984). In 
these experiments, rats treated with plasma which had been exposed to inactivated 
CNBr-Sepharose showed comparable reductions in tumour size to those treated with 
plasma exposed to SpA covalently linked to Sepharose. This suggested that the 
presence of SpA may not be the critical factor. Further clinical studies (reviewed by 
Fer and Oldham, 1985) to duplicate the very effective anti-cancer treatment using SpA 
described by Terman et al. (1981), have failed to elicit such dramatic results, even 
when an identical materials and methods procedure was followed (Fer et al., 1984). 
The only difference that could be traced was that the method used to produce the SpA 
by Pharmacia (supplied in both studies) had been modified to increase the yield and 
purity. This led to the suggestion (Fer et al., 1984) that other bioactive staphylococcal 
products may have previously co-purificd with protein A, and that these had been 
eliminated in the later Pharmacia product.
The rple o f SpA in perfusion systems is, therefore, controversial with some 
experimenters indicating that perhaps another component from S. aureus is the active 
factor, while others go even further and suggest that no bacterial product is necessary 
for the tumouricidal effects seen. The only common denominator necessary for tumour
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regression in all the studies being the need for plasmaphoresis of tumour-bearer plasma. 
Fer and Oldham (1985) have suggested that perhaps a broad range of materials may 
trigger certain mechanisms mediated by a plasma factor, and that it is only through a 
series of detailed and systematic studies that the role of plasma immunoadsorption, and 
thus the role of SpA in cancer therapy, if any, will become apparent.
Although the direct treatment of cancer using SpA may not be effective, SpA 
plasmaphoresis can still be a vital part of cancer therapy. SpA can be used to counter 
some of the side effects associated with some standard chemotherapy treatments; such a 
use is reported by Zimmerman et al., (1982) for the treatment of a tumour associated 
syndrome similar to thrombotic thrombocytopenic purpura. This syndrome arose 
following a rapid response in a patient treated with the chemotherapeutic drugs, 
fluorouracil, doxorubicin and mitomycin. It was hypothesised that as a tumour is 
reduced by chemotherapy the pre-existing state of antigen excess decreases, allowing 
the formation of soluble antigen-antibody complexes. These complexes induce the 
release of platelet substances which have the potential to initiate intramuscular 
coagulation and, because they accumulate in the blood vessels, cause local vascular 
injury, as well as initiating the deposition of platelets and fibrin, leading to the above 
syndrome. Plasmaphoresis was used in 5 treatment stages to reduce the CIC level of 
324 mg I '1 to within the normal range of 10 to 65 mg 1'1. This particular use for SpA 
may become more common as more effective chemotherapeutic drugs with greater 
potency are developed and a rapid response by the patient becomes a more common 
occurrence.
Plasmaphoresis using SpA-Sepharose can also be used as a procedure for removing 
high titre antibodies in short term therapeutic procedures. An example of such a case, 
where the role of SpA-Sepharose was vital, has been reported by Nilsson et al. (1981). 
A haemophiliac with a high titre of factor IX antibody required surgery for an invasive 
pseudotumour into the base of his left elbow. Exchange plasmaphoresis was not 
feasible because of the possibility of stimulating factor IX inhibitor, and the fact that
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the patient had antibodies against tissue antigens. It was not possible to neutralise the 
anti-factor IX antibodies using a factor IX concentrate, as the commercially available 
products contain small amounts of activated coagulation products, which in the amount 
necessary to treat the above case could have lead to intravascular coagulation. 
Treatment of 6000 ml of the patients plasma to remove antibodies by extracorporeal 
adsorption of the plasma to SpA-Sepharose, followed by transfusion, decreased the 
antibody titer and total immunoglobulin content to 20% of the original values. This 
allowed the remaining antibodies to be neutralised by infusion of factor IX concentrate. 
Conventional substitution therapy, combined with immunosuppression to prevent 
further antibody synthesis, was then given. This procedure allowed the operadon to be 
performed without further complications.
1.2 Choice of Host System for High-Level Expression of SpA
Recent developments in biological science dependent on the IgG binding properties of 
purified SpA or SpA-fusions have, of necessity, increased the requirement for the 
amount of purified SpA and SpA-fusion products. The normal method of protein A 
production and purification from a SpA producing strain of S. aureus becomes a 
limiting factor both in terms of safety and the complexity of the recovery process. As 
S. aureus is pathogenic and produces several endotoxins, large batch cultures must be 
grown and harvested under strict safety conditions. These rules also apply to S. aureus 
Cowan I, considered one of the least pathogenic strains of S. aureus. Recovery of SpA 
from S. aureus requires the use of lysostaphin to release the SpA from the Gram­
positive cell wall, where it is covalently linked to the peptidoglyan structure. In S. 
aureus strain Cowan I expression of the chromosomally located spa gene results in the 
production of SpA at a level of 1.7% dry weight of the bacteria (Sjoquist et al., 1972b).
Primarily, S. aureus is not suitable for large scale production of protein A on grounds of 
pathogenicity. An alternative host combined with a suitable plasmid vector system
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offers greater potential for increasing the production of SpA. The relative merits of 
using either a Gram-negative or Gram-positive bacterium as a host will be considered 
in the next two sections.
1.2.1 Gram Positive Host
The two Gram-positive bacteria considered as possible hosts for the expression of the 
SpA gene were; (i) a non-pathogenic staphylococcal species such as Staphylococcus 
xylosus, which is normally located on the human skin (Schleifer and Kloos, 1975; 
Uhlen et al., 1984b), or, (ii) Bacillus subtilis, a non-pathogenic, aerobic, soil bacterium, 
which is often grown in large scale fermentations in order to isolate one of the 30 
natural exo-proteins and is well documented (reviews Priest, 1977; Henner and Hoch, 
1980 and Young, 1980).
1.2.1.1 The potential of a staphylococcal host
The main advantage in using a staphylococcal host such as S. xylosus is the high chance 
of recognition of the spa gene transcription and translation regulation sequences and 
correct processing of the SpA polypeptide to yield an authentic native protein. There 
are several disadvantages in using S. xylosus. Of the few staphylococcal plasmids that 
are well characterised, none were isolated from S. xylosus. Any recombinant plasmid 
studies undertaken on staphylococcal species requires the use of a protoplast 
transform ation system  (Gotz e t al., 1981); inherently more d ifficult than the 
transformation system used in Gram-negative E. coli. There is also the possibility that 
S. xylosus may contain a gene regulation mechanism that will limit the production of 
SpA. Uhlen et al. (1984b) demonstrated that S. xylosus did not produce a protein A 
type protein. It is thought unlikely to carry a gene encoding SpA, as although SpA 
proteins have been reported for other staphylococcal species, these have been coagulase 
positive species such  as Staphylococcus hyicus (M uller et a l., 1981) and 
Staphylococcus intermedius (Lachia etal., 1979). No coagulase negative Staphylococci
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have been reported to produce IgG binding proteins, though they have been shown to 
produce other serum precipitating proteins (Langone, 1982a and Osland, 1981). 
However, S. aureus Wood 46, a strain thought not to produce SpA, has been shown to 
contain an spa gene within its chromosome whose transcription appears to be 
completely repressed (C. Duggleby, personal communication); Uhlen et al., 1984b). 
Uhlen et al. (1984b) have also shown that the expression o f the plasmid encoded 
protein A gene in various strains o f S. aureus is strongly correlated to the expression of 
the chromosomal spa gene, and that plasmid encoded spa when expressed in a 
staphylococcal coagulase-negative species is severely limited, producing only 12 to 
30% of the SpA coded for by the same gene when chromosomally located in S. aureus 
strains Cowan I and A676.
Therefore, it would seem unlikely that any non-pathogenic species of staphyloccoci 
would prove a suitable host for an expression vector capable of producing large 
amounts of SpA.
1.2.1.2 The use of Bacillus subtilis as the recombinant host
B. subtilis has a wide variety of well characterised and well used cloning vectors, the 
majority of which have been derived from S. aureus plasmids (Ehrlich et al., 1982, 
Gryczan, 1982). B. subtilis also has the ability to export many proteins to the exterior of 
the cell (Priest, 1977). B. subtilis shows a low bias in codon usage similar to that of 
S. aureus. Being Gram-positive it will have a similar cell wall structure to S. aureus, this 
may facilitate the correct localisation of a normally exported S. aureus gene product. 
Several S. aureus genes have been cloned into B. subtilis and expressed with varying 
degrees of success, indicating that B. subtilis, is able to correctly recognise some 
S. aureus secretion signals i.e. S. aureus a-haemolysin is correctly exported to the cell 
supernatant (Fairweather et al., 1983). The S. aureus gene encoding ^-lactamase has 
been successfully expressed when integrated into the B. subtilis chromosome (1% total 
cell protein). However, the P-lactamase produced was found to be cell-associated
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rather than secreted to the cell exterior as expected (Saunders et al., 1984).
A major problem with using B. subtilis for genetic manipulation is that many of the 
plasmids, in particular high copy number plasmids and recombinant plasmids, are 
extremely unstable when in B. subtilis. Two types of instability have been recognised 
firstly, segregational instability, which means, the loss o f the entire plasmid from the 
host cell (Kreft et al., 1982; Yoshimura et al., 1983). Secondly, structural instability, 
which involves rearrangement of plasmid sequences frequently involving the formation 
of deletions (Gryczan and Dubnau, 1978; Kreft et al., 1982). Some genes that could 
not be established on multicopy number plasmids in B. subtilis have been effectively 
expressed when integrated into the B. subtilis chromosome (Saunders et al., 1984). 
However, such strains will only carry a single copy o f the gene and the levels of 
heterologous protein produced may for this reason, be severely limited.
Subsequent parallel studies in this laboratory which attempted to introduce the spa gene 
intofl. subtilis using multicopy number plasmids based on the B. subtilis replicons 
pUBl 10 and pC194 (Ehrlich et al., 1982) failed to yield a stable transformant that 
expressed SpA (L.E. Clarke, personal communication). Further investigations revealed 
that major deletions and rearrangements of the spa sequence encompassing the 
promoter region and domains E, A and D of the IgG binding regions had occurred. 
Subsequent results published by Fahnestock et al. (1986a) showed that stable 
transformants carrying the entire spa gene could be obtained by integration of spa into 
the chromosome. However, using a multicopy plasmid system based on either the 
pUBl 10 or the pC194 replicon Fahnestock et al. (1986a) reported a similar lack of 
success in cloning the entire spa gene, but showed that the coding sequence of the 
native protein could be stably maintained as a pUBl 10 based plasmid providing the spa 
expression signals were replaced by an expression signal less active during growth. In 
this particular case Fahnestock et al. (1986a) rep laced  the spa promoter and 
translational start codon with the promoter region from a Bacillus amyloliquefaciens a- 
amylase gene. A similar plasmid stability problem was encountered by Saunders et al..
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(1984), when trying to express the S. aureus gene coding for P-lactamase in B.subitilis. 
The presence of the bla promoter, coding region for the signal sequence and first few 
a.a. of the native protein, destabilised a pC194 based shuttle vector which had 
previously been stable in B. subtilis. Therefore, it would appear that as well as the 
general stability problems encountered using recombinant plasmids in B. subtilis, the 
promoter regions of S. aureus genes may be incompatable with the S. aureus/B. subtilis 
shuttle vector system s currently used, by virtue o f their ability  to  cause an 
overproduction of the heterologous protein to an extent which is deleterious to the host 
organism.
It has since been established that the problems of structural and segregational 
instability often observed when using B. subtilis as a recombinant host were largely due 
to the type of plasmid employed in vector construction. The plasmids most frequently 
used were the small, staphylococcal antibiotic resistance plasmids which replicate by a 
rolling circle mechanism. A characteristic feature of this mode of replication is that it is 
easily perturbed. It follows that alterations to plasmid integrity (i.e., during vector 
construction or insertion of cloned DNA), or the use of plasmids in an alternative host, 
frequently leads to structural or segregational instability (see Gruss and Ehrlich, 1989).
Use of an alternative plasmid which does not replicate by a rolling circle mechanism, 
e .g ., pIP404 and pAM fil is now available, pAM|$l which replicates using a 
unidirectional theta mechanism, has been experimentally shown to result in 1000-fold 
greater structural stability in B. subtilis over a ss DNA (pC194) control (Janniere et al., 
1990).
1.2.2 Gram-Negative Host
One of the major considerations when deciding on an alternative host system for 
expression of a particular gene is the probability that the transcription and translation 
regulation regions of the heterologous gene are recognised by the new host. This
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concern increases the higher the degree of diversity between the two systems. Thus, a 
gene from a Gram-positive organism is less likely to be correctly expressed in a Gram­
negative host than in another Gram-positive host. In general, it has been shown that 
genes from Gram-positive bacteria are more likely to be successfully expressed in a 
Gram-negative bacterium than vice versa. It is thought that the RNA polymerase 
enzymes of Gram-positive bacteria are more stringent in their requirements for 
promoter recognition than those of E. coli. A barrier to gene expression also exists at 
the translational level. Thus Gram-positive genes, and in particular B. subtilis, have 
shown a requirement for a more extensive degree of homology between the mRNA 
Shine-Delgamo sequence and the 3' end of the 16s rRNA than that required by E. coli 
(Murray and Rabinowitz, 1982). It is, however, known that the spa gene from S. 
aureus Cowan I is expressed in E. coli and produces a functional protein, as the initial 
detection of the cloned spa gene from an E. coli host relied upon the production of a 
protein exhibiting IgG binding activity (Duggleby and Jones, 1983). The levels of 
functional SpA produced in E. coli (0.2% total protein) were 10-fold less than those 
produced by the chromosomally located spa gene in S. aureus Cowan I, despite being 
located on pBR328 (a multicopy plasmid derived from pBR322). This may be caused 
by a number of factors, including the poor recognition of the spa transcription or 
translational regulatory sequences, or may result from the incorrect processing of the 
SpA polypeptide, yielding a high proportion of inactive SpA.
The use of E. coli for expression of heterologous proteins is popular because of the ease 
with which the genome can be manipulated. The wide range of E. coli host strains and 
plasmid vectors available allows a high degree of control over factors such as plasmid 
stability, the production of some proteases, plasmid copy number, promoter efficiency 
and regulation, translation initiation strength, selection of marker for plasmid 
propagation and maintenance, and a w ell characterised origin of replication. 
Transformation of E. coli is highly efficient and relatively simple to perform, while 
other laboratory techniques used in the manipulation of recombinant DNA in E. coli are 
well documented (Maniatis et al„ 1982, Rodriguez and Tait, 1983 and Walker, 1984).
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Therefore, E. coli may prove a highly suitable host for the generation of SpA in order to 
study the properties of the gene, as it allows the easy manipulation of the various 
structural and regulatory regions of that gene.
A problem that is likely to be encountered in using E. coli as a host for SpA production, 
is the final cellular location of the heterologous protein. The cell wall of E. coli, a 
Gram-negative bacterium, is substantially different to that of a Gram-positive bacterium 
such as S. aureus, (Figure 1.2). In Gram-positive bacteria, proteins are located in the 
cytoplasm, in or on the cytoplasmic membrane or exported to the growth medium, 
whereas in Gram-negative bacteria, proteins can also be localised to the periplasmic 
space or to the inner or outer membrane. This difference in cell wall structure is 
reflected by the fact that E. coli in common with most enterobacteria excrete very few 
proteins to the exterior of the cell. Those that are fully exported are mainly toxins: 
(e.g., haemolysin, enterotoxins and bacteriocins such as colicin) and do not appear to 
rely on a common pathway for transport across the outer membrane. As is shown in the 
summary below, each of the above toxins utilises a different mode of exit from the cell. 
The heamolysin determinant consists of four genes, hlyC, hlyA, hlyB and hlyD of 
which only hlyA codes for the heamolysin protein, with the export being dependent on 
the products of hlyB and hlyD. These helper proteins are believed to interact with the 
C-terminus o f the hlyA  protein, allowing ATP-dependent transport through a 
transenvelope channel (Felmlee et at., 1985a and b; Mackman et al„ 1985). There are 
two E. coli enterotoxins. The heat stable enterotoxin is a monomer, and secretion is 
thought to be dependent on the small size (5 kDa) of the molecule. The heat labile 
toxin is a multimeric complex composed of an A subunit and five B subunits. The A 
subunit requires the presence of the B subunit for release (Yamamoto and Yokota, 
1982), which is thought to be facilitated by the conditions of low pH, low oxygen and 
bile salts present in the intestine (Hirst et al., 1984). Colicins are encoded on naturally 
occurring plasmids, which generally encode a lysis protein required for colicin release.
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a) Gram-positive cell envelope
b) Gram-negative cell envelope
Exported proteins
Figure 1.2 Schematic represen tat ion of the cell envelope of a typical Gram-negative and Gram-positi ve bacteria, 
showing the localisation of proteins
LPS: lipopolysaccharide chain. SP: surface proteins, consisting of additional surface layers such as protein matrices and 
capsules; and surface appendages such as fimbriae, pili and flagellae. AD: adhesion zone: an alternative route for secretion of 
proteins via a transenvelope structure rather than through the periplasm (Bayer, el a!., 1982).
This type of release is not considered to be true secretion as it is nonspecific and causes 
envelope damage by activating a phospholipase, resulting in the release of free fatty 
acids and alteration in outer membrane permeability (Pugsley and Schwartz, 1984).
In contrast to the above examples, transport across the E. coli cytoplasmic membrane of 
most E. coli proteins follows the "general" secretion pathway involving the sec genes 
and the presence of a signal sequence at the N-terminus of the polypeptide, as described 
in Section 3.3.3. In general terms the periplasmic export of proteins in E. coli and the 
secretion to the growth medium of proteins by Gram-positive bacteria are considered an 
almost identical process, requiring similar transportation signals. Therefore, any signal 
sequence present in the SpA polypeptide which would normally allow secretion to the 
cell wall or growth medium in S. aureus, even if recognised in E. coli may only allow 
the transport of the SpA polypeptide across the inner membrane to the periplasmic 
space. The final cellular location in E. coli of a heterologous protein normally found in 
the cell membrane or secreted to the growth medium of a Gram-positive organism 
appears to vary according to the individual protein expressed. Thus the a-amylase gene 
from Bacillus coagulans encodes for an exoprotein in its natural host, however, when 
expressed in E. coli the protein is secreted to the periplasmic space (Cornelis et al., 
1982). In contrast, Sarvas and Palva (1983) reported the export of the penicillinase 
encoded by the Bacillus licheniformis penicillinase (penP) gene to the outer membrane 
fraction o f E. coli. Here it is present as an amphiphilic protein with properties 
indistinguishable from those of the B.licheniformis membrane penicillinase, however, 
E. coli appears to lack the proteolytic enzymes necessary to cleave the membrane- 
bound lipoprotein form of the penicillinase to give the soluble exopencillinase found in 
the natural host.
The cellular location of a heterologous protein produced by E. coli can dramatically 
affect the final levels of protein recovered from a cell culture, both quantitatively and 
qualitatively. It has been shown to have a direct affect on the ratio of active to inactive 
forms of the protein, the degradation rate, the ease of final recovery of the product and
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finally on the growth rate and viability of the host organism itself. A protein that is 
normally located outside of the cytoplasm in its natural host, if  retained in the 
cytoplasm when expressed in a heterologous host such as E. coli, will often have little or 
none of the normal enzymatic activity. This is thought to be due to the incorrect 
folding of the protein brought about by the reducing environment of the cytoplasm. A 
high degradation rate is often seen for non-cytoplasmic proteins retained in the 
cytoplasm. This may be caused by a combination of two factors, the heterologous 
protein may not possess N- and C-terminal sequences resistant to the action of 
cytoplasmic proteases and the fact that there are a greater number of proteolytic 
enzymes present in the cytoplasm than in the rest of the cell. Eight separate soluble 
proteolytic acitvities have been reported in E. coli (Swamy and Goldberg, 1981). Five 
were located in the cytoplasm, two in the periplasm and one distributed evenly between 
the two compartments. Talmadge and Gilbert, (1982) have shown dissimilar rates of 
degradation for a hybrid proinsulin molecule when located in different cellular 
compartments. When secreted to the periplasm, the hybrid protein exhibited a 10-fold 
longer survival time than that remaining in the cytoplasm. Synthesis of high levels of 
some recombinant proteins in E. coli have resulted in the production of intracellular 
inclusion bodies (Klier et al., 1982; Weis et al., 1983; Williams et a!., 1982; 
Schoemaker, et al. 1985). The sequestering of the heterologous protein into dense 
insoluble inclusion bodies has been reported to protect a high percentage of the protein 
against proteolysis (Weis et al., 1983; Kleid et al., 1981; Cheng et al., 1981). Inclusion 
bodies can be advantageous in increasing the level of recovery of the protein by making 
the isolation and purification stages easier. However although some inclusion bodies 
are easily solubilised to yield large amounts of conformationally correct protein that 
retain their enzymatic activity, it is more common for the inclusion bodies to be 
composed of aggregates of the protein which are very difficult to solubilise and purify. 
Schoemaker et al. (1985) showed that in the case of recombinant prochymosin, 
aggregation was caused by the interlinkage of intermolecular disulphide bonds to form 
protein multimers. Though disulphide bonds are usually unable to form in the
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cytoplasm, it is suggested that they may be able to exist in an inclusion body, as the 
molecules are very closely packed and are therefore more likely to react with one 
another and as such are protected from the reducing environment of the cytoplasm. The 
presence of cysteine residues, and thus the potential for disulphide linkages, is a 
common feature in proteins seen to accumulate as inclusion bodies when present in high 
concentrations.
Secretion to the periplasm or outer membrane of E. coli would appear the preferable 
location for non-cytoplasmic heterologous proteins, in terms of reducing degradation 
and encouraging the correct post translational processing and final protein 
conformation while avoiding the formation of inclusion bodies. However, Emr et al. 
(1978; 1980) have reported that at high levels of protein production, secretion of the 
protein to the periplasm can be highly toxic to the cell, resulting in either reduced 
growth or cell lysis. In these studies cell lysis was brought about by the production of 
large amounts of a lamB -lacZ hybrid protein and the cells inability to efficiently export 
the hybrid protein to the periplasm, resulting in a lethal jamming of the normal cellular 
protein export machinery. Similar results were obtained by Rose and Shafferman 
(1981) when expressing the vesicular stomatitis glycoprotein. In this case cellular 
lethality was prevented by removing the hydrophobic core region of the signal 
sequence thereby almost certainly preventing its insertion into the cytoplasmic 
membrane. Brosius, (1984) revealed similar results when expressing a hybrid rat insulin 
gene, but also reported detrimental effects to the cell of a non-excreted form of the rat 
insulin gene when fused to an extremely strong promoter (rrnB). These latter 
observations indicate that other, more specific, effects may contribute to cellular 
lethality in individual gene cases. In such circumstances the formation of cytoplasmic 
inclusion bodies may serve to protect the host cell against the toxic effects of 
overproduction (Weis et al. 1983).
Despite there being problems of poor efficiency, poor yields and toxicity to cells when 
expressing a heterologous protein in E. coli these are only potential problems and might
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not arise in the case of SpA. Even if one or more were found to be rate limiting factors, 
the versatility that is possible using different E. coli hosts and plasmid systems would 
offer a greater chance of dealing with such a problem, than if it was found to occur in 
the less well understood Gram-positive systems that are currently available. Therefore 
E. coli was selected as the preliminary host for the development of a high expression 
system for SpA.
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1.3 AIMS AND RESEARCH OBJECTIVES
The primary aims of the project undertaken during the course of this PhD thesis was to 
determine the nucleotide sequence of the S. aureus Cowan I protein A gene and its 
surrounding regulatory regions. Once established it was anticipated that knowledge of 
the nucleotide sequence would facilitate the development of other areas of the project 
such as: i. a study of the efficiency of Grarn-positive gene regulatory signals in E. coir, 
ii. the cloning of the spa gene, to enable the high expression of SpA; and SpA-fusion 
proteins in a non-pathogenic host for commercial exploitation; iii. the performance of 
theoretical studies on the predicted a.a sequences and secondary structure of the 
encoded protein.
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2.1 MATERIALS
2.1.1 Chemicals and Materials
Except where stated below, all chemicals were purchased from BDH Chemicals Ltd., 
Poole, Dorset, and were of analytical reagent grade (AnalaR) wherever possible.
Amersham International, Bucks, England
[>.32p] ¿ATP (50% ethanol), [a -^ S ]  thio-dATP, Na*^Iodine. Protein molecular 
weight size markers [a-^2P] dATP (aqueous), [14C] methylated protein mixture.
Anderman & Co., East Molesley, Surrey, England.
Nitrocellulose sheets, nitrocellulose filter discs, manufactured by Schleicher & Schull.
Bethesda Research Laboratories (BRL/GIBCO), Paisley, Scotland
The following chemicals were ’ultra pure’ grade where possible. Urea, caesium 
chloride, agarose, ammonium persulphate, formamide, isopropyl thio-fi-galactoside 
(IPTG), phenol, tetramethylethylenediamine (TEMED), Lambda DNA, new bom calf 
serum.
Biorad Laboratories, Caxton Way, Watford, Herts
Acrylamide, methylene-bis acrylamide.
Difco Laboratories, West Molesley, Surrey, England.
Tryptone, yeast extract, agar.
ICN Biomedicals Ltd, High Wycombe, Bucks
Gelbond
May and Baker Ltd.
Glycerol, diethyl ether.
Biocell Ltd, Cardiff, Wales
Goat anti-rabbit labelled with gold.
Pharmacia (LKB) Ltd, Milton Keynes, England.
Sephadex G25 columns (PD-10), Sephadex G50 Protein A.
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Sigma Chemical Company (UK) Ltd., Poole, Dorset,England
Ethidium bromide, ampicillin, chloramphenicol, tetracycline, bromophenol Blue, 
xylene cyanol, orange G, ficoll, adenosine 5 * -triphosphate (ATP), DL-dithiothreitol 
(DTT), 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (BCIG/X-gal), isoamyl 
alcohol , dimethylformamide (DMF), polyethylene glycol (PEG; Mr 6000), sodium 
deoxycholate, polyvinylpyrrolidone, bovine serum albumin (BSA pentax fraction V), 
human IgG, salmon sperm DNA, thiamine, Triton X-100, Coomassie Brilliant Blue 
R250, polyoxyethylene 20 cetyl ether (Brij 58), nitrophenyl phosphate.
2.1.2 Enzymes
Boehringer Mannheim (BCL), Lewes, Sussex, U.K.
Calf intestinal alkaline phosphatase, T4 DNA polymerase, Klenow DNA polymerase I, 
Proteinase K, RNase T l, DNasel.
Bethesda Research Laboratories (BRL/GIBCO), Paisley, U.K.
All restriction endonucleases, T4 polynucleotide ligase, T4 polynucleotide kinase.
Sigma Chemical Co.Ltd.,Poole,U.K.
Lysozyme (Grade I), Lysostaphin
2.1.3 Media
All media listed below were prepared in double distilled, de-ionised water and 
autoclaved at 15 p.s.i. (121°C) for 15 min unless otherwise stated.
2.1.3.1. Routine Growth Media
L-broth. This medium was routinely used for the cultivation o f E.coli during the 
protein A project.
The pH was adjusted to 7.4 using 1M NaOH. For solid m edia (L-agar) 2% 
(w/v/purified agar was added).
2xYT Broth: This media was routinely used for the cultivation of E. coli during the 
alkaline phosphatase project and for the growth of phage containing E.coli JM101.
Bacto-tryptone 
Yeast extract 
NaCl
10.0
5.0
5.0
29
Bacto-tryptone 
Bacto-yeast extract 
NaCl
g l 1
16.0
10.0
10.0
The pH was adjusted to 7.4 using 1 M NaOH. For solid media (2xYT agar), 2% (w/v) 
purified agar was added.
Low phosphate broth (LP)
g l'1
Tris base 14.54
NaCl 4.68
KQ 1.49
NH4CI 1.07
Na2S04 0.97
MgCl2 0.203
CaCl2 0.0294
ZnCl2 0.0003
The pH was adjusted to 7.5 with 1M NaOH. For solid media LPB-agar, 1.5% (w/v) 
purified agar was added prior to autoclaving. Before use, the following supplements 
were added:
Final
Concentration
Bactopeptone 5% autoclaved separately
Casamino acids 0.05% autoclaved separately
Thiamine 20pg/ml (filter sterilised)
Glucose 0.2% (filter sterilised)
Ampicillin 50pg/ml (filter sterilised)
H-Top Agar: This medium was used for the soft agar overlays in the cultivation of 
M13 phage plaques.
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NaCl
Agar
g l 1
8.0
8.0
The pH was adjusted to 7.4 with 1 M NaOH.
M9 Salts (lOx stock): This defined minimal medium was used for the cultivation of E. 
coli JM83 [SpA]
g l 1
Na2HP04 300
k h 2po 4 150
NaCl 25
n h 4ci 150
The pH was adjusted to 7.4 with 10 M NaOH, and the mixture autoclaved. A volume 
of 20 ml of this lOx stock was added to 180 ml molten (50°C) agar/water 2% (w/v) 
prior to the addition of the following constituents:
1 ml 100 mM MgS04 (autoclaved separately)
1 ml 10 mM CaC^ (autoclaved separately)
2 ml 20% (w/v) Glucose (filter sterilised)
2.1.3.2. Antibiotics
Antibiotics were incorporated at appropriate concentrations in both solid and liquid 
media for the selection of resistant bacterial clones.
Ampicillin
Stock solution: 10 mg ml'1 of the sodium salt of ampicillin in distilled water. This was 
sterilised by filtration (0.22 pm Millipore disposable filter) and stored at -20°C.
Working concentration: 50pg m l'1.
Chloramphenicol
Stock solution: 5 mg m l'1 in 100% ethanol (v/v). This was stored at -20°C.
Working concentration for selection of resistant bacteria: 30 pg m l'1, for amplification 
of plasmids: 170pg m l'1.
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Tetracycline
Stock solution 5 mg m l '1 of tetracycline hydrochloride in ethanol/water (50% v/v). 
This was stored at -20°C in the dark.
Working concentration: ^ .S pgm r1.
2.1.4 Buffers and Solutions
All solutions listed below were prepared in deionised, double distilled water and 
autoclaved at 15p.s.i.(121°C) for 15 min unless otherwise stated.
TE Buffer (lx): Phosphate Buffered Saline
Tris-HCl 10 mM (PBS):
Na2EDTA 0.1 mM Na2HPQ4 8 mM
pH 8.0 KH2P04 1.5 mM
NaCl 137 mM
TES Buffer (lx): KC1 2.7 mM
Tris-HCl 10 mM pH 7.4
Na2EDTA 0.1 mM
NaCl 170 mM Tricine buffer (4x):
pH 8.0 gl’1
Tris base 38.8
SSC Buffer (20x): Tricine 17.8
NaCl 3.0 M Calcium Lactate 0.5
Na3Citrate 0.3 M
pH 7.0 Ligation buffer (lOx):
Tris-HCl 0.3 M
TBE Buffer (lOx): NaCl 0.3 M
Tris base 0.9 M MgCl2 0.075 M
Boric acid 0.9 M Spermidine 0.01 M
Na2EDTA 0.03 M ATP (Nasali) 0.0025 M
pH 8.3 DTT 0.02 M
Na2EDTA 0.002 M
TM buffer: pH 7.5 :Stored at -20°C.
Tris-HCl 0.1 M 
MgCl2 0.05 M 
pH 8.5
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Kinase buffer (lOx): 
Tris-HCl 0.5 M 
MgCl2 0.1 M
DTT 0.05 M 
pH 7.4
Stored at -20°C
T4 polymerase buffer (lOx)
Tris-acetate 0.33 M
K acetate 0.66 M
Mg acetate 0.10 M
DTT 0.005 M
BSA
(pentax Frac V) 
pH 7.9
Stored at -20°C.
1 mg ml" *
S.T.E.T buffer:
Sucrose 8 % (w/v)
Triton X-100 5 % (v/v)
Na2EDTA 0.05 M
Tris-HCl 
pH 8.0
0.05 M
Brij/Doc Solution
Brij 58 1%
Sodium deoxy- 
cholate (DOC)
0.4%
Tris 0.01 M
Na2EDTA
pH8.0
0.001 M
Birnboim lysis solution
(to make up 1ml)
Lysozyme 200 mg
Tris-HCl (pH8.0) 25 mM
EDTA (ph8.0) 10 mM
Glucose 50 mM
(this solution was prepared on 
day of use) and stored
Birnboim alkaline SDS 
Solution
NaOH 0.2 N
SDS 1%
RbCI Transformation buffer 
A
Mops pH7.0 10 mM
RbCI 10 mM
(this was sterilised by filtration 
using a 0.22 pm M illipore 
disposable filter) and stored at 
4°C
RbCI Transformation buffer 
B
Mops pH6.5 100 mM
C a d 2 50 mM
RbCI 10 mM
(this was sterilised by filtration 
using a 0.22 pm M illipore 
disposable filter) and stored at 
4°C
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Agarose gel (Ficoll) tracking 
dye
Ficol 50% w/v
Bromophenol 0.02% w/v
Xylene cyanol 0.02% w/v
Orange G 0.08% w/v
Denhardts reagent (50x)
Polyvinylpyrrolidone 10 
BSA (Pentax Frac V) 10 
Ficoll 10
Filter sterilised and stored at 
-20°C.
Prehybridisation solution
SSC
Denhardts
reagent
SDS
Denatured 
SS salmon 
sperm DNA
6x
lOx
0.2% (w/v) 
lOOngmT1
The salmon sperm DNA was 
denatured by heating to 100°C 
for 5 minutes.
40% (w/v) Acrylamide stock 
*1 1
Acrylamide 380
Bis-acrylamide 20
OJx TBE gel mix:
40% (w/v) acrylamide 150 ml 
lOx TBE 50 ml
Urea (ultra-pure) 460 g
Made up to 1 1 with distilled 
water.
5.0x TBE gel mix:
40% acrylamide 150 ml 
1 Ox TBE 500 ml
Urea (ultra-pure) 460 g 
Bromophenol blue 0.05 g
Made up to 1 1 with distilled 
water.
Formamide gel loading dye: 
Deionised formamide 95% (v/v) 
Xylene cyanol FF 0.05% (w/v) 
Bromophenol blue 0.05% (w/v) 
Na2EDTA 20 mM
SDS acrylamide stock 
solution:
*r’
Acrylamide 300
DATD 8
Made up to 1 1 with distilled 
water, de-ionised with 
Amberlite MB-1 resin, and 
filtered.
Made up to 1 1 with distilled 
water.de-ionised with Amberlite 
MB-1 resin, and filtered.
SDS-PAGE resolving buffer:
Tris-HCl 0.75 M
SDS 0.2% (w/v)
pH 8.8
34
SDS-PAGE stacking gel buffer
Tris-HCl 0.25 M
SDS 0.2% (w/v)
pH 6.8
SDS-PAGE electrophoresis 
buffer
Tris 25 mM
Glycine 190 mM
SDS 0.1% (w/v)
pH 8.3
SDS-PAGE sample loading 
buffer
Tris-HCl 0.2M
Glycerol 10% (v/v)
(S-mercaptoethanol 10% (v/v)
SDS 10% (v/v)
Bromophenol blue 0.005%(w/v) 
pH 6.8
Monorocket gel staining 
solution
Coomassie brilliant 0.45%(w/v) 
blue R250
Glacial acetic acid 100 ml
Methanol 450 ml
Monorocket gel destaining 
solution
Glacial acetic acid 10% (v/v) 
Methanol 45% (v/v)
Western blot transfer buffer
Tris -- 25 mM
Glycine 192 mM
Methanol 20% (v/v)
pH 8.3
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GAPDH Assay Mix
In total vol of 30 ml
50mM Sodium pyrophosphate, pH 8.5 27 ml
♦Fructose 1-6 diphosphate (85 mg ml-*) 1.0 ml
•NAD (10 mg ml"1) 0.5 ml
0.3 M Sodium arsenate 0.5 ml
♦make up fresh
2.1.4.1 Stocks and Solutions for dideoxy-sequencing method used in Section
2.2.10.4
lOx annealing buffer
100 rnM Trig, pH 8.5 
100 mM MgCl2
dNTP - mix buffer
50 mM Tris, pH 8.0 
1 mM EDTA
Dideoxytriphosphates (ddNTP) solutions
Stocks of 10 mM dideoxytriphosphates were kept frozen (-20°C) in 5 mM Tris-HCl, 
pH 8.0, 0.1 mM EDTA). Working stocks were diluted to the follow level. 0.3 mM 
ddTTP, 0.1 mM ddCTP, 0.15 mM ddGTP, 0.03 mM ddATP.
Deoxytriphosphate (dNTP) solutions
Stocks of 20 mM dNTPs and 0.5 mM working solutions were kept frozen (-20°C) in 
water.
Deoxytriphosphate (dNTP°) mixes
T° C° G° A°
dTTP dCTP dGTP dATP
0.5 mM dATP im 20 pl 20 pl 20 pl
0.5 mM dCTP 20 pi lp l 20 pl 20 pl
0.5 mM dGTP 
50 mM Tris,
20 pi 20 pl lp l 20 pl
pH 8.0, 1 mM EDTA 5 pl 5 pi 5pl 5 pl
the dNTP° were kept frozen (-20°C)
200 )il of 0.5 mM ATP in water was used for the chase.
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2.1.4.2. Stocks and Solutions for the dideoxy-sequencing Method Used in Section
2.2.10.5.
Dideoxytriphosphate (ddNTP) solutions
Working stocks of 10 mM dideoxyphosphate were kept frozen (-20°C) in T.E. buffer. 
Deoxytriphosphate (dNTP) solutions
Stocks of 50 mM deoxytriphosphate were kept frozen (-20°C) In T.E. buffer and 
working solutions at 0.5 mM in T.E. buffer.
Dideoxytriphosphate/Deoxtriphosphate mix (NTP)
These mixes were made from the working solutions as follows:
0.5 mM dTTP 
0.5 mM dCTP 
0.5 mM dGTP
10.0 mM ddTTP
10.0 mM ddCTP
10.0 mM ddGTP
10.0 mM ddATP 
T.E. buffer
T "C"
25 500
500 25
500 500
50
8
1000 1000
MGM "A"
500 500
500 500
25 500
16
2
1000 500
dNTP chase mix was made up of 0.25 mM of all 4 dNTP stocks diluted with T.E. 
buffer.
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2.1.5 Bacterial Strains
The bacterial strains used in this study arc listed below.
STRAIN DESCRIPTION/GENOTYPE SOURCE
E. coli MC1061 hsdR/ncrB, araDl39, (araABC-leu) N. Minton 
lacX74,gal\J sspLjhi
E.coli HB101 supE44JtsdS20 (rB"mB_)recA13, S. Jones 
ara-\4jjroAzUMcYl,galK2^psL20^cyr5,
mll-l
E.coli JM83 ara (lac-proAB), strA, thi N. Minton 
( Wdlactf, Z MI)
E. coli JM101 supE,thi (lac-proAB) F’{fraD36, proAB+, N. Minton 
lacfijacZ  M15]
E.coli JLM85 Derivative of JM83 carrying the recA N.Minton 
from JA221
E. coli TG2 supE, hsdS, thi (lac-pro AB) N. Minton 
[F’ ,traD pro AB+,latf9jacZ,M  15]recA
E.coli GM242 darn 3Mcm6,thr,~leu',thT, lacY A. Akrigg
galK2,gafT22,ara 14,ton A31 jsx78,
supE44
E.coli AW 1046 phoA, araD\39, (ara, leu)7697, N.Minton 
lacX74^aHJ, galK, strA.
E. co/i'BMH71-18mutL (lacj>ro),thi\F'proAB+, D.A. Barstow 
lacllacZMl5UupE
S. aureus Cowan I (NCTC8530) C. Duggleby
S. aureus Wood 46 (NCTC7121) R. Sharp
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2.1.6 Plasmids and Phages
The plasmids and phages used in this study were available in the Division and are 
shown below.
PLASMID MARKER REFERENCE
pBR327 Ap1 Soberon et al 1980
pUC9 Apr Vieira and Messing, 1982
pUC8 Ap* Vieira and Messing,1982
pNM52 Apr Gilbert et al, 1986
pMTL20 Apr Chambers etal, 1988
PHAGES REFERENCE
M13mp8 Messing and Vieira, 1982
M13mp9 Messing and Vieira,1982
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2.2 METHODS
2.2.1. Growth and Preservation of Bacterial Strains and Phages
2.2.1.1 E.coli
E. coli strains were routinely grown aerobically at 37°C in either 2xYT broth or L- 
broth. These strains were also cultivated on 2% agar solidified 2xYT broth or L-broth. 
Where necessary the medium was supplemented with the appropriate antibiotic. When 
requ ired  the plate medium was supplem ented w ith X-gal (40 mg m l"1 in 
dimethylformamide) at 0.08 mg m l'1 and with IPTG (20 mg m l'1 in distilled water) at 
0.05 mg m l'1. Cultures were maintained for the short term at 4°C on L-agar plates. 
Longer term storage was at -70°C as broth cultures supplemented with 15% (v/v) 
glycerol.
2.2.1.2 Bacteriophage M13
Bacteriophage M13 was propagated in the host strain BMH71-18 mutL and grown in 
2xYT broth. For preparation of plaques, phage was added at the appropriate dilution to 
3 ml H-top agar at 47°C containing 200 pi of an exponential culture or BMH 71-18. 
When required the H-top agar was supplemented with 30 pi X-gal (40 mg m l'1 in 
dimethyl formamide) and 20 pi IPTG (20 mg ml"1 in distilled water). The H-top agar 
was poured over solid 2xYT medium and allowed to set prior to incubation at 37°C for 
16 hours. Phage was stored as an infected E. coli culture at -70°C in 15% (v/v) 
glycerol.
2.2.2 T ransformation and Transfection of E. coli
Strains o f E. coli were transformed and transfected (with plasmid and M13 RF DNA 
respectively) by the rubidium chloride (RbCl) method of Kushner (1978).
2.2.2.1 Preparation of Competent Cells
The required E. coli strain grown overnight in L-broth at 37°C was used to inoculate 50 
to 100 ml of prewarmed L-broth at a dilution of 1:50 in a 250 ml conical flask. The
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culture was incubated at 37°C with vigorous aeration and the OD^jq of the culture 
monitored at 15 to 30 min intervals. When the OD65q reached 0.16 to 0.18 the flask 
was placed on ice and 1.5 ml aliquots of the culture pipetted into chilled Eppendorf 
tubes, these were centrifuged at 13,000 rpm for 5 min at 4°C. The bacterial pellet was 
washed in 1 ml of chilled (4°C) transformation buffer A, centrifuged at 13,000 rpm at 
4°C for 5 min and the pellet resuspended in 1 ml of chilled (4°C) transformation buffer 
B. After maintaining on ice for 30 min the cells were then centrifuged at 13,000 rpm at 
4°C for 5 min, resuspended in 0.2 ml of chilled (4°C) transformation buffer B and 
maintained on ice prior to use.
2.2.2.2 Transformation with Plasmid and M13 RF DNA
Transformation was achieved by incubation of the transforming DNA (typically 20 to 
200 ng of DNA in a maximum volume o f 10 pi) with the 0.2 ml aliquots o f the 
competent cells (2.2.2.1) on ice for 30 min, followed by a 30 sec heat shock at 45°C. 
Transformed cells were brought to room temperature, diluted in 0.5 ml o f L-broth, 
incubated without shaking at 37°C for 1 hour (if antibiotic resistance required) then 
used to inoculate appropriate L-agar plates in the case of plasmid transformation, or 
diluted in 2xYT broth and used immediately to inoculate soft agar overlays in the case 
of M13 RF DNA transfections (2.2.1.2).
2 2 J  Treatment of DNA with Enzymes
2.2.3.1 Restriction Endonucleases
The reaction conditions were in accordance with manufacturers’ instructions, except 
that a two to tenfold excess of enzyme was used routinely. The digestion products were 
analysed directly by agarose gel electrophoresis (2.2.6). If the restricted DNA was to be 
ligated the remaining restriction enzyme activity was destroyed by e ith e r heat 
inactivation at 70°C for 10 min (for heat labile enzymes), or by phenol extraction
02.4.7.1.).
41
2.2.32 T4 Polynucleotide Ligase
Ligation was typically carried out using DNA fragments at a final concentration of 15 
to 30 pg ml-1 in lx ‘ligation buffer’ (2.1.4; Lathe et al., 1984) which was added as a 
tenfold concentrate to the reaction mixture. T4 DNA ligase was added at a final 
concentration of 0.1 to 1.0 units p g '1 of DNA and the reaction mixture, in a 0.5 ml 
Eppendorf tube, incubated overnight at 15°C.
2.2.3.3 T4 DNA Polymerase
T4 DNA polymerase was used to convert ‘sticky-ended’ DNA to ‘blunt-ended’ DNA, 
in particular DNA fragments possessing recessed 5 ' termini, by the method of 
O'Farrell, (1981).
The DNA sample was diluted in an appropriate volume (20 to 50 pi) of lx  T4 
polymerase buffer supplemented with a one-tenth volume of dNTPs (0.25 mM each) to 
which 1 pi of T4 DNA polymerase was added. The reaction mixture was incubated at 
37°C for 30 min and the enzyme then inactivated by heat treatment (70°C for 10 min). 
Alternatively, the treated DNA was then purified by phenol extraction (2.2.4.7.1) and 
ethanol precipitation (2.2.4.7.3).
2.2.3.4 DNA Polymerase, Large Fragment (Klenow Fragment)
Klenow polymerase was used to "blunt end" recessed 3' termini by the addition of 
sequential bases (i.e end-labelling of //in d lll digested Lambda DNA). All such 
reactions were carried out in lxTM buffer (2.1.4) supplemented with a one-tenth 
volume of 0.25 M dNTPs, and 1 ml Klenow polymerase. Reactions were carried out at 
room temperature for 30 min. Remaining polymerase activity was inactivated by heat 
treatment (70°C for 10 min).
2.2.3.5 Calf Intestinal Phosphatase (CIP)
Dephosphorylation of the 5 ' terminus o f DNA was carried out using calf intestinal 
phosphatase (CIP). Following digestion of the DNA with the appropriate restriction
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endonuclease, CIP was generally added directly to the reaction tube, at a ratio of 1 to 5 
units of CIP p g '1 of DNA, and the tube incubated for a further 30 to 60 min at 37°C. 
Remaining CIP was removed by phenol extraction (2.2.4.7.1) and subsequent ethanol 
precipitation (2.2A7.3).
2.23.6 T4 Polynucleotide Kinase
T4 polynucleotide kinase was used to phosphorylate the 5 ' -hydroxyl terminus of 
synthetic oligonucleotides for use as primers for DNA sequencing, site directed 
mutagenesis or as radio-labelled oligonucleotide probes.
2.23.1 DNase free RNase
RNA was removed from DNA samples using DNase free RNase. Stock solutions of 
RNase A (10 mg ml"* in 10 mM Tris-HCl, pH 7.5) were boiled (100°C) for 15 min 
prior to use or storage at -20°C.
DNA samples were treated with RNase at a final concentration of 25-50 pg ml"1 by 
incubation at 37°C for 1 hour.
2.2.3.8 Determination of Conditions for Partial Digestion of Chromosome DNA with 
Restriction Endonucleases
This method was used to obtain a partial digestion of E. coli JM83 genomic DNA with 
Sau3A.
A reaction mixture was prepared which contained 50 pg of E. coli genomic DNA in the 
appropriate restriction enzyme buffer in a final volume of ISO pi. This mixture was 
aliquoted into eppendorf tubes as follows; 30 pi into tube 1, 15 pi into tubes 2 to 8, and 
the remainder into tube 9. All the tubes were chilled on ice for 10 min and then 20 
units of restriction enzyme was added to tube 1 and gently mixed. This gave an enzyme 
concentration of 2 units/pg DNA. Half of this (15 pi) was transferred to tube 2, and 
this step was repeated to give serial dilutions from tube 1 to 8. None of the restriction
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enzyme mix was added to tube 9. Tubes 1 to 8 were then incubated at 37°C for 60 min 
and the reactions stopped by chilling on ice and the addition of 1 ill of 0.5M Na2 
EDTA. A volume of 3 p.1 of tracking dye was then added to all nine tubes and the 
samples electrophoresed on a 0.8% agarose gel. Subsequent staining of the gel revealed 
the appropriate restriction enzyme concentration required to achieve partial digestion of 
the DNA.
2.2.4 Isolation of DNA
2.2.4.1 Chromosomal DNA Isolation
The isolation of genomic DNA from E. coli JM83 was performed by a slight variation 
of the method of Marmur (1961).
E. coli JM83 was grown overnight in 1 litre of L-broth. The cells were harvested by 
centrifugation (Sorval RC5B, GSA rotor, 6,000 r.p.m., 10 min) washed in saline- 
EDTA, recentrifuged, and the wet weight of the harvest determined. The cells were 
resuspended in saline-EDTA at a density equivalent to 10 ml of saline-EDTA per gram 
of cells (wet weight). Lysozyme solution (10 mg ml'* in distilled water) was added to 
the cell suspension at a dilution of 1 ml per 23 ml of cells and the mixture incubated at 
37°C for 30 min. Hot SDS (60°C, 25% w/v) was added to give a final concentration of 
2% and the mixture incubated at 60°C for 115 min with intermittent shaking. The 
mixture was then cooled to ambient temperature and 5 M sodium perchlorate added to 
give a final concentration of 1 M. An equal volume of chloroform : isoamylalcohol 
(24:1 v/v) was added and the emulsion gently shaken in a 10°C bath for 30 min. The 
emulsion was separated by centrifugation (Sorval RC5B, GSA rotor, 10,000 r.p.m., 5 
min, 10°C). The aqueous phase (top layer) was carefully removed and transferred to a 
chilled (-20°C) glass measuring cylinder. Two volumes of chilled (-20°C) absolute 
ethanol were gently added and the DNA precipitation at the ethanol/aqueous interface, 
spooled onto a sterile glass rod, and left to drain. The DNA was resuspended in 75% of 
the original volume of 0.1 x SSC, and the SSC concentration adjusted to 1 x SSC with 
10 x SSC. An equal volume of chloroform : isoamylalcohol (24 : 1 v/v) was again
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added, the solution extracted, the DNA precipitated and spooled on to a glass rod, 
exactly as before. The DNA was again resuspended in 0.1 x SSC, this time in a volume 
equivalent to 50% of the original volume, and the SSC concentration adjusted to 1 x 
SSC with 10 x SSC. DNase-free RNase (2.2.3.7) was then added to a final 
concentration of 50 pg m l'1 and the solution incubated for 1 hour at 37°C. SDS (25% 
w/v) was added to a final concentration of 0.5%, followed by the addition of proteinase 
K (20 mg m l'1 in distilled water) to a final concentration of 1 mg ml"1. The solution 
was incubated at 37°C for 60 min and then extracted three times with an equal volume 
of chloroform : isoamylalcohol (24 : 1 v/v). A 1/2 volume of phenol (2.2.4.7.1) was 
then added to the DNA solution and the mixture gently shaken at ambient temperature 
for 10 min. After separation of the phenol and aqueous phase by centrifugation (Sorval 
RC5B, SS34 rotor, 10,000 r.p.m., 5 min) the remaining traces of phenol were removed 
by 3 extractions with an equal volume of diethyl-ether (saturated with water). The 
aqueous phase was recovered and the DNA again precipitated with two volumes of 
chilled (-20°C) absolute ethanol, the DNA spooled onto a glass rod and the DNA 
eventually resuspended in a volume of 1 x SSC equivalent to 25% of the original 
volume. The DNA was finally precipitated by the addition of 1/10th volume of 
Acetate-EDTA (3.0 M sodium acetate; 0.001 M Na2 EDTA; pH 7.0) and the gradual 
addition of a 0.54 volume of isopropanol whilst simultaneously spooling the DNA on to 
a sterile glass rod. The spooled DNA was then washed in 70%, 80% 90% and finally 
100% ethanol, dried under vacuum, and resuspended in a minimum volume of 1 x TE 
buffer. The DNA concentration was determined spectrophotometrically by reading the 
optical density of a known dilution of the solution at 260 nm and the DNA solution 
stored at -20°C.
2.2.4.2 Small Scale Isolation of Plasmid DNA from E. coli
All small scale plasmid isolations were carried out using a modification of the rapid 
boiling method o f Holmes and Quigley (1981), referred to as the STET method 
throughout the thesis; or (if a higher quality of DNA was required) using a modification
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of the alkaline SDS method of (Birnboim and Doly, 1979) referred to as the mini- 
Birnboim method throughout this thesis.
2.2.4.2.1STET method
A 1.5 ml sample of an overnight L-broth culture was centrifuged in an Eppendorf 
microcentrifuge (MSE Microcentaur, 13000 rpm for 30 sec). The bacterial pellet was 
resuspended in 350 |Xl S.T.E.T. buffer (2.1.4) by vortexing and 25 ill of a freshly 
prepared solution of lysozyme (10 mg ml"1) in 25 mM Tris-HCl,pH 8.0 was added. 
After brief vortexing the suspension was placed in a boiling water bath for 40 sec. The 
suspension was immediately centrifuged (MSE Microcentaur, 13000 rpm for 10 min) 
the supernatant removed and reserved, and the pellet discarded. To the supernatant, 40 
111 of 2.5M sodium acetate,pH 5.2 and 420 ill of isopropranol were then added, the tube 
contents briefly vortexed, and placed at room temperature for 5 min. The plasmid 
DNA present was recovered from the precipitate by centrifugation (MSE Microcentaur, 
13000 rpm for 5 min at 4°C), the supernatant carefully decanted away, and the DNA 
pellet immediately washed with 1 ml 70% (v/v) ethanol, then dried under vacuum. The 
dried DNA pellet was resuspended in 34 p.1 lxTE buffer and l|il of DNase free RNase 
added (2.2.3.7). A 5 (ll aliquot of this sample was sufficient for visualisation by agarose 
gel electrophoresis (2.2.6.1) following restriction endonuclease digestion (2.2.3.1).
2.2.4.2.2Mini-Bimboim Method
A 1.5 ml sample of an overnight L-broth culture was centrifuged in an Eppendorf 
microcentrifuge (MSE Microcentaur, 13000 rpm for 80 seconds). The cells were 
resuspended in 100 p.1 of Bimboim lysis solution (2.1.4) by vortexing gently and chilled 
(0°C) on ice for 30 min. 200 ill of Bimboim alkaline SDS solution (2.1.4) was added, 
the tube contents briefly vortexed and chilled on ice for a further 5 min, after which 150 
111 of 3M sodium acetate, pH 4.8 was added. The tube contents were gently mixed by 
inverting the tube 3 to 4 times, and placed on ice for 60 min, mixing occasionally 
during standing. The suspension was then centrifuged (MSE Microcentaur, 13000 rpm 
for 5 min) and 400 |il of the supernatant removed. 1 ml of ethanol was added to the
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supernatant, it was mixed by inversion and then placed at -20°C for 30 min. The DNA 
pellet was recovered from the precipitate by centrifugation (MSE Microcentaur, 13000 
rpm for 2 min), and the supernatant carefully aspirated using a fine drawn-out Pasteur 
pipette. The DNA pellet was resuspended in 200 ill of cold ethanol, placed at -20°C for 
10 min, then recovered from the precipitate by centrifugation (MSE Microcentaur, 
13000 rpm for 2 min), the supernatant carefully decanted away and the pellet was dried 
under vacuum. The dried pellet was resuspended in 75 ill of lxTE buffer and 1 ill 
DNAse free RNAse (2.2.3.7) was added. 10 ill of this sample was sufficient for 
visualisation by gel electrophoresis (2.2.6.1) following restriction endonuclease 
digestion (2.2.3).
2.2.4.3 Large Scale Isolation of Plasmid DNA From E. coli
Plasmid DNA was purified from E. coli strains by the method of Clewell and Helsinki 
(1969).
500 ml L-broth supplemented with appropriate antibiotics was inoculated with 10 ml of 
an overnight culture and incubated overnight at 37°C with moderate aeration (200 
r.p.m. on a shaker platform). The cells were harvested by centrifugation (Sorval RC5B, 
GSA rotor, 6000 r.p.m. for 10 min) and resuspended in 2 ml of 25% (w/v) sucrose, 
50mM Tris-HCl,pH 8.0. Lysozyme, 0.3 ml of a 20 mg ml-1 solution in 25 mM Tris- 
HCl.pH 8.0, was added and the mixture left on ice for 3-5 min, after which time 2 ml 
of 250 mM Na2EDTA was added. After a further 5 min on ice, 3 ml of Brij/Doc 
lysing solution (2.1.4) was added, the solution mixed gently, and left on ice for 20 min 
or until lysis occurred. The cell debris and the bulk of the chromosomal DNA was then 
pelleted by centrifugation (Sorval RC5B, SS34 rotor, 6000 r.p.m. for 30 min at 4°C) 
and the cleared lysate recovered by decanting the supernatant into a fresh tube. The 
supernatant was then subjected to isopycnic centrifugation (2.2.4.5.).
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2.2.4.4 Large Scale Isolation of M13 (RF) DNA
Competent E. coli were transfected with single stranded M l3 template DNA (2.2.2.2). 
Immediately following the 42°C heat shock the transfected cells were used to inoculate 
10ml 2xYT broth which was incubated overnight at 37°C. The supernatant ("phage 
inoculum") was recovered following centrifugation (Sorval RC5B, SS34 rotor, 6000 
r.p.m. for 10 min) and stored temporarily at 4°C. Meanwhile, 10 ml of an overnight 
culture of E. coli was used to inoculate 1 litre of prewarmed 2xYT broth. This culture 
was incubated at 37°C with vigorous aeration until an OD^qq of 0.6 was reached. The 
10 ml ‘phage inoculum’ was then added and the culture incubated for a further 6 hours 
at 37°C with vigorous aeration. The cells were harvested by centrifugation (Sorval 
RC5B, GSA rotor, 6000 r.p.m. for 10 min) and a cleared lysate prepared as described 
in section 2.2.4.3. The cleared lysate was then subjected to isopycnic centrifugation 
(2.2.4.5.)
2.2.4.5 Isopycnic Centrifugation of Plasmid and M13 (RF) DNA
Chromosomal and plasmid DNA were separated by centrifugation to equilibrium in 
caesium chloride-ethidium bromide density gradients (isopycnic centrifugation) as 
follows.
To each 1 ml volume of cleared lysate 0.95 g of solid caesium chloride and 0.02 ml 
ethidium bromide solution (10 mg m l'1 in distilled water) were added and mixed gently 
by inversion. The contents were transferred to a Du Pont/Sorval heat seal tube and the 
tube completely filled and sealed by heating with a Du Pont/Sorval tube heating system. 
If insufficient gradient mix was available the heat seal tubes were topped up with 
paraffin ‘oil and balanced appropriately. The tubes were centrifuged in a Sorval Ti50 
fixed angle rotor at 48000 r.p.m. (10 ml tubes) for 36 to 48 hours (20°C). After 
centrifugation, the plasmid or M13 RF (lower) and chromosomal (upper) DNA bands 
were visualised with a UV long wave transilluminator (Blak-ray, Ultra-violet products 
Inc., San Gabriel, Ca, U.S.A.). The lower band was removed by piercing the side of 
the tube with an 18-gauge hypodermic needle 0.5 cm beneath the band and withdrawing
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it into a 2 ml syringe; an additional needle was used to pierce the top of the tube 
thereby facilitating a smooth removal of the desired band. Ethidium bromide was 
removed by extracting the sample 3 to 4 times with isoamyl alcohol which had been 
equilibrated with caesium chloride. The sample was then transferred to prepared 1/4" 
dialysis tubing and the caesium chloride removed by dialysis against one change of 
lxTES buffer at 4°C followed by three changes of lx TE buffer at 4°C. At least 1,000 
volumes of dialysis buffer were used and the buffer changed after 1, 1,2 and 4 hours 
of dialysis.
2.2.4.6. Recovery of DNA from Agarose Gels by Electro-Elution
DNA was extracted from agarose gels essentially as described by McDonnell et al.,
(1977).
Following resolution of the desired DNA fragment by agarose gel electrophoresis and 
staining with ethidium bromide, the band was visualised with the aid of a long wave 
UV transilluminator (Blak-ray, Ultra-Violet Products Inc., San Gabriel, Ca, U.S.A.). 
The desired DNA band was excised from the gel with a sterile scalpel, placed in an 
appropriate length of 1/4" prepared dialysis tubing and submerged in 0.2xTBE buffer. 
The ends of the tubing were sealed and the dialysis bag placed lengthways at right 
angles to the current in a horizontal gel tank partially filled with 0.2x TBE buffer. 
Electroelution was carried out at 240 V for 2 hours or at 40 V overnight. After this 
time the current was reversed for several sec to disengage the eluted DNA from the 
dialysis tubing. The TBE buffer, containing the eluted DNA, was removed from the 
tubing and extracted once with phenol (2.2.4.7.1), three times with water saturated 
diethyl-ether (2.2.4.7.2), ethanol precipitated (2.2.4.7.3), and resuspended in an 
appropriate volume of TE buffer.
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2.2.4.7 Solvent Extraction and Ethanol Precipitation of DNA
2.2.4.7.1 Phenol Extraction of DNA
Protein was removed from DNA samples by extraction with phenol, pre-equilibrated 
with TE buffer. A half volume of this TE-saturated phenol was mixed with the 
aqueous DNA sample and vortexed for 30 sec, left to stand for 2 min at room 
temperature, then vortexed again for 30 sec. After standing for 5 min the emulsion was 
separated by centrifugation (MSE Microcentaur, 13000 r.p.m. for 1 min). The aqueous 
phase was removed and transferred to a fresh tube. Diethyl-ether extraction was used 
to remove traces of phenol (2.2.4.7.2). The purified DNA sample was then ethanol 
precipitated (2.2.4.7.3).
2.2.4.7.2 Diethyl-ether extraction
Two volumes of diethyl-ether was added to the DNA sample, the tube vortex mixed for 
30 sec and the layers allowed to separate. The diethyl-ether (top layer) and any material 
at the interface were removed and discarded. Diethyl-ether extractions were repeated 
until all traces of phenol had been removed (typically 2-4 times).
2.2.4.7.3 Ethanol precipitation
DNA was precipitated from solution by the addition of a one-tenth volume of 3M 
sodium acetate (pH 4.8) and two volumes of chilled absolute ethanol (-20°C), followed 
by either incubation at -20°C for at least 1 hour or, incubation was at -70°C for 15 min. 
After precipitation, the DNA was recovered by centrifugation (MSE Microcentaur, 
13000 r.p.m. for 10 min). The supernatant was carefully decanted and discarded. The 
DNA pellet was washed in an appropriate volume of 70% (v/v) ethanol, prior to 
vacuum drying. The dessicated DNA pellet was resuspended in an appropriate volume 
of lx TE buffer.
2.2.4.7.4 Isopropanol Precipitation
Rapid precipitation of plasmid DNA from a mixed solution of DNA and other materials 
was performed by precipitation of the sample with a  0.4 volume of 5M ammonium
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acetate and two volumes of isopropanol, followed by incubation at room temperature 
for 10 minutes. The DNA was recovered by centrifugation (MSE Microcentaur, 13000 
r.p.m. for 10 min) the pellet washed, in 70% (v/v) ethanol and the centrifugation step 
repeated. The DNA was then vacuum dried and resuspended in an appropriate volume 
of lx TE buffer.
2.2.5 Spectrophotometric Analysis of DNA Preparations
2.2.5.1. Quantitative Analysis
A Pye Unicam SP6 spectrophotometer was used to quantitate the concentration of DNA 
in a given sample by measuring the absorbance at 260nm using quartz cuvettes. An 
OD26O reading of 1.0 was given by a concentration of 50pg ml'* of double stranded 
DNA, 40|ig ml'* of single stranded DNA or 20yig ml'* of synthetic oligonucleotide 
(Maniatis et al.,1982).
2.2.5.2 Qualitative Analysis
The degree of protein or phenol contamination in a DNA preparation, was estimated by 
determining the ratio of sample readings taken at 260nm and 280nm, where an 
^*^260/280 rat‘°  *css t*ian 1-70, indicated significant protein contamination. Such 
samples were cleaned by additional phenol and diethyl ether extractions followed by an 
ethanol precipitation step (2.2.4.7.3).
2.2,6. Electrophoresis of DNA
2.2.6.1. Agarose Gel Electrophoresis
This was performed with horizontal slab gel electrophoresis tank systems. The gel 
systems employed were of the Schaffner type (Maniatis et al., 1982), in which the gel is 
poured into a portable gel casting tray (20 x 20 cm gels), or of the ’mini-gel’ type 
where the gel is cast directly into the electrophoresis apparatus ( 5 x 8  cm). The 
apparatus was obtained from BRL (H4 system ) and Cambridge Life Sciences
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respectively. The gel routinely used consisted of agarose (BRL ultra-pure) at 
concentrations between 0.8 and 1.5% (w/v). The gel was formed by boiling together 
(in a microwave oven) appropriate amounts of agarose, lx TBE buffer and distilled 
water. The molten gel was allowed to cool to 60°C before pouring; 35 ml was routinely 
used for the horizontal mini gel and 250 ml was used for the analytical/preparative (20 
x 20 cm) horizontal gel. Perspex combs of varying teeth size were inserted into the 
molten gels, prior to setting, to create the loading wells. Samples to be electrophoresed 
were mixed with a one-fifth volume of Ficoll tracking dye and loaded into the wells of 
the gel submersed in lx  TBE gel running buffer. The gel was then subjected to 
electrophoresis to give a voltage across the gel of between 1 and 5 V cm'*. After 
electrophoresis the DNA was stained with 0.1 ml of ethidium bromide (10 mg ml'* in 
distilled water) and visualised by medium wave UV illumination and photographed 
with Polaroid 667 black and white film (ASA 3000) using a red filter. Exposure times 
of between 1 and 4 sec at an aperture setting of F8 was usually sufficient.
2.2.6.2 Denaturing Polyacrylamide Gel Electrophoresis
DNA sequence reaction products were resolved by denaturing polyacrylamide 
electrophoresis using the thin gel system of Sanger and Coulson (1978). The gel plates 
(20 x 40 cm), one of which had ’rabbit ears’ (the front plate) were cleaned thoroughly 
with pyroneg in solution followed by absolute ethanol. The front plate was then treated 
with 2% dimethyldichlorosilane in 1,1,1- trichloroethane (v/v). The back plate was 
treated with a solution comprised of 750pl 10% glacial acetic acid (v/v) and 75pl silane 
(t-[methylacryloxyj-propyltrimethoxysilane) in 25 ml absolute ethanol. After allowing 
the plates to dry, they were lightly polished with absolute ethanol and the with a dry 
soft tissue to remove excess coating. The gel ’sandwiches’ were then assembled with 
0.35mm plastic card spacers (Raven Scientific Ltd) using ’nitto’ tape (BRL). The 
’gradient’ gels routinely used were made from 40 ml 0.5x TBE gel mix and 7 ml 5x 
TBE gel mix. The gel mixes were polymerised by the addition of 25% (w/v) 
ammonium persulphate and TEMED to 0.2% (v/v) each. The gradients were poured in 
the following manner. Using a 10 ml pipette, 4 ml of the clear 0.5x TBE gel mix was
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taken up, followed by the 7 ml of blue 5x TBE gel mix. Two air bubbles were passed 
through the pipette to mix the contents slightly, and the mix then carefully pipetted into 
the gel sandwich followed immediately by the remaining 34 ml 0.5x TBE gel mix. A 
plastic card gel comb was placed in the top of the gel and the gel mix left to polymerise. 
Up to a maximum of 32 (8 x 4) samples could be loaded on one gel.
2.2.7 Immobilisation of DNA on Nitrocellulose Membranes
2.2.7.1 Southern Transfer from Agarose Gels 
Method of Southern (1975)
The gel was first stained with ethidium bromide and photographed to enable a later 
comparison with the post-blotted gel to give an indication of the extent of transfer. To 
facilitate the transfer of the larger DNA fragments the DNA was nicked prior to 
transfer. This was effected by partial depurination of the DNA. The gel was submerged 
in two changes of 0.25M HC1 for 10 to 15 min (Wahl et al., 1979), rinsed with water 
then soaked twice in 250 ml of denaturing solution (0.5M NaOH, 1M NaCl) for 30 min 
each. The gel was then soaked in neutralising solution (1.5M Tris-HCl.pH 6.5, 3M 
NaCl) for 60 min followed by a 10 min wash in 2x SSC buffer. The gel was then 
placed on a ’wick’ of Whatman 3MM filter paper (soaked in 20x SSC) draped over a 
glass plate resting on top of a plastic tray containing 1 litre of 20x SSC transfer 
solution. The ends of the wick were immersed in this buffer. The edges of the gel were 
sealed from contact with the wick by sliding strips of X-ray film underneath. A sheet of 
nitrocellulose membrane, soaked in 2x SSC for 10 min, was placed on top of the gel, 
care being taken not to trap air bubbles between the two surfaces. Three sheets of 
Whatman 3MM filter paper, cut to the size of the gel and were soaked in 2x SSC, and 
placed on top of the gel, and then a wad (10 cm) of blotting paper placed on top. A 
small weight (approximately 250-500g) was placed on top to ensure an even contact 
between the gel and the membrane. Transfer was allowed to proceed for between 18 to 
36 hours, after which time, the membrane was removed, washed briefly in 2x SSC, 
dried at ambient temperature and then baked at 80°C for 2 hours under vacuum. The
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gel was restained with ethidium bromide and photographed to visualise the extent of 
transfer of DNA.
2.2.1.2 In Situ Colony Hybridisation
The method employed was a modification of that described by Grunstein and Hogness 
(1975).
The bacterial colonies to be screened were replica-plated onto the ordered grid pattern 
of a 9 cm nitrocellulose filter discs (Schleicher & Schuell) placed on the surface of agar 
plates containing the selective antibiotic and in identical positions on agar master plates 
also supplemented with the selective antibiotic. Up to 100 colonies could be streaked 
on a single filter. Following overnight incubation at 37°C, the master plates were stored 
at 4°C and the filters peeled off the replicas. The cells were lysed using the following 
steps, these were performed by placing the filters, colony sides up, onto trays 
containing 3 layers of Whatman 3MM filter paper soaked in the appropriate solution. 
The filters were treated with 0.5M NaOH for 10 min, followed by 3 treatments with 1M 
Tris-HCl,pH 7.4 for 5 min each. Finally the filters were treated with 1.5M NaCl; 0.5M 
Tris-HCl,pH 7.4 for lOmin. The filters were then immersed in lx SSC, supplemented 
with 1 mg m l'1 proteinase K and 0.5% (w/v) SDS, and incubated at 37°C for 1 hour. 
The filters were then rinsed in 2x SSC, air dried, and baked in a vacuum at 80°C for a 
minimum period of 30 min.
2.2.8 Radio-Labelling of DNA
2.2.8.1 5' -End Labelling of Synthetic Oligonucleotides
Synthetic oligonucleotides were supplied deprotected at the 5 '-hydroxy terminus and 
therefore in a condition ready for phosphorylation at the 5 ' -hydroxy terminus with 
[7 -^ P ]  dATP by T4 polynucleotide kinase (Maxam & Gilbert, 1977).
Typically, 30 pi [>-^^P] ATP (3000Ci mmol"*; 50% (v/v) ethanol) was completely 
evaporated in a 1.5 ml Eppendorf tube under vacuum. To this, 150ng oligonucleotide 
probe, 3 pi of lOx kinase reaction buffer (2.1.4), and 1 pi lOOmM DTT was added and
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the reaction mixture made up to a total volume of 30 pi with distilled water. Following 
the addition of 0.2 units of T4 polynucleotide kinase, the mixture was incubated at 
37°C for 30 min. The reaction was stopped by the addition of 1 pi 0.5M Na2EDTA and 
kept on ice or frozen at -20°C prior to use. It was not usually considered necessary to 
remove excess label by chromatography through Sephadex G-50 as the oligonucleotide 
probe was usually in a 1.3 molar excess over ATP.
2.2.8.2 End-Labelling of Lambda///mdIU DNA Size Markers
Lambda DNA //indlll fragments were used as size markers on agarose gels and radio- 
labelled //i/idlll fragments were necessary to show up on autoradiographs of Southern 
blots.
Approximately 10 pg of lambda DNA HindSSl fragments were diluted to a total volume 
of 90 pi in sterile distilled water. To this was added 10 pi of lOxTM buffer (2.1.4), lpl 
(10 pCi) [a-32p] ATP and 2 pi Klenow DNA polymerase I. The mixture was incubated 
at room temperature for 30min. 50 pi of Ficoll tracking dye was added prior to storage 
at -20°C. Aliquots of about 4 pi were used directly for electrophoresis.
2.2.9 DNA-DNA Hybridisations and Autoradiography
2.2.9.1 Annealing of Oligonucleotide
The membrane was prewetted in 2 x SSC and then placed in a sealable perspex box and 
a sufficient volume of pre-hybridization solution (214) to cover the filter added (30 to 
100 ml). Prehybridization was carried out at 65°C for 15 to 30 min. The 5" -end- 
labelled oligonucleotide probe was then added to a final concentration of 1 ng m l'1 
(with a specific activity approximating 10^ cpm ml'*). Hybridization was carried out 
at the calculated dissociation temperature for the oligonucleotide less 5°C (Td-50C). 
The T j  was defined to be the temperature at which 50% of the duplexes dissociate in 6 x 
SSC (Wallace et al., 1979) and calculated as follows:
Td (°C = 4(G+C) + 2(A+T)
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Hybridization was normally carried out for 2 hours or until sufficient time had elapsed 
to enable the probe to reach a calculated value o f 1 to 3 x C o tj^*  *-0*1/2 is the 
calculated time required for half-renaturation of the probe (Maniatis el al, 1982) and 
was calculated as follows:
1/X x Y/5 x Z/10 = number of hours to achieve CQtj/2 
where,
X = The weight of probe added (in ug).
Y = The complexity of the probe (length of probe in kilobases).
Z = The volume of the hybridization reaction.
Following the hybridization the membrane was washed with several changes of 6 X 
SSC, 0.1% (w/v) SDS, for S min each at the hybridization temperature (unless 
otherwise stated). The membrane was finally rinsed with 6 X SSC at room temperature 
and either wrapped in saran wrap or air dried prior to autoradiography (2-2-9-3).
2.2.9.2 Re-hybridisation of Membranes
If a previously used membrane was to be re-hybridised with a different probe, the 
bound probe was removed by several washes with boiling O.lx SSC, 0.5% (w/v) SDS, 
for 5 min each. The membrane was finally rinsed in 2x SSC at room temperature and 
air dried. The membrane was then examined by autoradiography to ensure that all the 
probe had been removed before proceeding with the re-hybridisation.
2.2.9.3 Autoradiography
Autoradiography was carried out with Kodak X-Omat S, X-ray film which was 
positioned on top of the membrane or immobilised gel within a lightproof cassette, and 
left from 1 to 72 hour at room tempertaure before developing. When necessary the 
sensitivity of the autoradiography could be increased by the following methods, i. a 
calcium-tungstate-phosphor intensifying screen (Dupont Comex Lightning-Plus) was 
used in the assembly in the cassette (Swanstrom and Shank, 1978) and the
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autoradiography carried out at -70°C. ii. the film was sensitised by "preflashing", with 
a filtered photographic flashgun, prior to autoradiogrpahy (Laskey and Mills, 1977), 
and iii. films with lower threshold were employed such as Kodak XAR5 and 
Amersham’s Betamax film.
2.2.10 DNA Sequencing
The method employed was the "chain-termination" procedure first described by 
Sanger et al. (1977) using the large fragment o f E. coli DNA polymerase I. DNA 
fragments to be sequenced were first cloned into the replicative form (RF) of the M l3 
cloning vectors mp8, and mp9. These vectors contain multiple cloning sites in lacZ’, 
coding for the a-peptide of p-galactosidase. Insertion of foreign DNA into this 
polylinker sequence destroys active a-peptide synthesis such that recombinants are 
easily identified on media containing the chromogenic substrate for P-galactosidase, X- 
gal (BCIG) as "white" plaques. Single-stranded template DNA is prepared from the 
mature phage particles of the recombinants and is used directly in the sequencing 
reaction. An oligonucleotide primer, which is complementary to a sequence contained 
within the viral DNA ("sequence universal primer") or the inserted DNA, is hybridised 
3* to the template. Thus the sequence complementary to this insert DNA can be 
determined by sequential extension with the Klenow polymerase in the presence of both 
deoxyribonucleotides and the chain-terminating dideoxyribonucleotide analogues. 
Subsequent size fractionation of the reaction products by denaturing polyacrylamide gel 
electrophoresis enables the DNA sequence to be read.
2.2.10.1 Sub-Cloning of DNA into M13 Vectors
Routinely, 50ng of cleaved M13 vector was ligated with a two fold molar excess of 
target DNA fragments. The ligation products were used to transfect competent E. coli 
JM101 (2.2.2.). After transfection, the cells were added to a sterile universal, in a 47°C 
heating block, containing: 3 ml molten H-top soft agar, 20pl of IPTG (20 mg m l'1 in 
distilled water), 30pl of X-gal (40 mg m l'1 in DMF), and 200itl of exponentially
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growing E. coli JM101 cells. The mixture was poured onto a 2xYT agar plate and 
allowed to  set before the plate was inverted and incubated at 37°C overnight. 
Recom binants were identified as colourless plaques owing to the insertional 
inactivation of the functional (i-galactosidase a-peptide encoding sequence.
2.2.10.2 Sonication of DNA
Sonication of DNA is one of the methods used to generate the random sized fragments 
of DNA used in the "shotgun" approach to sequencing large DNA molecules. These 
random fragments were then cloned into M l3 vectors (Messing et al., 1977; Messing & 
Vieira, 1982). These are then sequenced and the data compiled to ultimately reveal the 
complete sequence. The sonication method followed was that of Deininger (1983), 
using an MSE soniprep ISO sonicator.
The sonication probe was sterilised by boiling in 1% (w/v) SDS for 15 min, rinsed well 
in ethanol and chilled to -20°C in ethanol. lOpg of the purified DNA fragment made up 
to a volume of 100 pi with lx  TE buffer. This was kept on ice throughout the 
procedure. The probe was inserted into the Eppendorf tube as far as possible without 
touching the tube and allowed to cool for 10 min by contact with the ice. With the 
sonicator switched to maximum output, and an amplitude setting of 3, four 8 sec bursts, 
with 1 min cooling periods between each, were applied to the DNA solution. The 
solution was recovered and adjusted to a volume of lSOpl with 20pl lOx T4 DNA 
polymerase buffer (2.1.4), 20pl dNTP mix (dATP, TTP, dCTP, and dGTP; 0.25mM 
each), 5pi T4 DNA polymerase, and lpl Klenow polymerase. The reaction mixture was 
then incubated at 14°C for 3 to 4 hours. The sample was electrophoresed on a 1.5% 
(w/v) agarose mini gel (2.2.6.1), alongside DNA size markers, until the Bromophenol 
Blue dye front had migrated 2 to 3 cm from the well. DNA fragments between 400 and 
800 bp in length were excised from the gel and the DNA extracted by electro-elution 
(2.2.4.6), and ethanol precipitated (2.2.4.7.3).
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2.2.10.3. Preparation of Template DNA
Recombinant plaques (colourless), were picked into 2 ml aliquots of 2xYT broth, 
containing 100 pi per 100 ml of an overnight culture of E. coli JM101, and incubated 
at 37°C for 6 hours with vigorous aeration. The cultures were then transferred to 
Eppendorf tubes and centrifuged (Sorval RC5B, SHTM rotor, 13000 r.p.m. for 10 min 
at 4°C). The supernatants (1.25 ml vol) were decanted into fresh Eppendorf tubes 
containing 250pl 20% PEG (6000), 2.5M NaCl, and the contents mixed well by 
inversion. After being left to stand for a minimum of 15 min, the tubes were again 
centrifuged (Sorval RC5B, SHTM rotor, 13000 r.p.m. for 10 min). The supernatants 
were discarded by aspiration leaving the phage pellets in the tubes, these were briefly 
centrifuged for 30 sec as above, and all traces of supernatant discarded by careful 
aspiration. The phage pellets were resuspended in 150 pi volumes of lxTE buffer 
(using an Eppendorf shaker) and extracted once with a 50 pi of TE saturated phenol. 
Following separation of the emulsions by centrifugation (MSE Microcentaur, 13000 
r.p.m. for 1 min at room temperature), 130 pi of the aqueous phase (top phase) was 
transferred to fresh Eppendorf tubes making sure not to transfer any of the bottom 
phenol layer, any traces of phenol were removed by extracting 4 times with 0.5 ml of 
diethyl ether. The samples were then ethanol precipitated (2.2.4.7.3.), washed with 70% 
(v/v) ethanol, dried under vacuum, and resuspended in 30pl lx TE buffer.
2.2.10.4 Methods used for the dideoxy-sequencing involving a-^P-dATP (used for 
sequencing the S. aureus spa gene) Modification by Coulson and Winter,
MRC Cambridge (personal communication)
2.2.10.4.1 Annealing of Template and Primer
The templates to be sequenced were first annealed with the appropriate oligonucleotide 
primer. This was carried out in a drawn out glass capillary tube. 5 pi of template 
DNA, 1 pi of 10 x annealing buffer, 1 pi of primer (2 ng p i-* in double distilled 
Millipore water) and 3 pi of double distilled water were drawn up into a capillary tube
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and mixed by pipetting in and out of the capillary several times. The capillary tube was 
then heat sealed at both ends and the contents annealed by incubation in a test tube of 
boiling water placed in a boiling water bath for 3 minutes, after which the test tube was 
removed from the water bath and allowed to cool slowly to room temperature.
2.2.10.4.2 Polymerisation (sequencing reactions)
These reactions were performed in autoclaved capless 1-5 ml Eppendorf tubes, the 
tubes were positioned in ordered racks (in an equivalent to a 4 x 4 matrix) volumes 
stated are sufficient for 4 templates.
Four 5 pi aliquots of a a-32P-deoxyadenosine triphosphate (specific activity 400 
ci/mmole were dried down using a vacuum line. 10 pi of C termination mix, 
(termination mix is made up of 5 pi of the corresponding ddNTP and dNTP° working 
solutions, (section 2.1.4.1)) was added to the first tube of dry 32P-dATP and mixed 
gendy to dissolve, this procedure was repeated with the T, A and G termination mixes. 
The capillary tubes containing the annealed template and primer were cut open and 1 
unit of Klenow polymerase drawn into each, this was mixed and then blown into the 
bottom of an Eppendorf tube and the capillary discarded. For each template, 2 pi of the 
DNA/polymerase mix was transferred to the inside wall of 4 individual tubes (forming 
the horizontal row) these being for the 4 independent sequencing reactions. Then 2 pi 
aliquots of the T,C,G and A termination 32P-dATP mixes were added to the inside wall 
of the appropriate reaction tubes (forming the vertical rows) care was taken not to mix 
this with the aliquoted template. The reactions were started by mixing using a brief 
centrifugation (5 sec, IEC Centra 4X with centra rack rotor) and the reaction allowed to 
proceed for 15 min at room temperature. During the reaction, a 1 pi aliquot of 0.5 mM 
dATP chase was aliquoted to the inside wall of the reaction tubes, this was mixed by 
brief centrifugation. Following a further 30 min incubation at room temperature, 4 pi of 
formamide dye mix was added to each tube and mixed by centrifugation. If the 
samples were not to be run on a gel immediately they were frozen without the addition 
of the formamide dye mix.
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2.2.10.5 Method use for dideoxy-sequencing involving a-^S-dATP modification
communicated by Bankier (1984) MRC Cambridge (personal communication)
2.2.10.5.1 Annealing of template and primer
The single stranded template and appropriate oligonucleotide primer were first 
annealed. This was carried out in capped Eppendorf tubes. 5 pi of templates DNA was 
mixed with 1 pi TM buffer, 3.5 pi distilled water, and 0.5 p i primer (2 ng pi"* in 
oligonucleotide storage buffer), and annealed by incubation of the tube in an 80°C 
water bath for 3 min, after which it was allowed to slowly cool to room temperature. 
The tube was then briefly centrifuged (IEC Centra 4X with centra rack rotor) for 5 sec 
to ensure recovery of the contents in the bottom of the tube.
2.2.10.5.2 Sequencing reactions (polymerisation)
These reactions were performed in autoclaved capless, 1.5 ml Eppendorf tubes 
positioned in ordered centra racks.
For each template, 2 p i o f the annealed mix was transferred to the inside wall of 4 
individual tubes; these being for the four independent sequencing reactions: with the 
"T", "C", "G", and "A" deoxy/dideoxynucleotide mixes which also contained [a -^ S ]  
dATP (0.125u Ci pi"*, specific activity 400 ci mmol'*) and Klenow polymerase 
(0.125 u pi'*). A volume of 2 pi aliquots of these nucleotide/polymerase mixes were 
transferred, onto the inside wall aliquoted template. The reactions were started by brief 
centrifugation (IEC Centra 4X with centra rack rotor) and the reaction allowed to 
proceed for 15 min at room temperature. 2 pi aliquots of sequence "chase" (0.25 mM 
dNTPs were then added to the inside wall of the reaction tubes and again mixed by 
centrifugation. Following a further 15 min incubation at room temperature, 2 x 2 pi of 
formamide dye was added to each tube and mixed by centrifugation.
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2.2.10.6 Loading and running of Sequencing Gels
Denaturing polyacrylamide gradient gels (2.2.6.2) were routinely used. The order of 
loading of the reaction mixes for each template was T,C,G,A. Immediately before 
loading, the samples were heated in a boiling water bath for 2 min and the gel wells 
flushed out with lx TBE running buffer. A 2.5 pi sample was loaded in each well 
using a drawn out glass capillary and a constant current of 25 mA was applied. The gels 
were normally run for 3.5 hours, by which time the Bromophenol Blue tracking dye 
had just run off the bottom of the gel. A fter electrophoresis, the gel, adhering to the 
back plate was fixed by immersion in 10% (v/v) glacial acetic acid, 10% (v/v) 
methanol, for 15 min. After being left to stand in a fume cupboard for 1 hour the gels 
were dried by incubation at 80°C for 2 hours, and then autoradiographed (2.2.9.3)
2.2.10.7 Compilation and Analysis of Sequencing Data
All computer analyses performed on sequence generated for the SpA DNA were 
undertaken using the programmes developed by Staden (1980). All computer analyses 
performed on sequence generated for the alk phos DNA were undertaken using the 
programmes supplied by DNASTAR Inc (Madison,U.S.A.).
2.2.11 Plasmid Sequencing
Preparation of Single Stranded Template from Plasmid DNA
Distilled water was added to 4 pg of plasmid DNA to give a total volume of 16 pi. The 
double stranded plasmid was denatured with 4 pi of a freshly prepared solution of 1 M 
NaOH/1 mM EDTA and incubated a t room  temperature. A fter 5 m in, the 
microeppendorf was placed on dry ice, and neutralised with pre-chilled 2 pi of 2 M 
ammonium acetate, pH 4.5. Immediately 60 pi of pre-chilled 10% ethanol was added, 
and the microeppendorf placed at -20°C. After 1 hour, the microeppendorf was spun for 
20 min in an Eppendorf microfuge (MSE Microcentaur, 13000 r.p.m.), the pellet 
washed with 60 pi pre-chilled 80% (v/v) ethanol, and the pellet briefly dessicated for 2 
min. The dessicated pellet was dissolved in 7 pi double distilled water, and used
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directly for primer annealing (2.2.10.5.1).
2.2.12. Site-Directed Mutagenesis
The method employed was a derivation of that described by Carter et al. (1985).
The DNA to be altered was first cloned into a suitable M13mp vector. The recombinant 
M l3 template DNA was then annealed with an appropriately phosphorylated mutagenic 
oligonucleotide. A subsequent Klenow polymerase-directed ’extension reaction’, 
primed by the phosphorylated mutagenic oligonucleotide, in a repair-deficient E. coli 
host, resulted in the generation of a mutant (-) M l3 strand. This (-) strand was then 
copied by the compromised host to give the mutant (+) M l3 strand. Resultant M l3 
clones were screened by hybridisation experiments with the mutagenic oligonucleotide, 
and those mutants identified, subjected to DNA sequence analysis.
2.2.12.1 Phosphorylation of Mutant Oligonucleotides
The freshly synthesised mutagenic oligonucleotide, which had been deprotected, was 
adjusted to a concentration of lOOng pi'*. A lOpl aliquot of the oligonucleotide was 
mixed with 2pl lOx kinase buffer (2.1.4), lp l lOOmM DTT, 2pl lOmM rATP, lpl T4 
polynucleotide kinase, and 4pl distilled water. The reaction mixture was incubated at 
37°C for 30 min and then the remaining enzyme inactivated by heat treatment (70°C 
for 10 min).
2.2.12.2 Extension Reactions and Transformation of E. coli BMH71-18
The M13 template DNA (DNA to be altered) was adjusted to an approximate 
concentration of 2 pg in 15 pi (approximately 20 pmol) in lxTE buffer. 15 pi of this 
DNA was added to a tube containing 4 pi of the phosphorylated oligonucleotide 
(2.2.8.1) and 2 pi of lOxTM buffer, and annealed as described in 2.2.9.I. Once the 
annealed template had cooled to room temperature the following were added: a further 
2 pi lOxTM buffer (2.1.4), 4 pi of a dNTP solution (2.5 mM dATP, TTP, dCTP, and 
dGTP), 1 pi 10 mM rATP, 2pl lOOmM DTT and lOpl distilled water. The reaction
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mixture was placed on ice and then 2 pi T4 DNA ligase (2.5 units pi"*) and 0.8pl 
Klenow polymerase (BCL, 5 units pi'*) was added and the mixture incubated at 15°C 
for 16 hours. The reaction was stopped with the addition of 200pl lOmM f^E D T A , 
100 mM Tris-HCl,pH 8.1.
A range of aliquots (1,5, and lOpl) of the arrested extension reaction mixture was used 
to transform 200 pi of amounts of competent E. coli BMH 71-18 mutL (2.2.2). The 
transformed cells diluted 10 and 100 times and added to 3 mis of molten (45°C) H-Top 
agar overlays, which were supplemented with 200 pi of exponentially growing E. coli 
JM101, were poured over 2xYT agar plates, and allowed to set. The plates were 
incubated overnight at 37°C.
2.2.12.3 Colony Screening of Mutants
For each mutagenesis experiment 100 M l3 plaques were picked and replica picked 
onto 2xYT agar plates in an identical asymmetric pattern, allowing the correct 
alignment of positive mutants to colonies on the master plate. The plates were 
incubated overnight at 37°C and then the plaques removed as follows a 9 cm 
nitrocellulose disc was placed gently on the surface of the agar plate, on which the 
phage-infected bacterial colonies had grown, and left to stand at room temperature for 1 
min. The filter was carefully lifted away, with the bacterial colonies adhering to it, and 
processed as described for in situ colony hybridisation (2.2.7.2) with the omission of 
the 2x SSC rinse and proteinase K treatment. The filter was placed on a sheet of 
Whatman 3MM filter paper, colony side up, and allowed to air dry at room temperature. 
The filter was then placed between two glass sheets to prevent it curling up and baked 
at 80°C in a vacuum oven for 30 min.
The filter was prewetted in 6x SSC for 5 min and hybridised with the mutagenic 
oligonucleotide which had been end-labelled with [ r -^ P ]  dATP (2.2.8.1). The 
screening was performed exactly as described in section (2.2.9) with the exceptions that 
the sheared heat denatured salmon sperm DNA was omitted from the pre-hybridisation
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solution and that the hybridisation was carried out at a T£j-15°C for the oligonucleotide. 
The filter was washed with 3 x 1  min changes of 100 ml 6x SSC at room temperature, 
covered in saran wrap and autoradiographed (2.2.9.3) at - 70°C for 1 hour. This 
revealed the asymmetric pattern of the bacterial colonies. The filter was then 
progressively washed (with 100 ml 6x SSC) at increasing temperatures, with 
subsequent autoradiography of the filter in between each wash, until the T j (°C) of the 
mutagenic oligonucleotide had been reached. As the Td temperature was approached 
the hybridisation signal of the non-mutant colonies decreased in strength relative to 
that o f the positive mutant colonies (as a consequence of the lower Td due to the 
mismatch). At the Td of the mutagenic oligonucleotide (or in some cases as a few 
degrees higher) the only hybridisation signals obtained were from the positive colonies.
2.2.12.4. Plaque Purification and DNA Sequencing
Individual mutants were obtained by the following procedures; single positive colonies 
were transferred to 10 ml of 2xYT-broth and vortexed. A 10 ¿¿1 volume of these 
diluents was added to 3 ml molten (47°C) H-top agar containing 200 nl exponentially 
growing E. coli J M 101 and poured onto a 2xYT agar plate to set, and incubated 
overnight at 37°C. Isolated plaques were chosen and template DNA prepared from 
them (2.2.10.3). The entire cloned insert of each template was subjected to DNA 
sequence analysis as described in 2.2.10.6. This was generally accomplished by using a 
number of custom synthesised oligonucleotide primers. DNA sequence analysis not 
only confirmed the mutated sequence but also checked that no other sequence 
alterations had occurred. Template DNA (1 |xl) of the chosen mutant(s) was used to 
transfect competent E. coli JM101 cells (2.2.2) and the transfected cells used to 
inoculate 10 ml 2xYT-broth for overnight incubation to provide the ’phage inoculum’ 
for the isolation of double-stranded RF DNA.only confirmed the mutated sequence but 
also checked that no other sequence alterations had occurred. Template DNA (lpi) of 
the chosen mutant(s) was used to transfect competent E. coli JM101 cells (2.2.2) and 
the transfected cells used to inoculate 10 ml 2xYT-broth for overnight incubation to 
provide the ’phage inoculum’ for the isolation of double-stranded RF DNA.
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2.2.13 Protein Analysis
2.2.13.1 Protein Assay
Protein concentrations were determined by the Folin method of Lowry et al. (1951), 
with bovine serum albumin as the standard.
2.2.13.2 Preparation of Cell Free Lysates from E. coli and S. aureus for Detection of
SpA by Western Blotting or Rocket Immunoelectrophoresis 
A single colony was inoculated into 10 ml of L-broth containing an appropriate 
antibiotic and grown at 37°C overnight. The cells were harvested by centrifugation 
(Sorval RC5B SS24, rotor), 6000 rpm for 10 minutes at 4°C, the supernatant removed 
and reserved (for later analysis for SpA) and the cells resuspended in 1.0 ml of 50 mM 
Tris HC1, pH 8.0, 25% sucrose. For E. coli cells 0.15 ml of lysozyme (20 mg ml'* in 
250 mM EDTA pH 8.0) was added and the cells left on ice for 20 minutes, swirling 
occasionally. For S. aureus cells 0.15 ml of lysostaphin (200 mg ml'* in 250 mM 
EDTA pH 8.0) was added and the cells left on ice for 5 minutes, swirling occasionally. 
Then 1.0 ml of 250 mM EDTA, pH 8.0, was added and the cells replaced on ice, 
swirling occasionally. After 5 mins 1.5 ml of Brij/Doc solution (2.1.4) was added, 
mixed thoroughly, the left on ice for a further 20 to 30 minutes or until lysis had 
occurred. The cell debris and bulk of DNA was then pelleted by centrifugation (Sorvall 
RC5B, SS24 rotor, 15000 rpm for 45 mins at 4°C) and the cleared lysate recovered.
2.2.13.3 Preparation of cell free sonicates (E. coli) for detection of SpA by western 
blotting and immunoelectrophoresis
The cells were grown and harvested as for section 2.2.13.2. They were then 
resuspended in 3 ml of 50 mM Tris HC1 pH 8.0, 25% sucrose. The cell suspension was 
transferred to an MSE sonication tube and sonicated using a MSE soniprep 150 
sonicator, maximum output, amplitude 2, for two sec bursts, with a 1 minute cooling 
interval at 4°C between bursts. The cell debris was then pelleted by centrifugation
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(Sorvall RC5B, SS24 rotor, 15000 rpm for 45 mins at 4°C) and the cleared sonicate 
removed.
2.2.14 Electrophoresis of Proteins
2.2.14.1. SDS-Polyacrylamide Gel Electrophoresis (PAGE)
Proteins were separated by electrophoresis using polyacrylamide gels under denaturing 
conditions. The proteins were denatured by heat in the presence of the anionic detergent 
SDS and the reducing agent (i-mercaptoethanol before they were loaded onto the gel. 
The denatured polypeptides bind SDS and become negatively charged. Because the 
amount of SDS bound is almost always proportional to the relative molecular mass of 
the polypeptide (lg  protein to 1.4g SDS) and is independent of its sequence, SDS- 
polypeptide complexes migrate through polyacrylamide gels in accordance with the 
size of the polypeptide.
SDS-polyacrylamide gel electrophoresis was carried out with a discontinuous buffer 
system in which the buffer in the reservoir was of a different pH and ionic strength 
from that used in the gel. For greater resolution, a stacking gel of high porosity was cast 
on top of the resolving gel.
SDS-polyacrylamide gel electrophoresis was performed with 12.5% (w/v) slab gels 
(linear range of separation approximately 14-60 kDa) run in an LKB vertical 
Electrophoresis Unit (Laemmli,1970). The gel was poured in two stages, the stacking 
gel being cast after the resolving gel had polymerised.
The resolving gel was prepared with 14.5 ml of 30% (w/v) acrylamide stock, 17.25 ml 
of resolving buffer and 5.6 ml of distilled water. The mixture was deaerated by partial 
vacuum and polymerisation initiated with 15 pi TEMED and 0.4 ml of a 10% (w/v) 
ammonium persulphate solution. Two glass plates were cleaned with detergent and 
polished with absolute alcohol, greased spacers (silicone grease) were placed on the 
sides of the "front" (indented) plate and the top plate placed on this and clamped into
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the running apparatus. This was then sealed with 2% hot agarose in SDS running buffer 
and allowed to stand for 30 min. The acrylamide solution was poured between the two 
glass plates leaving sufficient space for the stacking gel (the length of the teeth of the 
comb plus 1cm) to be poured. The gel surface was overlayed with isobutanol, and the 
gel left at room temperature to polymerise. The overlay was poured off and the gel 
surface washed with distilled water. The stacking gel was prepared with 3.0 ml of 30% 
(w/v) acrylamide solution, 12 ml of stacking buffer and 8 ml of distilled water. The 
mixture was deaerated by suction and polymerisation initiated with 20 p.1 TEMED and 
200 M-l of a 10% (w/v) ammonium persulphate solution. The stacking gel solution was 
poured directly onto the surface of the polymerised resolving gel. A teflon comb was 
then immediately inserted into the gel, being careful not to trap any air bubbles. 
Following polymerisation, the teflon comb was removed, and the wells washed out with 
distilled water. The wells were filled up with electrophoresis buffer and the samples 
loaded using a Hamilton microliter syringe (the samples were previously solubilised in 
at least 25% (v/v) of SDS loading buffer and heated at 100°C for 3 min). The gel was 
then mounted in the electrophoresis apparatus. The electrophoresis buffer was added to 
the top and bottom reservoirs, removing any air bubbles that became trapped at the 
bottom of the gel between the glass plates. Electrophoresis was carried out with a 
current of 12mA overnight, or until the Bromophenol Blue tracer had migrated off the 
end of the gel. Following electrophoresis, the gels were removed from between the 
plates and used for western blotting (2.2.15).
2.2.14.2 Rocket Immunoelectrophoresis
Electroim m unoassay introduced by Laurell, (1965), combines the speed of 
electrophoresis with the quantification of antigen provided by single radial 
immunodiffusion. In this modified version, the IgG is incorporated in the gel, and a set 
of protein A standards and cell lysates or supernatants containing SpA placed in wells 
cut into the gel. A direct current is applied and the SpA migrates into the gel according
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to its charge. While the SpA is in excess it will form soluble complexes in the gel, 
however at equivalence it will form a precipitate in the gel, as additional SpA arrives, 
the precipitate at the advancing front dissolves, while the precipitate along the sides 
remains. When no more SpA is left to enter the precipitate at the advancing front, the 
lines of precipitate converge producing a rocket-shaped appearance (monorockets). 
The area enclosed by the precipitation lines or, more roughly the height of the rocket is 
directly proportional to the initial concentration of SpA in the well.
Monorocket immunoelectrophoresis was performed with a 1% agarose/Tricine buffer 
slab gel placed on an LKB cooling plate, within a modified horizontal electrophoresis 
tank, connected to a Grant Thermocirculator containing antifreeze.
The immunogel was prepared with a 15 ml volume of 1% agarose in tricine buffer, this 
was allowed to cool to 45°C and 7.5 pi of a 4.5 mg m"1 (in water) stock of human IgG 
(Sigma) added to give a final concentration of 22.5 pg m l'1. The IgG containing 
agarose was then poured into a 10 x 10 cm perpex gel template, (which had previously 
been placed onto a levelled cooling plate and its edges sealed with 1% agarose), spread 
to the edges to give a final depth o f approximately 2 mm and left to set. The required 
number of wells, (no less than 0.75 cm apart) were punched into the gel with a 3 mm 
diameter punch, about 1.5 cm from the cathode end of the gel. The template was 
removed and the cooling plate and gel transferred to the electrophoresis tank, lx tricine 
buffer was added to the electrophoresis tank and used to soak 2 wicks cut from 
Whatman 3FF, these wicks were placed in contact with edge of the gel and the buffer 
tanks. The thermocirculator was connected to the cooling plate and set at 5°C.
A low electric current was maintained during sample loading to prevent diffusion and 
immunoprécipitation, and thus loss of sample, in the "wrong" direction. A known 
volume (usually 6 pi) of standards (made from a stock protein A solution, 0.64 mg m l'1 
in water, diluted with tricine buffer to give 8 standard concentrations ranging from 20 
pg m l'1 to 204 pg ml'1) and samples were loaded into the wells. The voltage was then
69
increased to obtain a potential difference of 200 V across the gel, and electrophoresis 
carried out for 6 hours. Following the electrophoresis, the gel was removed from the 
cooling plate and soaked in a 0.85% sodium chloride solution for 30 minutes to remove 
any unprecipitated protein from the gel. The gel was then washed 2 x 1 min in running 
water and then stained by soaking in staining solution (2.1.4) for 5 minutes prior to 
destaining in clearing solution (2.1.4). The monorockets were measured and a 
calibration curve produced by plotting distance travelled by the rocket against the 
known standard SpA concentrations. From this the unknown SpA concentration in the 
cell samples could be determined.
2.2.15 Immobilisation of Protein on Nitrocellulose (Western Blocking)
Proteins were applied to nitrocellulose membranes by electrophoretic transfer from 
SDS-polyacrylamide gels as described by Towbin et a/.(1979).
One side of the gel was placed in contact with a nitrocellulose filter. The gel and its 
attached filter were then sandwiched between 3 sheets of Whatman 3MM paper, two 
porous pads, and two plastic supports. The entire construction was then immersed in the 
electrophoresis tank containing the electrophoresis buffer. The nitrocellulose filter was 
placed towards the anode and a voltage of 60V applied for 4 hours, during which time 
the proteins became attached to the filter. Once transfer had occurred, the nitrocellulose 
filter was probed (2.2.17).
2.2.16 Iodination of Proteins
Proteins electrophoretically transferred to nitrocellulose filters were probed with 
iodinated proteins. Proteins were iodinated using a reaction in which 
generated by oxidation of N a ^ I  with chloramine T, attacks the side chains of tyrosine 
residues and.to a lesser extent, histidine residues (Greenwood et al., 1963). This 
modification, if not carried out to excess, generally does not affect the protein to protein 
interaction. For safety reasons, iodination was performed in a fume cupboard.
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100 (ig of human IgG was dissolved in 100 ¿il pBS in a 1.5 ml sterile Eppendorf tube. 
The iodinating conditions were created by the addition of 20pl lOmM chloramine T 
(freshly prepared in lxPBS buffer) followed by 0.2 pi of N a ^ I  (~200pCi). Iodination 
was allowed to proceed at room temperature for 3 min. Iodination was stopped by the 
sequential addition of 20 pi lOmM potassium metabisulphite, 60 pi lOmM potassium 
iodide and 100 pi of 10% w/v BSA (RIA trade) in lxPBS buffer.
The iodinated protein was separated from unincorporated iodine using a G-50 column 
(packed bed volume of approximately 25 ml). The column was equilibrated with 10% 
BSA, 0.1% Triton X-100 in 25 ml of PBS (running buffer). The iodinated probe was 
added to the column and eluted with running buffer. The first activity peak (total vol 
1.0 to 1.5 ml) was collected and used in probing the western blotted filters.
2.2.17 Probing of Western Blot Filters
Once transfer had occurred, the nitrocellulose filter was probed by the following 
method. The filter was soaked in 100 ml of 5% BSA (RIA grade), 1.0% Triton x 100 in 
phosphate buffered saline (PBS) for either 2 hours on a rotating platform at room 
temperature or overnight at 4°C, to saturate non-specific protein binding sites. The 
human IgG /I*^ labelled probe was added and incubation continued either at room 
temperature for 4-6 hours or overnight at 4°C. The hybridising buffer was then 
carefully removed and the filter rinsed in 6 changes of buffer, 2 x 30 mins in 5% BSA, 
1% Triton x -100 in PBS, then 2 x 30 mins in 1% Triton PBS; and finally 2 x 30 mins 
in PBS. The filter was removed and dried on Whatman 3 mm paper.
2.2.18 Enzyme Localisation in E. coli
The localisation of SpA within the E. coli cell to a particular ‘cell-fraction’: (cytoplasm, 
periplasm or membrane) was determined using an adaptation of the traditional cell 
fractionation technique of Heppel, 1967.
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A 50 ml culture of the E. coli clone under investigation was grown in L-broth (Ap 50 
pg m l'l) overnight at 37°C in an orbital shaker. A 2 ml aliquot was inoculated into 100 
mis of low phosphate broth (LPB) and grown as above until an OD^jq  of 1.0 was 
reached. The culture was then split into 3 amounts, a: 12 ml, b: 24 ml and C: 40 ml; 
and the cells harvested from each by centrifugation (8000 rpm in a Sorvall RCBS, SS34 
rotor, 10 m ins at 4°C). The supernatant was discarded and the cells washed by 
resuspending in a 5 ml of 10 mM Tris pH 7.0 followed by centrifugation (as above). 
Each of the 3 different harvest volumes were then treated separately.
The 12 ml cell culture volume was resuspended in 1.5 ml of 10 mM Tris pH 7.0 0.2 
mM DTT and stored on ice until assayed, this gave an indication of the amount of cell 
lysis.
The 24 ml cell culture volume was resuspended in 3 ml of 10 mM Tris pH 7.0, 0.2 mM 
DTT and the cells sonicated using an MSC soniprep 150 sonicator (3 x 20 sec bursts, 
set on medium frequency output, amplitude 2, with a 45 second cooling interval at 4°C 
between bursts). The cells were stored on ice until assayed, this would indicate the 
total cell enzyme content.
The 40 ml cell culture volume underwent cell fractionation in the following manner. 
The cell wall was disrupted by a mixture of osmotic shock and gentle lysis using 
lysozyme by resuspending the cells in 0.9 ml of 20% sucrose, 30 mM Tris pH 8.0,0.2 
mM DTT, to which 20 pi of lysozme (2 mg ml'* dH20 )  was added followed 
immediately by 40 pi of 0.1 M EDTA pH 8.0. This was then incubated for 10 mins at 
23°C and placed on ice where 300 pi of 10% BSA was added, followed by the addition 
of 5 ml of sucrose-tris-DTT (as above) this was mixed by 4 gentle inversions of the 
tube. The periplasmic fraction of the cell was then separated by centrifugation (8000 
rpm in a S orvall RCBS, using a SS34 rotor, 10 mins at 4°C) the supernatant
2.2.18.1 Preparation of cell fractions
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(periplasmic fraction) removed and placed on ice. The cell pellet was drained and 
resuspended in 5 ml of 10 mM Tris pH 7.0, 2 mM DTT and the cells disrupted by 
sonication (MSE soniprep 150, 15 seconds at low frequency, amplitude 2). The 
sonicate was then centrifuged at 3000 g for 10 min at 4°C (the pellet containing cell 
debris discarded) and the supernatant containing the cytoplasmic and membrane 
fractions placed in a 13.5 ml ultracentrifuge tube. The volume was made up with 10 
mM Tris pH 7.0, 0.2 mM DTT and then centrifuged in a Beckman OTD 75 
ultracentrifuge, Sorval Ti50 fixed angle rotor at (50,000 rpm) 4°C for 50 mins. The 
supernatant (cytoplasmic fraction) was carefully poured off and placed on ice until 
assayed. The pellet (membrane fraction) was drained and resuspended in 1 ml of 10 
mM Tris pH 7.0,0.2 mM DTT.
2.2.18.2 Detection of marker enzymes
Change in absorbance was measured using a Beckman spectrophotometer U8.
2.2.18.2.1 Alkaline Phosphatase (periplasmic)
To each 100 pi aliquot of extract, 900 pi of nitrophenyl phosphate (0.8 mg ml'^ in 1M 
Tris, pH 8.0) was added and the change in absorbance A E at 420 nm measured as the 
mixture incubated at 37°C. If the reaction was too rapid the cell extract was diluted in 
1M Tris pH 8.0 and the assay repeated. Units of activity per ml were determined using 
the following calculation:
units/ml = final sample volume (1 ml) xA E min
E (18.5) x path length x actual sample vol
(lcm ) (sample x dilution factor)
73
2.2.18.2.2 NADH oxidase
To each 100 pi aliquot of cell extract, 900 pi of assay buffer 0.7 ml Tris-HCl (50 mM 
pH 7.5) 0.1 ml NADH (0.12 mM), 0.1 ml DTT (2 mM) 0.1 ml was added and the 
change in absorbance A E at 340 nm measured as the mixture incubated at 37°C. If the 
reaction was too rapid the cell extract was diluted in 0.1 M Tris pH 7.5. Units of 
activity m~l were determined using the same formula as for alkaline phosphatase 
activity except the value of E = 6.22.
2.2.18.2.3 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
To each 100 pi of extract 1.5 ml of assay mix was added (section 2.1.4) and the change 
in absorbance A E at 340 nm measured as the m ixture incubated at 37°C. If the 
reaction was too rapid the cell extract was decreased (100 |xl - 5 pi). The units of 
activity ml"* were determined using the same formula as quoted for NADH-oxidase, 
except the total sample volume variable.
2.2.18.2.4 SpA
The amount of SpA present in each sample was determined using neat or diluted cell 
extract and monorocket electrophoresis (2.2.14.2)
2.2.19 Synthesis of Oligonucleotides
Oligodeoxyribonucleotides (oligonucleotides) were synthesised by ‘solid phase 
oligonucleotide synthesis’ using an Applied Biosystems Model 380A DNA synthesiser. 
The coupling chemistry employed was the phosphoramadite method which has 
inherently high coupling yields, typically 95-100%. The principles of this method of 
synthesis have been described elsewhere (Gait etal. ,1982).
2.2.20 N-Terminal Residue Analysis of Protein
Automated Edman degradation was introduced in 1967 (Edman and Begg,1967). 
Reagents in the gas-phase were introduced to replace liquid-phase reagents
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(Hunkapiller et al., 1983). The sequence of amino acid residues at the amino-terminal 
region of the protein was determined using automated Edman phenylthiohydantoin 
degradation with an Applied Biosystems Model 477A Pulse Liquid Protein Sequencer 
as described by Hunkapiller et al.,1983.
2.2.21 Light Microscopy
Samples were taken from exponentially growing cultures of E. coli JM83 containing 
each of the three pPA plasmids. Gram strains (Jensens modification 1984) were 
performed on each of the host/vector systems using E. coli JM83 as a negative control. 
Photographs were taken using a Leitz Dialux 20 microscope, with an automatic wild 
MPSS1 film holder.
2.2.22 Electron Microscopy
Immuno-electron microscopy was used to analysis the effect of SpA on host cell 
structure and to determine the location of SpA within the cell.
2.2.22.1 Preparation of sections of host organisms for structural analysis 
A sample from the continuous culture experiments was centrifuged (6000 rpm in a 
Sorvall RCBS SS34 rotor, at 4°C, 10 min) and fixed by resuspension in 2.5% 
glutaraldehyde in 0.1 M phosphate buffer for 2 hours at 4°C. This was followed by a 
buffer wash before post-fixation in 1% osmium tetraoxide in phosphate buffer for 2 
hours at 4°C. The organisms were then pelleted (6000 rpm 10 min), the supernatant 
discarded and the pellet gently mixed with 2% molten agar (Oxoid N o.l). When set, 
the agar was cut into approximately 1 mm cubes which were dehydrated in graded 
ethanol series (30%, 50% for 10 min. each: 70%, 90% for 30 min each) through to 
absolute ethanol (2 changes of 30 min) followed by 20 min (2 x 10 min changes) in 
100% propylene oxide.
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Embedding was carried out by infiltrating the agar cubes with 50:50 propylene oxide : 
araldite CY212 resin mixture for 4 hr followed by 24 hr in 100% araldite mixture. All 
of the above procedures were carried out at room temperature. The agar cubes were 
then placed in BEEM embedding capsules (size 00), covered with fresh araldite mixture 
and allowed to stand for a further 24 hour at room temperature before being cured at 
60°C for 72 hour.
Thin sections (80 nm) were cut from the resulting blocks on a Reichert OMU2 
ultramicrotone using a diamond knife and were picked up on 400 mesh copper EM 
specimen grids. After staining in aqueous uranyl acetate (2% for 30 min) followed by 
Reynolds lead citrate (10 min) (Reynolds, 1963), the sections were stabilised by carbon 
coating in an Edwards 12E6 vacuum coating unit prior to examination in a Phillips 
EM400T electron microscope operated at 80 Kv.
2.2.22.2 Preparation of sections of host organisms for the detection of SpA 
Organisms were pelleted form the continuous culture medium by centrifugation (6000 
rpm 10 mins at 4°C) and fixed by resuspension in 0.1% glutaraldehyde, in 0.1 M 
phosphate buffer for two hours at 4°C. The procedures followed in section A were then 
carried out, omitting the post-fixation of osmium tetraoxide.
2.2.22.3 Preparation of whole cells for the detection of SpA
A sample from the continuous culture medium was centrifuged (6000 rpm, 10 mins at 
4°C) then resuspended and fixed in 0.1% formalin in 0.1 M phosphate buffer. The cells 
were then adhered to formvar/carbon filmed E.M. grids by leaving a drop on the 
surface for four minutes. The cells could then be probed for SpA as in 2.2.22.4.
2.2.22.4 Assay system for the detection of SpA using electron microscopy
The grids were first resuspended on a 150 til droplet of new bom calf serum for 30 min 
so as to inhibit any non-specific binding. They were then washed 3 x 5  mins in PBS 
(pH 7.6) and incubated for 1 hour on a 150 p.I droplet of 1:500 (in PBS pH 7.6) of
76
rabbit anti-SpA for sections and 1:5000 for whole cells. The grids were then washed 3 x 
5 min in PBS and blocked with new bom calf serum for 30 mins. The grids were again 
washed in PBS (pH 8.2) then placed on ISO droplets o f 1:10 (in PBS pH 8.2) goat 
anti-rabbit labelled with gold (Biocell Ltd.) for 1 hour. Finally the grids were washed 
3x in PBS (pH 8.2) and dried on filter paper. All the above incubations were carried 
out at room temperature.
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3.1 INTRODUCTION
The S. aureus Cowan I spa gene was previously cloned by Duggleby and Jones (1983). 
A genomic library was constructed in E. coli HB101 by the insertion of chromosomal 
DNA, partially digested with Sau3A, into the Bam\U site of plasmid pAT153. Three 
positive clones, shown to direct the synthesis of SpA in E. coli, were identified and 
designated 7-D4, 8-G4 and 10-C9. The recombinant plasmids carried by these clones 
contained S. aureus derived DNA inserts of 8.9 kb, 5.9 kb 6.6 kb in size respectively. 
Restriction mapping indicated a 3.2 kb pstl fragment common to all three plasmids. 
This fragment was subcloned into the pstl site of pBR328 to yield the recombinant 
plasmid pSPA3. E. coli HB101 cells carrying pSPA3 produced two major IgG binding 
polypeptides with molecular weights of 43 kDa and 41,000 kDa.
Although the above studies demonstrated that S. aureus spa genes could be expressed 
in E. coli, the levels of SpA attained (0.5 mg ml'* culture), were of the same order of 
magnitude as that found in the natural host (Duggleby and Jones, 1983). A primary 
aim o f  this study was to elicit the high expression o f spa in E. coli. Such an 
undertaking would be facilitated by the availability of the entire nucleotide sequence of 
the spa structural gene and its regulatory regions. At the onset of these studies spa was 
known to reside on a 3.2 kb Pstl fragment (Duggleby and Jones, 1983). The 5' end of 
the gene had been determined by locating the spa promoter to a 300 bp region using a 
beta-galactosidase promoter probe vector. This located the spa promoter to a position 
between 1.9 kb to 2.2 kb from the 5 ' end of the 3.2 kb Pstl fragment containing the 
spa gene enabling it to be subcloned as a 1.9 kb EcoRl/Pstl fragment prior to 
nucleotide sequencing.
3.2 RESULTS
3.2.1 Generation of M13 Template Clones
Nucleotide sequence determination by the dideoxy method (Sanger, et at., 1980) allows 
up to 350 bp to be accurately read per M13 template on any one gel. Larger regions of
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DNA are therefore first fragmented into smaller overlapping segments, inserted into M13 
and the sequence data subsequently obtained compiled into a single continuous 
sequence using computer software. At the inception of this project fragmentation was 
universally achieved using restriction enzymes. Two strategies could be employed : (i) 
subcloning using a specific enzyme map; and (ii) the separate "random' cleavage of the 
DNA with two different restriction enzymes with 4 nucleotide recognition sequences 
and subsequent insertion of the restriction fragments generated into M l3, to yield two 
distinct template subsets. The restriction enzymes most commonly used in this latter 
strategy were SauSA and Taql. Both the above strategies were initially used in the 
sequencing of the SpA gene. The gene had been localised to a 1.9 kb EcoRl/Pstl 
restriction fragment Accordingly, the extremities of this region were isolated as 1.252 
kb £coRI///i/idIII and 0.586 kb H indlll/P stl subfragments and inserted into 
appropriately cleaved M13mp8 and mp9. In addition, the 1.9 kb EcoRl/Pstl fragment 
was isolated by agarose gel electroelution, recovered (2.2.4.6), cleaved with SauSA and 
Taql, and the cleavage products ligated to M13mp8 digested with BamHl and AccI, 
respectively. However, upon subsequent transformation of E. coli JM101, no 
recombinant "white" plaques were evident with the latter ligation mix. The suggestion 
that the 1.9 kb DNA fragment was lacking in Taql sites was confirmed by appropriate 
digestion of the purified DNA. In contrast, cleavage of the same DNA with SauSA 
yielded subfragments of 840 bp, 420 bp and 380 bp in size, with evidence of DNA 
fragments smaller than 150 bp.
To enable the sequence information derived from the above templates to be ordered 
into a continuous sequence, a further set of recombinant M l3 templates was required 
which carried overlapping subfragments. Rather than utilising a third restriction 
enzyme with a 4 nucleotide recognition sequence, use was made of a novel procedure 
(published during the course of this study; Deninger, 1983), which relies on sonication 
for fragmentation. Accordingly, the purified 1.9 kb EcoRl/Pstl fragment was subjected 
to sonication and the sheared fragments blunt-ended by treatment with T4 polymerase.
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DNA fragments of between 400 and 800 bp were isolated by size fractionation on 
agarose gels and inserted into Smal cleaved, dephosphorylated M13mp8.
A summary of the different types of template generated are given in Figure 3.1.
3.2.2 Compilation of Nucleotide Sequence Information
The nucleotide sequence data obtained from the different types of Ml 3 template 
generated were compiled into a contiguous sequence using a CTL computer and the 
DNA analysis programmes of Staden (1980). As the sequence data accumulated, a 
number of problems peculiar to this project became apparent.
The assembly of the sequence data into a complete nucleotide sequence using the two 
Staden DNA comparison programmes DBCOMP and SEQF1T proved difficult due to 
the repetitive nature of the spa gene in both the IgG binding domains and the cell wall 
binding region. The programme DBCOMP compares two DNA sequences, usually a 
new file against the consensus sequence. It allows the minimum match number o f 
sequential bases to be altered, and although it will list the number and position of any 
matches fitting the set parameters, it will only print the first match found in each 
contiguous sequence (contig, Staden, 1980) of the consensus sequence, regardless of a 
better match further in the contig. Therefore, if  a newly inputted sequence has two 
regions that have the same number of sequentially matching bases to the same contig in 
the consensus sequence, only the first match will be shown. Either the second match 
has to be assessed by hand or the programme SEQFTT used. SEQFIT will also allow 
the comparison of a new file against the consensus sequence, however it allows a 
percentage match parameter to be chosen, rather than a minimum sequential match, 
and, will display all matches found. A major problem was found with this programme 
when comparing files against a consensus sequence that contained more than one 
contig. If sequence data from the new file matched a region of sequence near the end 
of a consensus contig, the programme would carry the comparison over the into next 
consensus contig, where very little homology occurred and generate a value for
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Figure 3.1 Schematic Drawing of the 5. aureus Cowan I (NCTC8530) spa Gene
The figure shows the promoter region (P), signal sequence (Si). IgG-binding domains (E. D. A. B and C) and the cell-wall-and 
cell-membrane-binding regions (X). The restriction sites used for sequencing are shown; £ct>RI (Ec); Oral (Dr); Sou3A (S). 
//indlll (H); PsA (Ps) and £coRV (Ev). The region of the spa gene sequenced by each of the different cloning techniques is 
represented as follows; (1) sonicated DNA, (2) site-directed templates and (3) Sou 3A-cleaved DNA.
percentage match which was not necessarily the correct alignment; the position of 
lower percentage matches within the consensus contigs therefore, had to be taken into 
account. Normally these limits in the application of the above programmes would not 
become apparent, as it is unusual to see more than one significant match. The 
aforementioned problems have occurred entirely due to the high levels of internal 
homology seen within the spa gene.
A similar problem arose when sequencing the cell-wall binding domain (Xr). This 
consists of a region 2S5 bp in length and can be interpreted as a set of ten and a half 24 
bp repeats, the non identical repeat units vary from one another at only 1 or 2 
nucleotide positions (Figure 3.10). Of all the templates derived from sonicated DNA, 
none were found that contained the entire Xr region. Of the templates analysed that 
started within the repetitive region it was found that a single dubious base reading was 
sufficient for the computer to alter the alignment between a new file and the consensus 
sequence, causing the number of repeat units to vary between 5 and 18. To resolve the 
number of 24 bp repeats present it proved necessary to run a sequencing gel covering 
the entire Xr region and at least 24 bp to either side. The only template available that 
was known to cover this region was a site directed Pstl/HindlU, SpA insert in M13 mp8 
which required the region 165 bp to 465 bp upstream of the Pstl to be determined. This 
entailed reducing the ddNTP concentration in the sequencing mixtures which reduced 
the frequency of dideoxy chain termination and so increased the distance away from the 
primer to which the sequence could be accurately determined.
A further recurrent problem arose when nucleotide sequence data from Sau3A-derived 
templates was analysed. Many of these templates (greater than 25%) appeared to 
contain a single consecutive region (i.e., no internal Sau3A site) but were found to 
match two completely separate areas of the 1.9 kb EcoRl/Pstl fragment. Analysis of 
the nucleotide sequence around the areas where the mismatch occurred, revealed the 
presence of one of the following sequences: GAGC, GACC or GATG; leading to the
81
conclusion that the SauSA used was slightly less than specific in its activity, and would 
recognise a 4 base sequence that only varied from the correct recognition sequence 
(GATC) for one base at either the third or fourth position. Indeed, later manufacturers 
instructions from BRL advised that their SauSA was not suitable for sequencing as low 
levels of non-specific cleavage activity were present.
3.2.3 Initial Analysis of the spa Nucleotide Sequence
Translation of the DNA sequence into an amino acid sequence revealed an open 
reading frame 439 codons in length, beginning with a TTG start codon at position 698 
(Figure 3.2) and running beyond the Pstl site at position 2015. The absence of a 
termination codon at the 3 ' terminus of the 1.9kb EcoRl/Pstl fragment, indicated that 
the entire spa gene was not carried by pPA3, nor any its derivatives. Plasmid pPA3 
directed the expression of IgG-binding polypeptides identical in size to those produced 
by the clone 8G4 (54 kDa; 43 kDa and 42 kDa), including a band of identical size to 
native protein A produced by Cowan I (54 kDa). This would appear to indicate that 
either the cloned spa fragment coded for almost the full length protein, or that fusion 
proteins were being generated between the spa gene and the host plasmid at the 
insertion site. Analysis of the nucleotide sequence of pBR328 and at the site of spa 
DNA insertion, indicated a gene fusion consisting of 438 ¿pa-derived codons, followed 
by a 100 codons (correct reading frame) from the C-terminus o f the pBR328 p- 
lactamase gene. This resulted in a predicted molecular weight for the SpA fusion pre­
protein of 61 kDa and SpA fusion mature protein of 57 kDa. In pPA16 the same spa 
codons were fused to 14 codons (incorrect reading frame) of the pUC8 (J-galactosidase 
gene, giving a predicted molecular weight for the SpA fusion pre-protein of 49 kDa and 
SpA fusion mature protein of 45 kDa. Although the generally accepted molecular 
weight for protein A, determined by equilibrium sedimentation, varies from 41 kDa to 
43 kDa; a molecular weight of 55 kDa to 56 kDa is usually obtained if determined by 
SDS-polyacrylamide gel electrophoresis (Movitz, 1976. Langone, 1982a).
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3.2.4 Isolation of a Full Length Clone
As neither pPA3 nor pPA16 contained the entire spa gene it was necessary to return to 
the original recombinant plasmids of clones: 8G4, 7D4 and 10C9. Comparison 
between the restriction endonuclease cleavage map for the pPA3 spa fragm ent 
(Duggleby and Jones, 1983) and that of the spa gene from S. aureus 8325-4 (Lofdahl, 
et al., 1983) revealed 60% homology. The map for 8325-4 extends beyond the Pstl site 
and positions an EcoRV site immediately 3' to the translation termination codon. 
Therefore the three original clones were cleaved with EcoRI and EcoRV, all gave a 2.2 
kb fragment with restriction sites matching those of pPA3. The 2.2 kb fragment from 
clone 8G4 was inserted between the EcoRI and Smal sites of pUC8 to give pPA30 and 
transformed into JM83, where it was shown to express low levels of IgG binding 
polypeptides.
The nucleotide sequence of the 3 ' end of the SpA gene from the Pstl/EcoRV site was 
obtained by cloning the EamHI-//mdIII spa encoding fragment from pPA30 into M13 
mp9 and sequencing from the BamHl site across the Pstl site towards the //mdlll site 
in order to overlap the sequence already obtained from pPA3. The sequence o f the 
complementary strand was obtained by cloning the BamHl-Pstl spa encoding fragment 
from pPA30 into M13 mp8.
A total of 90% of the entire sequence data (95% of the SpA gene) was derived from 
both complementary strands, the remaining 10% of sequence data was obtained on only 
one strand from the site directed templates £coRI///indIII and PstUHindUl.
3.2.5 Analysis of the SpA Nucleotide Sequence, Predicted Amino-Add (a.a) 
Sequence and Secondary Structure
Translation of the DNA sequence into a.a. sequence reveals an open reading frame of 
508 codons, beginning at position 698 with a TTG start codon and ending at position 
2224 with a TAA stop codon. The protein, including the signal sequence of 36 a.a,
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consists of 508 a.a. giving a molecular weight of 55 kDa. The a.a. sequence deduced 
shows Cowan I SpA to consist of: a 36 a.a. signal sequence; five highly homologous 
domains (Figure 3.2), 56 to 61 a.a. in length, four of which are known to exhibit IgG 
binding properties (Sjodahl, 1977b) and a C-terminal region, X, 180 a.a in length which 
is thought to be responsible for cell wall and cell membrane and cell membrane binding 
properties of the protein (Sjodahl, 1977a). The X region can be subdivided into a highly 
repetitive region of 84 a.a. consisting of 10.5 octapeptide repeats (Xr) followed by a 
non-repetitive region of 81 a.a. (Xc), Figure 3.3.
3.3 DISCUSSION
3.3.1 Codon Usage and Amino-Acid Composition
The genetic code provides two or more options for all the amino acids except 
methionine and tryptophan which are coded for by a single codon. From the sequence 
studies carried out on many procaryotic and eucaryotic mRNA species, it is evident that 
preferences exist for the use of alternative codons; both between different species and 
between the mRNA involved in normally highly expressed genes compared with that 
involved in weakly expressed genes.
It is thought that the non-random distribution of synonymous codons may be related to 
the level of gene expression, by affecting the efficiency of translation. Examination of 
the correlation in E. coli codon usage and content of the respective tRNA by Ikemura 
(1981a and 1981b) and Ikemura and Ozeki (1982), together with studies to determine 
which synonymous codon is preferred in strongly and in weakly expressed genes (Gouy 
and Gautier, 1982; Grojean and Fiers, 1982; Königsberg and Godson, 1983; and 
Wain- Hobson el al., 1981), has enabled the construction of a set of proposals to 
explain the codon preference exhibited. These proposals can be subdivided into two 
groups; those dependent on the levels of the various tRNAs available to the gene, and 
those concerned with codon-anticodon interaction energies.
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Figure 3.3 A dot Matrix Homology Plot for SpA (NCTC8530)
The plot shows areas of internal homology within SpA. The axes relates to the amino acid 
sequence of SpA (with position 1 on each axis corresponding to the N-terminal residue of the 
signal peptide). The functional domains of SpA are indicated parallel with the axes. The plot 
shows two regions to be homologous if six or more residues from a block of ten are identical 
(and in the same relative position) within the block.
The most important appears to be the correlation, reported by Ikemura (1981a), 
between highly abundant tRNAs and a strong bias towards their respective codons in 
highly expressed genes. Ikemura and Ozeki, 1982, also state that, where two 
isoacceptors are present in equal amounts in the cell, one of which responds to two 
codons whereas the other responds to only one of the two codons, then the codon that is 
recognised by both the tRNA isoacceptors will be more frequently used than the other. 
It is proposed that codons corresponding to minor tRNAs or weak isoenzymes, may act 
as modulator codons regulating the elongation rate of the nascent polypeptide during 
translation.
The second group of rules concerning the choice between synonymous codons appears 
to be on the basis of the optimisation of codon-anticodon pairing energies, Grosjean 
and Fiers (1982), have suggested that the translational efficiency is facilitated by 
intermediate strength reactions rather than strong or weak reactions. In general, 
codons of the (A/U)-(A/U)-pyrimidine type form intrinsically weak interactions, 
preferring a C in the wobble position to stabilise the codon- anticodon interaction. 
Codons of the (G/C)-(G/C)- pyrimidine type are involved in intrinsically strong 
interactions and prefer a U in the wobble position, to weaken the codon- anticodon 
interaction and so optimise translation. In certain circumstances, such as modification 
of the nucleotide in the wobble position, the above rules have been found to be invalid. 
A number of such examples have been reported (Ikemura, 1981a and 1981b; Ikemura 
and Ozeki, 1982). Thiolation of uridine, such as that found in E. coli tRNA^lu and 
tRNALys, or 5 ' -carboxymethalation of uridine restricts wobble G.U pairing and so 
produces a preference for using the A-terminated codon over the G-terminated codon. 
Inosine in the wobble position produces a preference for U and C terminated codons 
over the A terminated codon and so leads to purine-purine pairing. It has also been 
noted by Gouy and Gautier, 1982; and Nichols et al., 1980) that the aforementioned 
pyrimidine-ending codon preference is only independent of amino acid composition in 
highly expressed genes. In weakly expressed genes codon usage appears to more 
consistent with the G+C content of the genome, and where the G+C content is
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unusually high or low this bias is often disproportionately represented in the wobble 
position of the codon.
3.3.1.1 Codon usage in Staphylococcus species
Unlike E. coli no major studies have been undertaken on S. aureus or other 
staphylococcal species to establish the number of tRNA species and their abundance 
within the cell. Although the studies on the closely related enteric organisms E. coli 
and Salmonella typhimurium (Ikemura, 1985) have shown a similar pattern of codon 
usage, S. aureus is a Gram-positive organism unrelated to the former two organisms 
and has a different G+C content, and thus might exhibit a different codon usage pattern. 
From the fact that organisms as diverse as Saccharomyces cerevisiae and E. coli have 
shown that their genes differ more in the degree o f bias rather than its direction, it 
might be predicted that other procaryotes would have a codon usage pattern similar to 
that of E. coli. However the only Gram-positive organism which has been examined 
for codon usage preference to any great extent, B. subtilis, (examination of the 
nucleotide sequences of 21 B. subtilis genes by Ogasawara (1985) and 56 B.subtilis 
genes by Shields and Sharp (1987)) has revealed several differences in codon usage 
from E. coli. Firstly, there appears to be comparatively little codon bias in B.subtilis 
genes, substantial codon bias only being seen in very highly expressed genes. 
Secondly, there is no apparent preference for codons with an intermediate codon- 
anticodon interaction energy. Finally there appears to be no evidence of selection in 
favour of purine- any nucleotide-pyrimidine codons (G/A-X-C/U), reported by 
Shepherd (1984) to be seen in excess in most other organisms. It is has been proposed 
by Void (1985) that the unique organisation of tRNA genes of B. subtilus is responsible 
for the unusually unbiased codon usage of this organism. As the tRNAs present in S. 
aureus have not been recorded it it not possible to predict codon usage for S.aureus or 
other staphylococcal species. Therefore codon bias will have to be determined by the 
examination of the known nucleotide sequences for staphylococcal genes. This data is 
very limited and unfortunately, most of those sequenced to date reside on staphylococcal 
plasmids and transposons, and as such may have originated from a different bacterial
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species. A comparison between the codon usage predicted from the spa nucleotide 
sequence and the codon usage predicted from the nucleotide sequences of IS 
staphylococcal genes (further details of genes selected are given in Table 3.1), is 
presented in Table 3.2. A substantial difference between the G+C content of the 
plasmid derived genes and the chromosomal and transposon genes is evident (Table 
3.2), a factor which may influence the codon bias (as stated earlier). Accordingly, the 
staphylococcal genes were segregated into the three different categories, on the basis of 
origin, (Table 3.2), and three separate comparisons undertaken.
The comparative date obtained revealed slight differences in the codon preference 
between the 3 categories (chromosome, plasmid and transposon) of genes examined: 
plasm id genes had a higher content o f the codons G C U ^ a and CAA®*n; 
chromosomal genes had a higher content of the codons CGU^r£, GGU®*y and 
AAGLys, and a lower content of the codon A C U ^ r; while transposon genes had a 
higher content of the codon UGC^ys. Comparison of spa with these preferences 
revealed that it showed greater similarity to plasmid codon preference for residues Ala, 
Gin and Lys, with only the residue Cys showing the same codon preference as the 
chromosomal genes.
The spa nucleotide sequence showed a codon bias substantially different to all the other 
15 staphylococcal genes examined for eight particular residues. 1) Of the six codons 
corresponding to the residue Arg, there was a marked preference for the codon CGC 
(44% of the Arg residues), while AGA was never used. In the case of the other 15 
genes, AGA and CGC accounted for between 35%-65% and 0%-3% respectively, of 
the Arg codons. 2) O f the two codons corresponding to the residue Glu, GAA was 
seen to be approximately 25% higher and GAG 25% lower than the corresponding 
codons in the other 15 genes. 3) Of the four codons corresponding to Gly, GGA was 
seen to account for only 8% of the residues, rather than 26%-39% in the other 
staphylococcal genes. 4) Of the six codons corresponding to the residue Ser, there is a
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TABLE 3.1
Staphylococcal Species Genes Selected for Codon Usage Comparison
Gene/Product 
of DNA
Organism
content
Origin
reference
%G+C Sequence
Enterotoxin B S. aureus C 37.9 Jones & Khan, 1986
Staphylokinase S. aureus C 34.5 Sako & Tsuchida, 1983
Lipase S. hyicus c 39.5 Qotzetal., 1985
Alpha toxin S. aureus C 34.5 Grey & Kehoe, 1984
Protein A S. aureus C 38.1 Shuttleworth et al., 
1987
Exfoliative 
toxin B
S. aureus p 28.7 Jackson & Iandolo 
1986
Lysostaphin S. simulans p 37.1 Recsei et al., 1987
linA
&(Lincomycin R )
S. haemolyticus p 28.6 Brisson-Noel 
Courvalin, 1986
ß-lactamase S. aureus p 27.9 Wang & Novick, 1987
spc
(Spectinomycin R)
S. aureus T 36.4 Murphy et al., 1985
ermA
(Erythromycin R )
S. aureus T 32.3 "
tnpA
(transposition)
S. aureus T 32.2 "
tnpB
(transposition)
S. aureus T 33.9 "
ynpC
(transposition)
S. aureus T 39.9
* Organism from which DNA was isolated
Origin of DNA: C = chromosome, P = plasmid and T = transposon
All the above genes are thought to be moderately expressed excepting B-lactamase and 
Protein A which are more strongly expressed and die transposition genes which are 
weakly expressed.
TABLE 3.2
Codon usage in 15 staphylococcal species genes compared with that for spa
Residue Source of gene
codon Plasn:id Chronosone Tran sposon SPA
ZB« z b « SB A ZB
Ala GCA 17 27 35 48 28 41 17 34
Ala GCC 8 13 8 11 8 12 1 2
Ala GCG 1 2 16 22 8 12 4 8
Ala GCU 36 58 14 19 24 35 28 56
Ar g AGA 15 65 14 35 50 54 0 0
Ar g AoG Ü 0 3 8 15 16 0 0
Arg CGA 3 13 3 8 5 5 0 0
Ar g CGC 0 0 1 2 3 3 4 44
Arg CGG 1 4 3 8 4 4 0 0
Arg CGU 4 18 16 40 15 16 5 56
Asn AAC 14 17 18 26 23 21 42 70
Asn AAU 67 83 50 74 86 79 18 30
Asp GAC 15 23 19 21 11 12 17 45
Asp GAU 51 77 72 79 80 88 21 55
Cys UGC 0 0 0 0 5 29 0 0
Cys UGU 4 100 1 100 12 71 0 0
Gin CAA 31 97 38 83 54 70 37 100
Gin CAG 1 3 8 17 23 30 0 0
Glu GAA 51 77 67 77 89 64 39 95
Glu GAG 15 23 20 23 50 36 2 5
Glv GGA 27 39 23 26 34 44 3 8
Gly GGC 5 7 19 21 6 8 13 33
Gly GGG 4 6 12 13 11 14 0 0
Gly GGU 33 48 36 40 27 35 24 60
His CAC 7 26 13 30 10 22 1 20
His CAU 20 74 30 70 35 78 4 80
lie AUA 29 39 23 32 49 37 1 6
lie AUC 5 7 12 16 14 11 9 50
lie AUU 41 55 38 52 70 52 8 44
Table 3.2
Residue Source of gene
e °‘ °"
Plas mid Chronosone Tran SPP
IB« A I B A
Leu CUP 7 9 8 11 28 15 4 9
Leu cue 1 1 0 0 7 4 0 0
Leu CUG 3 4 5 7 9 5 0 0
Leu CUU 9 12 9 13 35 19 8 19
Leu UUP 47 oO 33 46 67 36 27 63
Leu UUG 11 14 16 23 38 21 4 9
Lys PPP 96 79 19 58 127 70 51 82
Lus PPG 25 21 14 42 54 30 11 18
Met PUG 24 24 41 4
Phe UUC 8 22 10 24 20 25 13 81
Phe UUU 2 9 78 31 76 60 75 3 19
Pro CCP 20 51 19 40 28 46 10 32
Pro CCC 1 3 1 2 4 7 0 0
Pro CCG 3 8 9 18 4 7 2 6
Pro e c u 15 38 19 40 24 40 19 62
Ser PGC 9 12 14 15 12 11 11 48
Ser PGU 17 22 14 15 32 29 4 17
Ser UCP 31 41 31 33 27 24 3 13
Ser UCC 0 0 5 5 7 6 0 0
Ser UCG 3 4 12 13 7 c 0 0
Ser UCU 16 21 19 20 27 24 5 22
Ter UPP 2 100 3 100 2 50 4 67
Ter UPG 0 0 0 0 0 0 1 17
Ter UGP 0 0 0 0 2 50 1 17
Thr PCP 34 4c 6-1 56 35 38 4 3c
Thr PCG 2 3 11 10 14 15 0 0
Thr AC G 7 9 19 17 15 16 0 0
Tpr PCU 33 43 17 16 29 31 7 64
Trp UGG 13 16 25 0
Tyr UPC 13 21 10 21 8 11 0 0
Tyr UPU 49 79 37 79 63 89 6 100
Ual GUP 36 47 21 30 39 30 6 43
Ua 1 GUC 4 5 14 20 17 13 2 7
Ual GUG 6 8 10 14 21 lb 2 14
Ual GUU 30 39 25 36 51 40 5 36
Columns headed A represent total number of codons. The codon usage was derived 
from the nucleotide sequences of the genes present in Table 3.1.
Columns headed %B represent percentage synonym use, and was obtained by dividing 
the number of times a codon was used in the relevant genes by the number of times all 
codons specifying the same amino acid were used , expressed as a percentage.
Ter, Termination codon.
minimum of 69% higher content of the codon AGC and a significantly lower content 
of the codons UCA and UCC, compared to that found in the other staphylococcal 
genes. 5) The codon AUC, corresponding to the residue lie, is substantially higher in 
the spa gene while the synonymous codon AUA is greatly reduced. 6) There is little 
codon bias shown between the two synonymous codons corresponding to the residue 
Asp in spa, whereas in the other staphylococcal genes (excepting erm, equal codon 
usage) the codon GAU is far m ore common than GAC. The most substantial 
difference in codon bias is seen for the residues Asn and Phe where 7) the codon 
content between the two possible synonyms for Asn in spa are 70% (AAC) and 30% 
(AAU), whereas completely the opposite usage is seen in the other staphyloccocal 
genes 17-26% (AAC) and 74-83% (AAU), except in erm where AAC represents 45% 
of the codon content and AAU 55%. 8) An almost identical bias is seen for the
residue Phe, with codon usage in spa  being 81% (UUC) and 19% (UUU), compared 
with 22-25% (UUC) and 75-78% (UUU)in the other staphylococcal genes except that 
for alpha toxin where codon usage is 50% of each synonym.
The most likely explanation for the difference in codon bias between the spa sequence 
and the sequences of the other staphylococcal species genes examined, is the fact that 
SpA is a fairly abundant cell protein (1.7% of total cell protein, Sjoquist et al., 1972b) 
whereas all the other genes examined code for less abundant proteins. The codon bias 
seen in spa may be indicative of the codon bias needed for near to optimum translation 
potential in S. aureus. All the above codon preferences (points 1 to 8) exhibited by the 
spa sequence correspond to the codon bias present in strongly expressed E. coli genes 
(Table 3.3). This would appear to indicate that the codon usage pattern of S. aureus is 
very similar to that of E. coli, however until further S. aureus strongly expressed genes 
have been sequenced, their codon usage determined and tRNA abundance in S. aureus 
examined the above statement cannot be substantiated.
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TABLE 3J
Codon Usage in spa Compared with Optimum Codon Usage in E.coli
optimal »RNH optimal codon
abundance in -anticodon
E.coll binding
codon usage 
in strongly
£ co11 genes
»Pa E ■ c o l 1 
s y n . j y n .
Ala GCA 0
Ala GCC N N
Ala GCG 0
Ala GCU 0 0
34
56
Arg AGA N 
Arg AGG N 
Arg CGA 0 
Arg CGC 0 
Arg CGG N 
Arg CGU 0
N
0
35
3
58
Asn AAC Ú
Hsn AAU O
O
N
70 76
R  30 24
Asp GAC 
Asp GAU
45 49
55 51
Cys UGC 
Cys UGU
0 58
0 42
Gin
Gin
CÁA
CAG
R 100 27
0 73
Glu
Glu
95 73
5 27
Gly GGA N 
Gly GGC O 
Gly GGG N 
Gly GGU O
I 8 5
33 41
I 0 7
60 48
His
His
CAC
CAU
lie AUA N
H e  AUC O
lie AUU 0
50 62
44 37
Leu CUA N 
Leu CUC N 
Leu CUG O 
Leu CUU N 
Leu UUA N 
Leu UUG N
Lys AAA O
Lys AAG O
82 77
18 23
Residue
and
codon
opt inai tRNA 
E.coli
optinal codon 
binding^
E.coli
ongly
îs£a 
use %
E c o l isyn . 
use \
Met AUG N - .
Phe UUC N 0 81 56
Phe UUU N N 19 44
Pro CCA 0 32 20
Pro CCC N N R 0 6
Pro CCG 0 6 65
Pro e c u N 0 R 62 9
Ser AGC N 48 22
Ser AGU N I 17 6
Ser UCA N I 13 8
Ser UCC N 0 26
Ser UCG N R 0 1 1
Ser UCU N 22 27
Thr ACA N R 36 t
Thr ACC 0 0 51
Thr ACG N R 0 20
Thr ACU 0 64 24
Trp UGG N 0 -
T vr UAC 0 0 0 59
Tyr UAU O N 100 41
Cal GUA 0 43 23
‘Ja 1 GUC N 7 13
<Jal GUG 0 14 27
<Ja 1 GUU 0 36 38
O: optimal codon. N: non-optimal codon. Determination of optimal and non optimal 
codons correlating to tRNA abundance was according to Ikemura (1981), and Ikemura 
and Ozeki (1982). Determination of optimal and non-optimal codons correlating to 
optimal codon-anticodon binding interaction was according to Grosjean and Fiers 
(1982), Ikemura (1981) and Ikemura and Ozeki (1982).
I: Infrequently used codons. R: Rarely used codons. Determination of infrequently and 
rarely used codons was according to Königsberg and Godson (1983); where, of the 23 
E.coli genes examined, infrequently used codons totalled an average of 12.1% of all 
codons used, and rarely used codons totalled an average of 4.2% of all codons used.
t spa and *E. coli percentage synonym (syn.) usage was calculated as detailed in the 
legend to Table 3.2. Codon usage for the spa gene is also detailed in Table 3.2 and 
codon usage for the 23 E.coli genes can be found in the paper by Königsberg and 
Godson, 1983.
3.3.1.2 Expression potential of spa in E. coli indicated by codon bias 
One of the main objectives of this project was to synthesise SpA in E. coli at a higher 
level than by the native organism. As translational efficiency is a major factor in final 
protein levels, a comparison of codon usage of the spa gene against that preferred by 
strongly expressed E. coli genes and the relative abundance of the corresponding E. 
coli tRNA species was performed; the results are presented in Table 3.3.
The spa gene appears to have the same codon bias for many of its residues (Lys, Ser, 
Val, Arg, Asn, Asp, Gly, and He) as seen in most highly expressed E. coli genes. For 
the residues Ala, Glu and Phe the direction of codon bias is the same as that for highly 
expressed E. coli genes, however, the degree of bias is greater. Several SpA residues; 
Gin, His, Leu, Pro, Thr and Tyr have a completely different codon preference to that of 
E. coli. The codon bias seen for these six residues in spa is apparent throughout all 
staphylococcal genes sequenced to date (see Table 3.2). With the exception of Tyr 
(where the optimum synonym depends on codon- anticodon interaction strength), all 
have the synonym bias, which in E. coli has been shown to be dependent on tRNA 
abundance. Such a strong codon preference throughout all the staphylococcal species 
genes examined may be indicative of a difference between E. coli and staphylococci in 
the relative abundance of the different tRNA species. The presence of a different 
synonym bias for Gin, His, Pro and Thr will probably not reduce the expression 
potential of the spa gene in E. coli, to any great extent, as there is only a minor 
difference between the E. coli cellular content of the tRNA species corresponding to the 
preferred synonym in spa and that preferred by E. coli. Whereas for the residue Leu 
there is a major difference in their relative tRNA abundances, with the E. coli content, 
of the tRNA corresponding to the preferred E. coli synonym for Leu (CUG) being 4 
times higher than the tRNA content corresponding to UUA (the preferred Leu synonym 
in spa, (Ikemura, 1981a&b). Whether the predominant use of the synonym UUA in the 
spa gene will result in a reduction of its translation rate in E. coli may well depend on 
their position within the gene. Robinson et al., (1984) inserted a 6 amino acid 
synthetic oligonucleotide into the CAT (chloramphenicol acetyltransferase) gene of E.
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coli such that a favoured synonym was substituted with a rarely used synonym for four 
consecutive residues. This modification had no effect on the amount of protein 
produced at moderate transcription rates, however, upon maximal induction of the 
preceding trp promoter the synthesis of CAT and the CAT-derived protein from the 
gene with the favourable synonym insen increased 3-fold, whereas the synthesis of the 
CAT-derived protein from the gene with the rare synonym insert did not increase.
The position of the synonyms corresponding to Leu in the spa gene are shown in Figure
3.4. Although the close proximity of UUA codons in the N-terminal region of IgG- 
binding regions B and C may have some effect on the rate of translation, it is more 
likely that the cell-membrane association region, Xc, may limit the translation rate of 
the spa gene in E. coli. This hypothesis is corroborated by later experiments (section 
4.2.1.2) where a plasmid (pPA34) carrying a C-terminally truncated spa gene, lacking 
the Xc region, produces almost twice as much SPA as a similar plasmid (pPA31) 
carrying the entire spa gene.
The most noticable difference in codon usage between the E. coli and the 
staphylococcal species genes examined is in the choice of translation initiation codon. 
The codons AUG, GUG and UUG are thought to be able to function as initiation 
codons as they have all been shown to stabilise the binding of initiator fMET-tRNA to 
ribosomes in vitro (Clark and Marcker, 1966). Comparison of the initiation codons of 
126 E. coli genes ( Gen Bank, 1984) have shown a marked preference for ATG to be 
present as the initiation codon, 115 (91.2%) times against 6 (4.5%) TTG initiation starts 
and 5 (4.0%) GTG initiation starts. Comparison of the initiation codons from 20 
staphylococal species genes (DNASTAR Gen bank, 1987) shows a less marked 
preference for ATG as the initiation codon, 13 (65%) ATG initiation starts against 4 
(20%) TTG initiation starts and 1 (5%) GTG initiation starts. Reddy et al., (1985) has 
shown that replacement of the TTG initiation codon in the E. coli adenylate cyclase 
(cya) gene with ATG and GTG resulted in a 3-fold and 2-fold increase in the gene
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Figure 3.4 Position of Synonymous Codons Corresponding to  Leucine Residues in spa
Amino acid sequence positions are indicated down the left hand side o f figure, the different 
domains o f SpA are indicated above the sequence and are designated as already described in 
Figure 3.2. Codons are represented by a -, except for the synonymous codons corresponding to 
Leucine which are written in full. Lettering beneath the codon designates the tRNA which 
corresponds to that particular codon (nomenclature is that used by Ikemura, 1981); r:Leu tRNA 
UUR (£. co/i content = 0.24), m ; Leu  tRNA CUA (£. coli content = minor), 2 : Leu tRNA CUU 
(£. coli content = 0.3).
product, respectively. Thus although it is not unusual for spa to possess a TTG 
initiation codon it might adversely affect its translation initiation frequency when 
expressed in E. coli.
3.3.2 Features of the 5 ' Non-Coding Regions
3.3.2.1 Transcription Initiation Signals
A promoter is defined as a segment of DNA that contains signals for the proper binding 
and subsequent activation of RNA polymerase holoenzyme, to a form capable of 
initiating the synthesis of RNA, it usually precedes the coding section of the gene.
Comparison of the nucleotide sequences of E. coli and related bacteria (Raibaud and 
Schwartz, 1984; Rosenburg and Court; 1979 ) have revealed several common features, 
enabling the construction of a consensus sequence for the general prokaryotic 
promoter. Numbering of the DNA sequence of this region is such that nucleotide +1 is 
the start of the mRNA transcript. There are two conserved hexanucleotide sequences: 
one around the -35 position consisting of a highly conserved trinucleotide TTG and a 
less conserved ACA sequence, (TTGaca); the other around the -10 position, often 
referred to as the Pribnow box (Pribnow, 1975), consists of three highly conserved 
nucleotides in the first, second and sixth positions and three less conserved nucleotides 
in the centre, TAtaaT. The -35 promoter sequence is thought to be important for the 
initial recognition of the transcription initiation region by RNA polymerase (Schaller, 
1975). The -10 promoter sequence is proposed as the initial binding site for RNA 
polymerase at which the helical DNA unwinds in order for initiation to occur at a 
purine residue normally 7-9 bp downstream (Rosenberg and Court, 1979).
The Cowan 1 spa nucleotide sequence (Figure 3.3) contains 2 hexanucleotide sequences 
that correspond closely to the consensus -35 and -10 promoters. At positions 638 to 
643 the spa nucleotide sequence TTGCAA only differs from the -35 consensus 
sequence in the less conserved trinucleotide region by an inversion of the fourth and 
fifth bases. At positions 661 to 666 the spa sequence TATGAT differs from the -10
91
consensus sequence at the less highly conserved fourth nucleotide where a G (instead 
of an A) is present. Further evidence in support of these two hexanucleotides 
representing the position of the transcription initiation region of the spa gene is 
obtained by comparison with other procaryotic promoters. Firstly, the -10 promoter is 
in close proximity, 14 bp upstream, to a possible ribosome binding sequence (see 
section 33.2.2). Secondly, the nucleotide spacing between the -35 and -10 promoter 
has been shown by Stefano and Gralla (1982a) to be a crucial factor in promoter 
strength. Almost all the prokaryotic promoters they examined had a spacing of 17 + 1 
with 17 considered to result in maximum promoter strength. Thus, the SpA promoter 
region is not only typical, with a spacing of 17 nucleotides, but is also potentially a very 
strong promoter. Thirdly, the rigidity of the DNA in the promoter region has been 
proposed to play a crucial role in its interaction with the RNA polymerase (Travers, 
1986). The rigidity o f DNA is often dependent upon the presence of rigid 
homopolymer dA:dT stretches, usually 4 bp or greater in length. The statistical survey 
undertaken by Travers (1986), indicated that such rigid sequences occur most 
frequently around the -45 and -55 position and are preferentially excluded from the 
regions immediately upstream of the -35 and -10 sequences, and from a region around 
-23 to -25. The nucleotide sequence of the proposed spa promoter region conforms to 
this pattern in that it has no A or T blocks greater than two nucleotides in the region 
from the -35 to the -10 promoter and has a stretch of 4 T’s from positions -43 to -46.
3.3.2.2 Translation initiation region
In order for translational initiation to occur, a small ribosome subunit must specifically 
bind to the region of the mRNA containing the initiation codon. Hence there must be 
some mode of differentiation by the ribosome subunit between an initiation codon and 
internal AUG, GUG and UUG codons. Shine and Dalgamo (1975) first proposed the 
presence of a specific base sequence prior to the initiation codon, after observing that 
all of the coliphage RNA ribosome-binding sites reported and the ribosome- binding 
site of an endogenous E. coli mRNA, contained all or part of the sequence 5 ' 
-AGGAGGU-3' (Shine-Dalgamo sequence, S.D ), which in turn is complementary to
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the sequence (5' -ACCUCCU-3, ) they had shown to be present at the 3' terminus of 
E. coli 16S RNA. This would suggest a direct base pairing role in the initiation of 
protein synthesis, rather than a dependence on the secondary structure of the region.
Subsequent analysis of the translation initiation region (-25 to +20, where position 1 
represents the first nucleotide of the initiation codon) from 123 DNA sequences by 
Stormo et al., (1982) revealed a number of additional features present in the preferred 
ribosome binding region. There appeared to be discrimination against the purine G 
occuring on both sides of the S.D sequence, possibly to diminish misalignment during 
annealing to the 16S RNA. A preference for the pyrimidine T rather than C, which 
may prevent complementation with the purine G tract of the S.D sequence, and a 
preference for the purine A in most of the region outside the S.D sequence itself. A 
further feature noted was a translation termination codon commonly found 
immediately S' to the initiation codon. Atkins (1979) has examined this latter point in 
detail and reports that in 50% of the 92 sequences considered, a termination codon 
occurs within the first three codons 5 to the translational start and in nearly all the 
remainder within the first seven codons. It was also noted that 60% of the sequences 
have a termination codon (in a different reading frame to that of the gene) within the 
first four codons following the initiation codon. The proportion of each of the 
termination codons is noticeably different, with TAA occuring twice as often as TGA, 
and TAG not present as the first termination codon preceding the translation initiation 
codon in any of the functional genes examined. Furthermore, TAG only constitutes 
5% of the termination codons found immediately following the initiation codon. 
Atkins has proposed that the termination codons TAA and TGA may be very important 
for ribosome recognition. However, a later review by Gold et al., (1981) concludes that 
although the frequencies of the different termination codons reported by Atkins are 
correct, it is purely coincidental that they are termination codons. Their presence can 
be explained as a side effect of the preference for the purine A and the discrimination 
against G and C seen in this region. Gold et al. (1981) also points out that the non- 
termination codon TTA is present at the same level as TAA. Also the apparently
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significant discrimination against TAG is due, not only to the fact that it is the least 
abundant o f all the trinucleotides, but also because both TAA and TGA are 
complementary to the 3' end of the 16S RNA (3' -AUUCCUCCACU-5' ) and can 
overlap the initiation codon, whereas TAG cannot. Although Gold et al. (1981) queries 
the role of termination codons in translation initiation, he accepts that there is evidence 
that the ribosomes might scan for T’s and A’s in this region, in particular the sequence 
TTAA.
The nucleotide sequence immediately preceeding the spa structural gene complies 
extensively with the aforementioned characteristics of a translation initiation region. 
Within the initiation region there are only two C’s 5* to the S.D sequence and none 3* 
to it. Furthermore, apart from the S.D sequence, this region contains only two G’s (one 
at position +3 and the other at position +9). The entire region is very A rich. Thus, 
excluding the poly G tract of the S.D sequence, 23 of the 40 nucleotides are A’s. The 
"termination" codons TAA and TGA are found respectively, 4 nucleotides prior to, and 
overlapping, the initiation codon. The actual spa S.D sequence (5' -AGGGGGT-3') 
only varies at one nucleotide position, the central G, from the accepted consensus 
sequence (5 -AGGAGGT-3 ) and thus would form a stable ribosome binding complex 
with a AG of -12.2 Kcal mol’*. The number of nucleotides between the S.D sequence 
and the initiation codon in spa is 6, which falls within the normal range of 5 to 9 .
Unlike the RNA polymerase binding site, variations in both the nucleotide spacing 
between pertinent features within the translation initiation region and the large 
differences in free energy values (-4 to -22 Kcal mol'*, Stormo 1982) determined for 
ribosome binding, appear to have no correlation with translation initiation rates. 
Experimental evidence reviewed by Gold et al. (1981) indicates that the secondary 
structure, in particular hairpin loops, of this region may play an important role in the 
control of initiation, with rates dependent upon the accessibility of the S.D sequence 
and the initiation codon. The nucleotide sequence of the spa gene gives no evidence of 
any such secondary structure control mechanism in the translation initiation region, 
though it is possible that tertiary structure control mechanisms may exist.
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3.3.2.3 Features 5' to the spa -35 transcription initiation region
The regulation of gene activity is often controlled by the regulation of the frequency of 
transcription initiation. As the understanding of the promoter regions of genes has 
increased, it has become apparent that initiation of transcription in many systems is 
strongly influenced by sequences well upstream of the genes they regulate i.e., lac 
operon, gal operon, ara operon, the genes coding for tryptophanase, D-serine 
cheaminase and histidase are just a few examples.
These initiation control signals can be divided into two categories, (i) those where the 
actions of regulatory proteins inhibit transcription initiation (repressors), and (ii) those 
where the action of regulatory proteins stimulate transcription initiation (activators). 
These regulatory proteins are thought to operate to enhance or prevent the binding of 
RNA polymerase, by one of two modes (i) interaction with the RNA polymerase itself 
or ( ii)  interaction with the nucleotide sequence surrounding a potential RNA 
polymerase binding site. Such interaction may cause an alteration in the DNA 
configuration which will effect the binding rate of the RNA polymerase i.e., it may 
enhance a sequence that normally varies from the recognised consensus to such an 
extent that it is not recognised by RNA polymerase; the presence of an activator may 
allow recognition or alternatively may alter the conformation of a previously inhibitory 
nearby DNA sequence allowing promoter activity. One of the most common regulator 
proteins known to be an activator for the expression of lac and other systems controlled 
by catabolite repression is the catabolite receptor protein (CRP), the product of the crp 
gene. In the presence of 3 '-5 ' cyclic adenosine monophosphate (cAMP), the protein 
has been shown to bind at specific sites in the vicinity of several promoters and have a 
stimulatory effect on transcription initiation. Examination of the CRP binding site 
(CBS) of several genes (Ebright, 1982; Raibaud and Schwartz, 1984) has shown that 10 
nucleotides within a continuous 17 nucleotide sequence are normally conserved, 
Ebright proposes that these nucleotides constitute the CRP-DNA contact points. 
Computer analysis of further 7 operator regions from genes known to have CRP-
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binding sites by Studnicka (1987) has shown that some nucleotides of the binding site 
are more strongly conserved that others, those strongly conserved are shown below.
The nucleotide sequence upstream of the spa-10 promoter was examined for homology 
with CBS and other known operator sequences. Two possible CBS/operator sites 
(CBS1 and CBS2) were identified (Figure 3.5) between nucleotides 93 and 117 and the 
second between nucleotides 292 and 316, these are shown below compared with CBS
consensus.
CRP binding site a a . T G T G A  . . t a . . t C a a/c A t a/t t . a/t g . 
sequence
CBS 1 A A c T G T t A g a g c t c T C A A t a A T t T a  76% homology
CBS2 A A g T G c t g T A t t c t A A A g T g c c a  72% homology
spa CBS1 homology has a spacing of 6 nucleotides between conserved regions and also 
shows a region of dyad symmetry associated with the 3' and 5' halves of the CBS or 
operator site. The spa CBS2 homology has a spacing of 5 nucleotides between the two 
conserved regions, though an extra spacing of one nucleotide would also realign the spa 
CBS to increase the level o f homology among the most strongly conserved nucleotides 
of the 3' half of the binding site.
Abrahmsen et al., 1986 reported experimental results following "heat-shock" treatment 
that suggest the existence o f a stress induced promoter in front of the spa gene. 
Comparison of the region upstream of the -35 spa promoter with known "heat shock" 
promoters (Reznikoff et al., 1985) proposes putative -35 and -10 sites (shown in Figure
3.5).
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CAATTCACAATTCTACCTATTATCACTTCTCAAAATAAAAACATCCTTCTTCTTAAACATTTAATTCAAACAATCCACCATAAATACCCTCAAACTGTTA
CACCTCTCAATAATTTAAAAAACCAACCCTATCTAATAAAACAACCCCTCAACTCAACATCAAACAAAAATTTTAATTCATATCAATCACCCCCACCAAC
ACCATCCTCAACAATTATTACCTCAACTCAATCAArrATTCCCACATAAAAATCATTTACATCTTCTTTTTCAATAATATCTCTATTACCCAACTCTCCT
CTATTCTAAACTCCCATTCTCTTTTCTATTTTTTAATAAAACCTCACCACATTATCAACAACTTTCTATTTTCTATATCTCTTAAAACCATTTCCCAAAT
TAAACCTCACCACATTCAAAATTCCATTTTATTCTTAAAAATATTTTTTAACTCATATCTAATAAACCCCnTCATTATAAAAAATATCTATATAnTTA
TCTCTTTTIATTAATCCCAATACCCTCATTTTCCCCTTTTAACCC^T T A cft^dT C A jTAAATCTTTCCACAA A A T ^T ATTTTATAACTTCTAAAAC
TTACCTTTAAATTTAATTATAAATATACATTTTACTATT&CAATACATAATTCCTTATA'tTTATCATCiactttacaaatacata a^Ccccctattaat
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Figure 3.5 Features 5 to the spa Coding Region
The nucleotide sequence upstream of the none heat shock -10 promoter was also 
examined for sequences that could result in a secondary structure formation which 
would affect transcription from a cloning vector promoter positioned upstream of the 
EcoKl site. Only one small area of dyad symmetry was found (the position of which is 
indicated in Figure 3.S) this region was short in length (31 bp) and apart from the 
potential to form an RNA hairpin loop it exhibits none of the structural features (such 
as a G.G inverted repeat sequence followed by a run of consecutive thymidine residues 
in the non template DNA strand), normally associated with termination sequences. 
This region is unlikely to have any effect other than decreasing the rate of transcription 
from an upstream vector promoter.
Although the spa gene is known to be subject to regulation in S. aureus this is 
dependent on growth phase of the cell (production has been shown to cease after 
stationary phase has been reached Lindmark et al., 1977); not on catabolite levels. The 
agrA gene (accessory gene regulator) and agrB and agrC genes together with the 
associated 5-lysin gene (hid) have been shown to be involved in the agr locus 
regulation of post-exponential-phase synthesis of staphylococcal proteins including 
SpA (Recsei et al., 1986; Peng et al., 1988; Janzon et al., 1986, 1989; Novick et al., 
1989 and Janzon and Arvidson, 1990). The agrA gene is thought to act at the mRNA 
level, though its exact mode of action is unknown. All known regulatory RNAs in 
procaryotic systems seem to be antisense RNA which act as transcription terminators or 
translation inhibitors by base pairing with the target transcript. However, as the agr 
locus has both positive and negative regulatory effects the situation would appear to be 
complex.
No regulatory system involving a binding protein has been proposed for control of SpA 
synthesis. As it is unusual to have regulatory sequences 3 to a  structural gene it is 
unlikely that these "CBS" homologies are associated with a gene upstream of SpA. It 
was therefore decided to examine the possible role that such an operator sequence could
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play in the natural host. The mechanism of catabolite repression in Gram-positive 
bacteria is largely unknown. Studies on the lactose operon of S. aureus have shown 
that the lac genes are subject to catabolite repression (McClutchy and Rosenblum, 
1963; Oskouian and Stewart, 1990). However, as cyclic AMP has not beem found in 
physiologically significant concentrations in S. aureus (Blumenthal, 1972; Oskouian 
and Stewart, 1990) it is unlikely to be involved in this type of regulation. Oskouian and 
Stewart (1990), provide evidence to support a model for catabolite repression of the S. 
aureus lac operon which involves a negative acting transcriptional regulator which 
binds to the promoter region of the operon and prevents transcription.
Examination of these gene systems and other catabolite repressed Bacillus genes by 
Weickert and Chambliss, 1990 have shown homologous sequences to exist at the 
promoter region, which suggested a common regulatory site may be involved in 
catabolite repression in B. subtilis. The consensus sequence of this regulatory site in B. 
subtilis catabolite repressed genes can be seen to be very similar to the CRP site and 
other known operator sites in E. coli.
B.subtilis T G t/a . A . C G . T . t / a C A
E. coli a a . T G T G A . . t a . . t C a m A t w t . w g .
Comparison of the spa promoter region with the Gram-positive operator region showed 
no significant homologies, however the regions upstream of the spa promoter 
designated CBS1 and CBS2 did show homologies, in particular CBS1 (93%). As SpA 
is not subject to catabolite repression in S. aureus, the absence of significant homology 
in the promoter region was not unexpected. It is, however, possible that the CBS 1 
sequence upstream of the spa gene act as an operator site for another regulatory protein 
in S. aureus.
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3.3.3 Signal Sequence
Bacterial proteins can be subdivided in two groups, those that remain in the cytoplasm 
after synthesis and those exported across the cytoplasmic membrane to locations within 
the cell envelope, or, external to the cell. This latter group, which includes SpA, are 
referred to as exported or secreted proteins. All secretory proteins have been found to 
possess precursor and mature forms. The precursor consists of the mature form with an 
N-terminal extension of 15-40 a.a’s, known as the signal sequence. Several basic 
models describing the mechanism of protein export have been proposed (Oliver, 1985; 
Perlman and Halvorson, 1983), which differ slightly in their interpretation of the role of 
the signal peptide in this process. It has been established that signal sequences are 
required for protein export and are removed during, or shortly after this process by the 
precursor processing enzymes, signal peptidase I (encoded by the gene lepB), or signal 
peptidase II (encoded by the gene lepA). These proteins are 36 kDa and 18 kDa in size, 
respectively, and have been shown to be integral inner membrane proteins that span the 
membrane several times, and possess a large periplasmic domain (Wolfe, et al., 1983; 
Innis et al., 1984; Moore et al., 1987).
Genetic studies on E. colt have identified a number of genes that code for essential 
components of the export machinery and interact with the signal sequence. Six 
secretion genes (sec) have been identified so far: sec A  (prlD), secB, secD, secE (prlG), 
secF and secY (prlA). Their detection and the evidence for their role in secretion has 
been reviewed by Schatz and Beckwith (1990) and a model for protein export 
proposed. This states that during, or soon after, the emergence of the preprotein from 
the ribosome, secB (acting as a molecular chaperone) will bind to the mature part of the 
protein, in order to stabilise the export component conformation until the protein 
associates with later components of the secretion apparatus. The signal sequence 
appears to be responsible for retarding the folding of the native protein to allow secB to 
bind. Some proteins appear not to require a molecular chaperone at all, or may use an 
alternative chaperone protein.
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The signal sequence of the precursor peptide-secB complex then interacts with secA 
and other components in the membrane (this membrane compound includes the inner 
membrane spanning protein secY and secE) stimulating secA’s ATPase activity and the 
initiation of the translocation reaction. The secD and secF proteins are both integral 
inner-membrane proteins containing several potential membrane-spanning sequences. 
They have a large periplasmic domain and mutational studies suggest their involvement 
in the later stages of translocation.
Signal sequences from both eucaryotic and procaryotic sources have been shown to 
work in either host system (Oliver, 1985), and bacterial processing enzymes to 
correctly cleave the signal peptide from a eukaryotic precursor to generate the mature 
protein (Watts et al., 1983). Thus one might expect to see a significant level of 
conservation, both structurally and functionally, between signal sequences from diverse 
sources. However, examination of 277 signal sequences compiled by Watson (1984) 
reveals no significant homology in either their nucleotide or a.a sequences; with the 
exception of the signal peptide processing, where Perlman and Halvorson (1983) 
reported a marked preference for the sequence Ala-X-Ala immediately preceding the 
cleavage position. The overall length of the signal sequence was also found to vary 
considerably, from 13 a.a.’s in mouse (3-crystallin to 36 a.a.’s in S. aureus protein A. 
However, signal sequences have been found to be homologous in that all consist of 
three structurally dissimilar regions; (i) a positively charged N-terminal region; (ii) a 
central hydrophobic region, and (iii) a more polar C-terminal region. Examination of 
these regions have enabled von Heijne (1983, 1984a, b, 1985) to suggest criteria for a 
minimal signal sequence.
The signal sequence of the spa gene is found to conform to the outer limits of these 
criteria in most respects. However, at 36 a.a’s it is unusually long, in particular the 10 
a.a C-terminal region where it exceeds the maximum "limit" by 3 a.a’s. The N- 
terminal region, 11 a.a’s in length, carries a net charge of +5 (Figure 3.6) compared 
with the mean value of +1.7 for prokaryotes (ignoring the a-NH2 at the N-terminus).
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Figure 3.6 Semi Graphic Printout for SpA Signal Peptide
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This charge is thought to participate in binding and orientating the leader sequence with 
respect to the cytoplasmic membrane surface. The central hydrophobic core (60% 
hydrophobic residues) consisting of IS a.a’s, is one of the longest prokaryotic core 
sequences so far elucidated. It has been proposed to function by partitioning the 
membrane lipids and spanning the bilayer and perhaps act as a target for the signal 
recognition particle in establishing the translational block. Using Chou-Fasman 
conformational parameters (1978) it is predicted to be a (i-sheet rather than an a-helix 
(Figure 3.6). Oliver (1985), however, questions the advisability of using rules based on 
protein folding within an aqueous environment on proteins in the nonpolar environment 
of the membrane. Von Heijne (198S) predicts that the secondary structure of the 
hydrophobic core will depend on its length i.e., 8 residues in a fully extended chain 
structure will have a length of 27 A and therefore be able to span the 25 to 30A thick 
membrane interior, whereas it would take a 20 residue helix to span this distance. 
Therefore, as a helical conformation should be thermodynamically preferred in a non­
polar environment, part of the 15 amino acid sequence of the hydrophobic core could 
be expected to be present in a helical conformation.
The C-terminal region of the signal sequence and the five N-tcrminal amino-acids of 
mature protein, are thought to be responsible for cleavage specificity. This C-terminal 
region consists of a (J-tum following the hydrophobic core (thought to be important for 
peptidase access to the cleavage site; Perlman and Halvorson, 1983), and a signal 
peptidase recognition site. The spa signal sequence C-terminal region has a 5 residue 
p-tum immediately following the hydrophobic core (Figure 3.6) and, although the C- 
terminal region is unusually long, it conforms to most of the following preferences 
observed by Perlman and Halvorson (1983) and von Heijne (1983, 1984a): small 
neutral residues in positions -1 and -3 (counting from the cleavage site between 
positions-1 and +1) with Ala the most preferred residue at position-1 and common at 
position +1, but rare in positions -2 and +2 to +5; large polar and aromatic residues are 
common at position -2; charged and large polar residues are enriched in positions +1 to
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+5; Pro is absent from positions ns -3 to +1 but common at position -5 and; Gly is found 
predominately between residues -4 to +1. The SpA signal sequence cleavage region 
has the residue Ala at positions -4, -3, -1 and +1; the large polar residue Gin at position 
+2 and three large charged residues at positions +3, +4 and +5; the large polar residue 
Asn at position -2, and Pro at position -5, but Gly residues are found at positions -8 and 
-9 rather than between positions -4 to +1 (Figure 3.6).
3.3.4 IgG binding regions
The IgG binding regions of SpA have been defined by Sjodahl (1976, 1977 a and 
b), as the functional IgG binding units produced upon cleavage of the mature protein 
with trypsin. These four units: D, A, B and C are consecutively arranged from the N- 
terminal part of the protein (Figure 3.2).
3.3.4.1 Sequence analysis
Analysis of the predicted SpA a.a. sequence reveals four homologous regions 
corresponding to the above IgG binding units and an additional region (E), which also 
exhibits extensive homology with regions D, A, B and C (Figure 3.7). Region E has 
subsequently been shown to possess weak IgG binding properties (Moks et al., 1986). 
The five IgG binding regions vary slightly in length, with A, B and C consisting of 58 
amino-acids, D consisting of 61 amino-acids and E of 56 amino-acids. Alignment of 
the IgG binding regions to give maximum homology (Figure 3.7) allows the 
comparison of both the nucleotide sequence and predicted amino acid sequence of each 
o f the IgG binding regions with one another. This indicates the existence of an 
homology gradient, where the closer the IgG binding regions are to one another, the 
greater the degree of homology seen (Table 3.4). The level of homology between 
regions E and D would at first appear to be an exception to this observation, with region 
E having greater homology to regions A, B, and C than to region D. However, this 
anomaly is a result of region D containing three more amino acids than regions A, B,
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Table 3.4 Comparison of the 5 IgG-binding Regions to Show Ihe Existence of i 
Homology Gradient.
A- E D A B C TOTAL
E 0 (0) 19 (56) 16 (41) 18 (40) 22 (57) 75 (194)
D 0 (0) 9 (36) 14 (40) 17 (49) 59 (181)
A 0 (0) 6 (15) 11 (38) 42 (130) 
0 (0) 5 (25) 43 (120)
C 0 (0) 55 (169)
TOTAL 274 794
%  HOMOLOGY 81 82
E D A B C  TOTAL
E 0 (0) 19 (53) 16 (43) 18 (44) 22 (54) 75 (194)
D 0 (0) 9 (32) 12 (37) 15 (47) 55 (169)
A 0 (0) 5 (16) 10 (36) 40 (128) 
0 (0) 5 (26) 40 (123)
C 0 (0) 52 (163)
TOTAL 262 777
%  HOMOLOGY 80 82
A. S. aureus Cowan I (NCTC8530)
B. S. aureus 8325-4
T o ta l n u m b e r  o f  m a tch in g  a m in o  a c id  re s id u e s  and  n u c le o tid e s  ( f ig u re s  in 
b rackets), fo r each o f  the 5 IgG -binding  regions com pared w ith one another, and 
level o f overall homology across the lgG-binding domains is indicated.
and C and five more than region E, where these extra amino acids (nucleotides) are 
counted as non-homologous. Region E is the least homologous of the IgG binding 
regions, as it possesses a completely different, six amino acid, N-terminal region from 
any of the other IgG binding regions. This difference in the N-terminus is almost 
certainly due to region E being positioned immediately downstream of the signal 
sequence, for, as mentioned in section 3.3.3, the first five amino acids of the mature 
protein sequence appear essential for the correct functioning of the signal sequence. It 
might therefore, be germain to position the start o f region E six amino acids 
downstream of the N-terminus of the mature protein. In order to maintain a degree of 
consistency with previously published material of Colbert et al., 1984a&b; Guss et al., 
1985; Moks et al., 1986; Uhlen et al., 1984 a and c, this has not been done.
Comparison of the number of changed amino acids with the number of changed 
nucleotides of the identically positioned residues, when the IgG binding regions are 
aligned and compared in pairs (Table 3.4), shows that the codons have changed at a 
faster rate than the amino acids. This is indicative of evolutionary pressure to preserve 
the particular amino acid sequence.
The homology plot (Figure 3.3) also shows the presence of internal homologies within 
IgG binding regions D, A, B and C. Region A (Figure 3.7) shows the greatest degree 
of internal homology with 24 of the 30 nucleotides coding for the ten amino acids from 
residue A sn ^ l to residue Phe^® identical to the nucleotide sequence coding for ten 
amino acids from residue Asn^® to residue P h e ^ .
3.3.4.2 Secondary structure prediction and analysis
The structural interaction between SpA region B and an IgG Fc fragment has been 
studied using X-ray crystallography at 2.9-A resolution by Deisenhofer (1981) . These 
studies indicate that SpA fragment B consists mainly of two antiparallel a-helices 
(though Langone (1982a) mentions a third region of a-helix), the rest of the fragment
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consisting of irregularly folded polypeptide. They reveal extensive contact between the 
two antiparallel a-helices occurring at residues Gin*28 to Leu*^6 and residues G lu*^ 
to A sp * ^  and the CH2 and CH3 dom ains of the IgG Fc fragment. The residue 
numbers above correspond to the Cowan I SpA mature protein sequence residue 
numbers 184, 192, 199 and 211, respectively,as shown on Figure 3.7. This discrepancy 
in amino acid numbering results from the fact that, for the secondary structure analysis, 
the amino acid sequence of Cowan I NCTC 8530 is numbered from the N-terminus of 
region E ,the start of the mature protein. Deisenhofer numbers from the start of region 
D, this begins 56 amino acids downstream of region E, which was only identified later 
upon subsequent nucleotide sequencing o f the spa gene. All numbering of amino acids 
within this section, (3.3.4), will be according to the NCTC 8530 SpA mature protein 
sequence displayed in Figure 3.8. Of the 21 amino acids forming the two a-helices the 
following 10 have been proposed as essential for binding to the IgG Fc domain. These 
comprise Phe180, four amino acids residues prior to the first a-helix; the first a-helix 
amino acids Gin*8*, Gln*8^, Asn*8*\ Phe*88, Tyr*89, Leu*92; and the second a- 
helix amino acids: Asn2®-*, Ile2®*\ Gln2^ ;  (Figures 3.7 and 3.8)
Comparison of the modified computer prediction of secondary structure for NCTC 
8530 SpA fragment B (Figure. 3.8) w ith the model produced by Deisenhofer (1981) 
reveals some differences in the extent and position of the a-helix regions in fragment B. 
The first region of a-helix  is three residues longer, Lys*82 to His*9 -*, than 
Deisenhofer’s interpretation. Gin184 to  Leu192. The second region of a-helix is far 
shorter than in Deisenhofer’s model, consisting of only 6 residues, Glu199 to Gly2®* 
rather than 12 residues from Glu2®® to Asp2* *. The residues from Phe2®^  to Asp2* * 
(including two residues considered essential for IgG binding) are predicted to form a B- 
turn rather than a-helix. A third a-helix  region of 15 residues is predicted to occur 
from residue Leu199 to the C-terminal residue, Lys2®^, of fragment B. Although this 
third helical region is mentioned by Langone (1982a), Deisenhofer (1981) records this 
region as having no regular structure. This discrepancy between the computer
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Figure 3.8 A Secondary Structure Prediction for S. aureus C ow an I Protein A
Circled residues represent a-helix, boxed residues represent (i-sheet and residues below a solid 
bar are proposed to form P-tums. The secondary structure was predicted using the hydropathic 
profile of SpA (Figure 3.9) and the predicted parameters of Chou and Fasman (1978).
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predicted secondary structure for SpA fragment B and that indicated using X-ray 
crystallography may have been caused by any one, or a combination, of the following 
factors: Firstly, Deisenhofer obtained 2.8A resolution data in refining his model for the 
complex between the Fc fragment and SpA fragment B, which is greater than the 
peptide bond length of 1.9A, thus he may not have detected all the existing backbones; 
this could alter the final structural model. Secondly, Deisenhofer examined the two 
fragments (and not intact proteins) in their interactive form, whereas the computer 
prediction is of the full mature SpA molecule in its quiescent state; and  the 
configuration of the protein may alter considerably between these two states. Thirdly, 
the accuracy of a computer prediction for protein secondary structure depends on the 
algorithm used and even when accurate with known proteins is of a limited value in 
predicting "unknown" proteins.
Examination of the hydropathic profile of the two anti-parallel a-helices of region B 
reveals that both consist of a strongly hydrophilic region followed by a hydrophobic 
region (Figure 3.8). The first a-helix, consisting of residues L ys^2 to H is^^  follows 
a hydrophilic B-tum region from residue Asp*22. The first 5 residues of the a-helix 
are also hydrophilic. The second a-helix (residues G lu * ^  to Gly2®'*) is entirely 
hydrophilic. It is preceded by a 4 residue hydrophilic P-turn and followed by a 
hydrophobic 4 residue ($-tum , the latter p-tum contains the IgG binding residues lie2®® 
and Gin2®2. The hydrophilic regions are likely to exist as surface loops in the main, 
therefore exposing the IgG binding residues within them, and the immediately adjacent 
hydrophobic region, on the aqueous surface of the protein. The rest of the first a-helix 
and the p-turn immediately following the second a-helix is hydrophobic, this agrees 
with Deisenhofers statement that the actual contact between the IgG Fc fragment and 
SpA is predominantly hydrophobic.
Comparison between the predicted secondary structure of region B and the other four 
IgG binding regions (Figures 3.7 and 3.8) shows that regions A and C are identical to 
B, except that the third helical region in region C is one residue longer. Region D
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varies in having a 6 residue region of a-helix at its N-terminus, and, in having a shorter 
region of a-helix at its C-terminal end. It is also unusual in that one of 11 residues 
considered necessary for IgG binding (corresponding to Asn^8^ in region B), is 
replaced by a Ser residue. However, this alteration does not effect the helical structure 
of this region. Region E shows the greatest variation from region B. The principle 
differences are; (i) it contains only one region of a-helix composed of 9 N-terminal 
residues positioned at the N-terminus which incorporates only three of the essential 11 
IgG binding amino acids (Gln^, GInland Asn^); (ii) of the 17 residues normally found 
in helical form in the other 4 IgG binding regions residues 13, 14, 22 and 23 are 
different; (iii) of the 11 essential IgG binding residues the first residue corresponding to 
Phe18® is altered; (iv) additionally, the hydrophilicity plot (Figure 3.9) of region E 
(Gln”^ to Gln^®) is almost identical to the hydrophilicity plots of the corresponding 
residues in the other four IgG binding regions. Together with the fact that region E 
exhibits the weakest IgG binding activity (Moks et al., 1986) these differences suggest 
that either the altered residues, or the a-helical structure, or both, are crucial to the 
binding properties of the region.
3.3.5 Cell-Membrane and Cell-Wall Binding Domain
Protein A produced by NCTC8530 is normally bound to the cell wall. The C-terminal 
domain of SpA, region X, is thought to act as the cell wall anchorage domain for the 
protein. The position of the N-terminal of region X is defined as the fifth trypsin 
cleavage site within the protein, and is only accessible in cell wall bound molecules 
which have been released by lysostaphin digestion. The X region is 181 codons in 
length and consists of two structurally different domains: Xr- a highly repetitive, 
hydrophilic, region consisting of a 24 nucleotide unit repeated 10.5 times and; Xc- a 
non-repetitive sequence, 98 codons in length, concluding with the termination codon 
TAA. The boundary between the Xr and the Xc region is defined by the end of a 24 
nucleotide repeat pattern at nucleotide position 1933 (Figure. 3.10). The Xc region is 
mainly hydrophilic in nature, except for the C-terminus which consists of a stretch of
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Figure 3.9 Hydropathic Plot of the Amino Acid Sequence of Cowan I protein A
This plot was made using the programs of Larson and Messing (1983) on an Apple II microcomputer, hexapepdde averages 
were determined from the values of Hopp and Wood (1981). Peaks above the abscissa represent hydrophilic regions, and 
below, hydrophobic regions. The position of the SpA functional domains are marked.
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Figure 3.10 Alignment to Show the Repetitive Nature of the Xr Region of 
NCTC8530 spa
20 strongly hydrophobic amino acids followed by a 5 a.a charged tail (Figure 3.9).
This hydrophobic C-terminal structure suggests that this region of SpA may well be 
associated with the cell membrane (Guss et al., 1984a and b). Similar regions in other 
Gram-positive cocci surface proteins have been identified and used to predict the 
membrane anchors (Fischetti et al., 1990). Von Heijne (1981), has suggested that the 
basic residues present at the C-terminus of a membrane-penetrating protein are 
designed to help anchor the protein to the negatively charged cytoplasmic surface of the 
cell membrane. The 5 charged C-terminal residues of SpA may act as a stop-transfer 
sequence (Blobel, 1980), these sequences are proposed to interrupt the translocation 
process by preventing a distinct segment of the nascent polypeptide from translocation 
across the membrane and in so doing will cause the integration of the protein into the 
membrane.
The 2S2 nucleotides that constitute the Xr region show a high level of internal 
homology. Hydropathic analysis of this region reveals that it is extremely hydrophilic 
(Figure 3.9) and secondary structure prediction suggests the entire region consists of a 
series of (J-tums (Figure 3.8). Alignment of the nucleotide sequence to give maximum 
internal homology (Figure 3.10) reveals the presence of a 24 nucleotide (octapeptide) 
unit, repeated 10.5 times. The homologous nature of the region is particularly apparent 
at the amino acid level, with the 84 codons of region Xr coding for only 6 different 
types of amino acid: Glu, Asp, Asn, Lys, Pro and Gly. Comparison of the octapeptide 
repeats revealed that, apart from the presence of an Asn instead of a Gly at residue 
position three (repeat XI), 6 of the octapeptide residues are identical throughout the Xr 
region. The two remaining residues, positions 3 and 4, follow a regular alternating 
pattern with Asn replacing Gly as residue 3, and Lys replacing Asn as residue 4, in 
octapeptide units 4 and 6 (Figure 3.10 and 3.13). Examination of the sequence at the 
nucleotide level reveals signs of a 48-nucleotide repeat as well as the 24-nucleotide 
repeat. There also appears to be evidence of an homology gradient throughout the 
region with both the N-terminal ( XI) and C-terminal (X8, X9, X10 and X I1) repeat
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units showing greater divergence than the central repeat units. The significance of the 
Xr region in terms of providing evidence for the stepwise duplication of nucleotide 
sequences in gene evolution will be discussed further in section (3.4).
Sjoquist (1972b) and Sjodahl (1977a) have reported that SpA is bound to the 
peptidoglycan of the bacterial cell wall by the X region of the protein. However, 
although these studies indicate a strong association between the presence of protein A 
and the presence of peptidoglycan in the experiments undertaken, there is no direct 
evidence to indicate that the protein A is covalently linked to the peptidoglycan. 
Similar work undertaken by Pancholi and Fischetti, 1988 on the streptococcal M6 
protein, which has a strong C-terminal homology to SpA indicates that this protein is 
probably intercalated within the cross-linked peptidoglycan and not covalendy linked to 
it, thus casting doubt on the type of association between SpA and the cell wall 
peptidoglycan.
Uhlen et al., (1984b) has confirmed the role of the X region of the SpA in binding 
protein A to the cell-wall, in experiments where the spa coding for a cell-wall bound 
SpA was cleaved at the C-terminus of the IgG binding domain C. The resulting 
truncated gene, lacking the entire region X, when expressed in the same S. aureus host 
system as the full length gene, was found to produce a lower molecular weight, 
extracellular SpA.
Results presented in Chapter 4 of this thesis for pPA34, a plasmid containing a 
truncated spa gene lacking only the Xc portion of the X region, show that when 
produced in E.coli, the truncated protein was not extracellular. This suggests that either 
the Xr portion of the X region plays a substantial role in anchoring the protein to the 
cell or that its presence prevents secretion through the cell wall of a Gram-negative 
organism.
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3.4 Comparison of the Nucleotide Sequences from Three Different spa 
Genes
During the course of this study the complete nucleotide sequence for the spa genes 
from S. aureus 8325-4 and S. aureus Cowan I (ATCC12598) were determined by 
Uhlen etal., (1984a) and Colbert etal. (1984a and b), respectively.
Comparison of the above two nucleotide sequences with the nucleotide sequence of 
the spa gene of S. aureus NCTC8530 reported in this thesis, reveal some interesting 
differences (Figure 3.11), particularly between ATCC12598 and NCTC8530 which are 
nominally the same strain.
All three spa sequences are identical in the region coding for the signal sequence. The 
nucleotide sequence of the promoter regions of the spa gene of 8325-4 and NCTC8530 
are also identical. Upstream of the promoter sequence Uhlen et al., identifies a possible 
hairpin loop transcription termination sequence running from nucleotide position 547 to 
position 578 (Figure 3.5). However, it is unlikely that this sequence functions as a 
terminator as not only is the A G value of +2.6 kcal mol'* for the proposed stem-loop 
structure of the RNA transcript not indicative of structural stability, but the comparable 
region in NCTC8530 differs at 4 of the 18 nucleotide positions forming the stem-loop 
structure and so will obviate any possible relevant secondary structure. Colbert et al. 
(1984b) have not published nucleotide sequence data for ATCC 12598 DNA upstream 
of the spa structural gene, so no comparison is possible. This region has also been 
identified by Abrahmsen et al., (1986) as a possible stress induced promoter, Figure
3.5.
Comparison of the IgG binding regions of the three genes reveals 20 nucleotide 
differences between the 8325-4 and NCTC8530 (Figure 3.11), but only a single 
difference between the two Cowan I spa genes, a t position 1054. Of these 21 
nucleotide differences only 3 result in amino acid changes (at residues 99, 120, and
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199) indicating a strong selective pressure to conserve the amino acid sequence. 
Selective pressure also appears to apply to the secondary structure, as only one of the 
amino acid changes (residue 120) occurs in one of the antiparallel helices (region D) 
this is not, however, one of the 11 amino acids actively involved in binding to the Fc 
fragment of the IgG molecule. None of these amino acid changes alter the predicted 
secondary structure of the region. Analysis of the homology gradient between the IgG 
binding regions of 8325-4 compared with a similar analysis on NCTC8530 (Table 3.4 a 
and b) indicates that a slightly higher degree of homology exists within the 5 IgG 
binding domains for the latter SpA, at both the nucleotide and amino acid level.
The most significant differences between the three spa nucleotide sequences occur in 
the Xr region of the gene. In NCTC8530 this region consists of a 24-nucleotide unit 
repeated ten times. The comparable regions in ATCC12598 and 8325-4 contain eleven 
and twelve 24-nucleotide repeat units respectively. The differing number o f 24- 
nucleotide repeat units makes a direct comparison of the Xr regions difficult, 
particularly between the two Cowan I "strains" and 8325-4, where it is not possible to 
determine the position of the insertion/deletion of two of the 24-nucleotide units. 
Alignment of the nucleotide sequences to give the least nucleotide mismatch (Figure 
3.11) positions the extra 48 nucleotides of the Xr region from 8325-4 immediately 
before the First 24- nucleotide repeat unit of the Xr region from NCTC8530, and the 
extra 24 nucleotides of the Xr region from ATCC12598 between the eighth and ninth 
24-nucleotide repeat unit from NCTC8530. This alignment results in 23 nucleotide 
differences coding for 6 amino acid differences between the Xr region of NCTC5830 
and 8325-4, and 2 nucleotide differences coding for 2 amino acid differences between 
the Xr region of NCTC8530 and ATCC12598.
Comparison of the three X r regions reveals evidence for the role of stepwise 
duplication in the evolution o f this repetitive region (Figure 3.12). Both Cowan I Xr 
regions show a very similar pattern, in having three, 48-nucleotide, repeat blocks (each
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NCTC 8530 AT CC 12598 8325-4
XI GAA GAC AAC AA0 AA0 CCT G<g] AAA XI GAA GAC AAC AA£] A ^3 CCT GCffl AAA
X2 GAA GAC GGC AAC AAA CCT GGT AAA X2 GAA GAC GGC AAC AAA CCT GGT AAA
X3 GAA GAC GGC AAC AAA CCT GGT AAA X3 GAA GAC GGC AAC AAA CCT GGT AAA
GAA GA© GGC 
GAA GAT* GGC 
GAA GAT*GGC 
GAA GA© GGC
AAC AA© CCT 
AAC AA©'CCT 
AAC AA©'CCT 
AAC
GGT AAA 
GGT AAA 
GGT AAA
GAA GA© GGC 
GAA GAT* GGC 
GAA GAT*GGC 
GAA GAT* GGC 
GAA GAO GGC
AAC AA© CCT 
AAC AAA CCT 
AAC AA©' CCT 
AAC AA©* CCT 
AAC
XI GAA GAC AA© AAC 
X2 GAA GAC AA©* AAC 
X3 GAA GAC AA©* AAC 
X4 GAA GAC AAC AAC 
X5 GAA GAC AAC AAC
GGT AAA 
GGT AAA
M3* CCT GGC* AAA 
M3* CCT GGC* AAA 
MS* CCT GGC* AAA 
M3* CCT GGC* AAA 
M3* CCT GO® AAA
XI2 GAA GA©*GGC AAC AA® CCT GO© AAA 
XI3 GAA GA©’ GO© AAC
Figure 3.12 Alignment and Comparison of the Nucleotide Sequence of the Xr Regions of the SpA Genes
The octapeptide repeats of the Xr regions have been aligned to give maximum homology. The position of the three 48 mer 
repeats of each gene are shown (sequence within large rectangular box), and the nucleotide differences between them are 
boxed (□). The 24 mer repeats proposed to have evolved by duplication of either the 5 or 3 octapeptide of the 48 mer 
sequence are shown and the mutational divergence from the "parent" octapeptide indicated by a circle (O). The overall 
evolutionary trends within the Xr region are indicated by an asterisk (*).
interrupted by a 24-nucleotide repeat (X3, which appears to be a direct duplication of 
X2, the second half of the first 48-nucleotide block) between the first and second 48- 
nucleotide repeat unit. Repeat unit X9 of ATCC12598 is not present in NCTC8530 and 
appears to have arisen from a direct duplication of X7. X10 (NCTC8530), X10 and 
X I1 (ATCC12598) appear to have arisen by direct duplication of X9 (NCTC8530). A 
major dissimilarity occurs between the two Cowan I spa genes in repeat unit X4 
(residues 5 and 6) where the nucleotide sequence for ATCC12598 is reported as AAC 
(Asn) and CTT (Leu). Whereas at residues 5 and 6 of the other octapeptide repeats in 
all three spa genes, the sequence is AAG or AAA (both coding for Lys) and CCT (Pro), 
respectively. Both of these amino acid changes result from a single nucleotide 
substitution, creating a unique octapeptide unit in an otherwise highly conserved region. 
This a.a. substitution dramatically alters the hydropathic plot of the Xr region (Figure 
3.13). It is possible that these substitutions could be the result of an error in the 
sequence data. Alignment of the repeat units of the Xr region from 8325-4 reveals a 
quite different pattern (Figure 3.12). The three 48-nucleotide repeat units (almost 
identical to the 48-nucleotide units of both Cowan I genes) are in the C-terminal half of 
the Xr region. Unlike Cowan I there is only one 24-nucleotide repeat duplication, X12 
(which appears most likely to have arisen from a duplication of X9) in the 3 ' direction, 
with the other five 24-nucleotide repeat units X5 to XI appearing to have arisen by 5 ' 
duplication of X6. Hence the Xr region of Cowan I and 8325-4 appears to have 
evolved independently or diverged in nucleic acid evolution by a process of stepwise 
duplication from an original 48-nucleotide unit.
There are two nucleotide differences between NCTC8530 and 8325-4 in the Xc region 
at positions 2131 and 2182 (Figure 3.11), neither of which alter the amino acid 
sequence. However, it is of interest to note that the former of these occurs in the highly 
conserved hexapeptptide sequence (PXTGE, as discussed further in Section 3.5). 
There is a single difference between the Xc region of NCTC8530 and ATCC12598 at 
position 1956 (Figure 3.11). In the latter sequence, Colbert and Anilionis (1984) report
Figure 3.13 Hydropathic Plots to  Compare the Peptide Structures o f  the Xr Region of 
the Three SpA M olecules
T hese p lo ts w ere m ade using  the  prog ram s o f  L arson  and M essing (1983) on an A pple 11 
microcomputer. Follow ing the recommendations o f  H opp (1986), hexapeptidc averages were 
determ ined from  the values o f  H opp and W ood (1981). Peaks above the abscissa represent 
hydrophilic regions, and those below , hydrophobic regions. The position o f  the octapeptide 
repeats are m arked  and  num bered. T he m ost com m on oc tapeptide  sequence ( i.e ., X2) is 
shown. Variations in the octapeptide sequences occur in only 4 a.a. positions and are represented
as follows: positions ill ■ __, position tv position v -  * and position vi = f , w ith the a.a.
alteration indicated.
a C compared to the G present in NCTC8530, however, this C might be a misprint 
since they translate the resultant codon (GCT) as Gly (which GGT would give) instead 
of Ala.
3.5 Homology of SpA with Other Proteins
The IgG binding domains of SpA display some primary sequence homology with the 
IgG-binding proteins from Group G streptococci (streptococcal protein G, SpG), two 
cloned and sequenced by Fahnestock (1987); the other partially sequenced by Guss et 
al., (1986). Although the arrangement and number of IgG-binding regions differs 
between these SpG proteins, there is complete identity between the proposed FC- 
binding domains. Despite the fact that SpA and SpG both compete for the same binding 
region of the Fc receptor there is no significant homology between their primary 
sequences (Figure 3.14), and a secondary structure prediction of the IgG-binding 
region C2, did not reveal any a-helices as found in SpA (Guss, 1986). However, there 
is 80% homology between four Fc-binding regions of SpA (D, A, B and C) and the 
repeat units A l and A2 of the SpG sequence reported by Fahnestock et al., (1986b), 
(Figure 3.14). These units have been proposed to have affinity for human serum 
albumen (Bjorck, et al., 1987). When analysed for 100% homology, only the 
pentapeptide LAEAK is common (IgG-binding domains A, B and C of SpA, domain 
A2 of SpG ( Fahnestock et al., 1986b) and domains B1 and B2 of SPG (Guss et al., 
1986))
The pentapeptide sequence IQSLK found in all five IgG-binding domains of SpA is 
also present in the IgG-binding fragment of the murine macrophage-lymphocyte Fc 
receptor for IgG (amino acid sequence determined by Hibbs et al., 1986). Nucleotide 
sequence analysis of the gene (Lewis et al., 1986) yields a slightly different 
pentapeptide sequence ,IQVLK, within the same surrounding peptide sequence 
determined by Hibbs. Neither IQSLK nor IQVLK is found in either sequence of SpG. 
This suggests that the binding sites of mamalian macrophages might be similar to those 
of SpA.
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SPA
Figure 3.14 Dot M atrix Homology Plot o f  SpA  Against SpG
The primary sequence o f  SpA  (left to right on horizontal axis) is compared with that o f  SpG (top 
to bottom). Blocks o f  5 a.a. o f  the SpA sequence w ere compared sequentially with 5 a.a. o f  the 
spG sequence. W here there w as identity at a  predeterm ined level (here we show 3 a.a. out o f  5. 
equivalent to 60% hom ology) a  dot was plotted. Regions o f  homology show  as diagonals. The 
arrow heads (►) indicate those regions which were present at the 80% homology level. The plots 
were generated by an A pple II microcomputer using the  programs o f  Fristensky e t al.. (1982). 
The positions o f  the Ig-binding domains o f  SpA (A , B , C , D  and E) and SpG (B1 and B2), the 
cell-wall-binding region, X r, o f  SpA, the repeated regions, A l and A2, and the highly charged 
repeat structure, C, o f  SpG  are  indicated on the axes.
The cell wall attachment domain of SpA shows a repetitive P-turn structure and 
displays obvious homology with the presumed repetitive wall and membrane 
attachment sites of SpG. The SpA repetitive P-tum structure however appears to be a 
structurally sharper turn than the more relaxed repetitive P-tum cel! attachment domain 
of fibronectin (Pierschbacher et al., 1983, Pierschbacher and Ruoslahti, 1984a and b) 
and more akin to the sharper P-tum membrane anchor sequence of type-M6 protein of 
group A Streptococcus (Hollingshead et al., 1986), and the glycosaminoglycan-binding 
domain of vitronectin (Suzuki et al., 1985), all of which show marked structural 
homology with both SpA and SpG in this domain. There is a high extent of sequence 
homology between fibronectin and the repetitive cell wall attachment domain of SpA. 
The sequence GNKPG, which occurs seven times in the ten octapeptide repeats 
forming the cell wall-binding region of SpA, has 80% homology with the sequence 
GLKPG found in fibronectin. Homology of the primary sequence of the cell wall 
domain attachment site of SpA with the consensus octapeptide sequence XDGNKPGX, 
found exclusively in most cell-wall- or membrane-binding proteins, is now evident 
(Taylor et al., 1986).
Sequence analyses of 11 other surface proteins from Gram-positive cocci has revealed a 
16-21 a.a. hydrophobic region to be common to the C-terminus (Fischetti et al., 1990). 
It has also shown a highly conserved hexapeptide sequence (LPXTGE) to be located 
about nine amino acids N-terminal from the C-terminal hydrophobic region. The SpA 
protein contains such a sequence (LPETGE), 10 a.a prior to its hydrophobic membrane 
anchor region. The strong conservation of this hexapeptide sequence at both the DNA 
and protein level among surface proteins from different Gram-positive cocci suggests 
that it must be of importance in the anchoring of the surface proteins.
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4.1 INTRODUCTION
Successful production of a foreign protein in an organism is dependent on many 
factors, including; efficiency of gene transcription, efficiency of mRNA translation and 
correct processing of post-translational polypeptides. Problems at the level of 
transcription are often caused by the gene promoter not functioning properly in the 
foreign host, or, even if the promoter functions normally, it may be too weak to direct 
sufficient transcription to produce a recoverable amount o f the protein. Efficient 
translation of the mRNA relies on the stability of the message, its ability to bind 
ribosomes and the presence of sufficient quantities of the appropriate tRNA (section 
3.3.1). Even if the foreign gene is successfully expressed, the desired protein recovered 
from the host cell may be altered from that produced by the natural source. The host 
organism may incorrectly process the polypeptide in several ways. It may lack the 
enzymes necessary to recognise specific cleavage sites, essential for the development of 
the mature protein from a precursor form. Alternatively it may possess enzymes that 
cleave the protein at inappropriate positions and so produce degraded polypeptides. 
The host cellular transport mechanisms may fail to recognise signals carried by the 
foreign protein, so preventing its localisation to the appropriate position for processing. 
A fault in any one of these three major processes will severely limit o r prevent 
production of the desired protein.
The detection of the spa gene in a S. aureus gene bank was dependent upon 1^5  
labelled IgG binding to SpA released from lysed E. coli colonies (Duggleby and Jones, 
1983). The success of this screening procedure demonstrated that E. coli HB101 was 
capable of producing an active form of SpA.
Prelim inary experiments were carried out by Duggleby and Jones (personal 
communication) using two different plasmids: pBR327 (medium copy no. of 150 per 
cell) and pUC8 (high copy number of 500 to 600 per cell, and carrying the lac promoter
upstream of the multiple insertion site region); to express a 2.012 bp fragment of the 
spa gene. These constructs were designated pPA12 and pPA16 respectively (further 
details in Section 4.2.1.1). The level of SpA production achieved (quantitated using an 
ELISA system rather than a modified monorocket technique) was no higher than that 
attained using S. aureus Cowan I. The four-fold increase in SpA yields observed for 
pPA16 (2.4pgm l'1) over pPA12 (O.tipgml"1) is not consistent with an increase in 
expression due to the presence of the lac promoter. Indeed, the increase could be solely 
attributable to a gene dosage effect, as a consequence of the higher (3-4 fold) copy 
number of pPA16 compared to pPA12, and suggested that, transcription from the lac 
promoter had no discernible affect on spa expression.
In this Chapter, experiments are described which aimed to improve the level of SpA 
production in E. coli. This involved the construction of various recombinant plasmids 
containing either authentic or modified (by deletion of structural/regulatory components 
and/or alteration o f the translational initia tion codon) spa genes. All these 
manipulations were made possible by the availability o f the nucleotide sequence 
described in Chapter 3.
4.2 RESULTS
4.2.1 Protein A Production in E. coli
Aside from investigating the genetic factors which affect spa expression, an 
investigation of the physiological characteristics of high level SpA production was also 
required. Accordingly, the studies described in this section describe the levels of SpA 
production obtained with the initial recombinant plasmids, the effect of production on 
the host and the characteristics and cellular localisation of the IgG-binding polypeptides 
produced. A more detailed examination of gene expression is described in the later 
sections, 4.2.2 and 4.2.3.
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4.2.1.1 Plasmid Constructions Utilised
Various recombinant plasmids carrying spa specific DNA were initially constructed to 
evaluate the effects of a number of parameters on SpA production levels in E. coli. 
These parameters included plasmid copy number, the presence or absence of C-terminal 
spa codons, and the effect of placing a strong promoter (lac) at two different locations 
5 ' to  the spa gene. Restriction maps of these pUC8 based plasmids (pPA16, pPA30, 
pPA31 and pPA34) are illustrated in Figure 4.1 and their pertinent features listed 
below.
pPA12: A 2.012 kb EcoRl/Pstl fragment inserted between the appropriate sites of 
pBR327. This plasmid, therefore has a relatively low copy number (150 copies per 
cell; Chambers et al., 1988) and, aside from the spa promoter, has no recognised strong 
promoter 5* to the staphylococcal insert. The spa gene itself lacks 69 codons at the 3' 
(Pstl) end, which are replaced by 100 codons derived from the 3' end of the vector bla 
gene.
pPA16 and pPA34: Composed of either a 2.012 kb EcoRl/Pstl fragment (pPA16) or a 
1.404 kb Dral/Pstl fragment (pPA34) inserted between the £coRI and Pstl sites 
(pPA 16), or the Smal and Pstl sites (pPA34), of the multicopy plasmid pUC8. Both 
plasmids have high copy numbers (600 copies per cell; Chambers et al, 1988) and lack 
69 codons from the 3 ' end of their spa genes. In both cases fusion has occurred 
between the remaining 438 spa codons and 14 nonsense codons from the vector lacZ 
region (see 3.2.3). The two plasmids differ only in that the translational initiation 
codon of the spa gene carried by pPA16 is separated from the vector lac promoter by 
an additional 608 bp of staphyloccocal DNA compared to pPA34.
pPA30 and pPA31: Derived by insertion of either a 2.252 bp EcoRl/EcoKW fragment 
(pPA30) or a Dral/EcoRW fragment into pUC8 cleaved with EcoRl/Smal and Smal, 
respectively. Plasmids pPA30 and pPA31 are identical to pPA16 and pPA34,
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Figure 4.1 Construction of the SpA Plasmids pPA16-*pPA42
Mutagenic changes from the original spa sequence are indicated by an *
The Restriction Enzymes (RE) used to cleave spa and pUC8 prior to recombination are 
indicated. Where two different RE’s were used to produce compatible sites, for exam ple  
Dral/Smal, the first RE is that used to cut spa and the second RE that used to cut pUC8.
respectively, except for the fact that both carry the entire spa structural gene, including 
the spa translation termination codon (TAA) and thus do not produce an SpA fusion 
protein.
All of the pPA plasmid constructions contain no recognisable transcription termination 
sequences before the 3' end of the cloned S. aureus DNA fragment.
4.2.1.2 Preliminary Estimation of the Level of SpA Production
The four plasmids, pPA16, pPA30, pPA31 and pPA34, were transformed into JM83, to 
allow constitutive expression of the pUC8 lac promoter. The cultures were grown 
according to the conditions set out in section 2.2.1.1. The SpA was recovered from the 
cells and the amount determined using monorocket electrophoresis; as detailed in 
sections 2.2.13.2 and 2.2.14.2 respectively.
To obtain a crude idea of the levels of SpA being produced by the various recombinant 
clones, each was grown overnight in a 10 ml culture volume. The levels of SpA 
produced are summarised in Table 4.1. Estimates of the SpA levels produced by the 
different recombinant clones varied considerably from each experiment, as evidenced 
from the large standard deviation values obtained. To determine whether there was a 
significant difference in the levels of SpA production between the different clones, a 
statistical comparison was necessary. A non-parametric method of analysis (Siegel, 
1956) was employed as the SpA results d id  not comply with one of the main 
requirements for a parametric test, in that the populations to be compared did not have 
the same variance. The Kruskal-Wallis one-way analysis of variance was used to 
determine the probability that a significant difference existed between the populations 
in question. If a significant difference was indicated, then the Mann-Whitney U test 
was used to determine the level of significance between the SpA results from each of 
the plasmids. Analysis of the data used to calculate Table 4.1, showed that: (i) there 
was no significant difference at the 10% level between SpA levels from Cowan I and 
pPA16; (ii) that the SpA levels produced by pPA30 compared with those of Cowan I
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TABLE 4.1
Comparison of the SpA Levels Achieved by the Different 
Plasmid Constructions in 10 ml and 500 ml Culture Volumes
Culture SpA pg m g'1 Cells Dry wt.
Size
Cowan I pPA30 pPA16 pPA31 pPA34
10 ml 29.6 5.5 32.2 65.5 123.7
(7.6) (0.76) (7.8) (13.2) (30.2)
500 ml - - 59.5 116.0 279.2
- - (11.8) (22.0) (29.8)
Results from o/n and timed runs at 37°C, 100 rpm, 10 ml in 20 ml container and 500 ml 
in 2 L container. SpA was released from JM83 cells using lysozyme Brij/Doc lysis.
SpA was released from Cowan 1 cells using lysostaphin
10 ml cultures: Cowan 1 and pPA30, samples from 6 sets of experiments.
pPA16, pPA31 and pPA34, samples from 11 sets of experiments.
500 ml cultures: samples from 5 sets of experiments.
Figures in brackets ( ) = std. deviation values (n-1) to show sample spread.
and pPA16 were significantly different at the 5% levels (significant, 1 in 20 chance of 
error), and; (iii) that the rest of the comparisons between plasmid SpA levels were 
significant at the 1% level (highly significant, 1 in 100 chance of error).
Comparison of the mean SpA levels obtained for each plasmid derived from pUC8, 
indicated that deletion of either the upstream spa non-coding region (EcoRI to Oral, 
i.e., pPA31) or the 69 codons from the 3' end of spa (Pstl to EcoRv, i.e., pPA16), or 
both (pPA34) significantly increased the levels of SpA attainable. Taking the results 
obtained with pPA30 as the baseline (i.e., a plasmid carrying the whole spa structural 
gene and upstream 608 bp non-coding region), deletion of 69 codons from the spa 3' 
end (pPA16) resulted in a 6-fold increase in the levels of SpA produced. Alternatively, 
deletion of the 608 bp of non-coding DNA from between the vector lac promoter and 
putative spa promoter (pPA31) resulted in a 12-fold increase in SpA production. A 
combination of both deletions (pPA34) resulted in a 24-fold increase in the levels of 
SpA obtained.
4.2.1.3 Time Course of SpA Production
The previous results represented the level of SpA production achieved following 
growth of each clone into stationary phase. A Further series of experiments were, 
therefore, undertaken on cells carrying pPA16, pPA31 and pPA34, in which the level of 
SpA production at various points in the growth phase was monitored. A 2 L falsk 
containing 500 ml of prewarmed 2xYT broth, ampicillin (50 pgmT*) was inoculated 
with JM83 [SpA] from an overnight culture to give a starting density of 0.02 mg cells 
per ml. The cultures were shaken at 160 rpm, 37°C, and 10 ml samples taken at regular 
intervals, lysed and SpA levels determined as detailed in sections 2.2.13.2 and 2.2.14.2.
Under these growth conditions, an overall increase in SpA production was observed in 
cells carrying all three plasmids (Table 4.1). A growth curve of the amount of SpA 
recovered from lysed cells versus number of cells present, was plotted (Figure 4.2).
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Figure 4.2 Change in SPA levels of 3 recombinant clones as cell 
density increases
From the graph it can be seen that after an initial lag phase, during which cell growth 
increased at a far greater rate than SpA production, SpA production increases in 
proportion to cell growth. The rate of SpA production directed by plasmids pPA16 and 
pPA31 was virtually identical until a cell density of 0.45 mg ml-1 was attained, 
whereupon, SpA production by cells carrying pPA16 was seen to decrease 
considerably. The rate of SpA production directed by pPA34 was consistently higher 
than that seen for the other two plasmids. However, between the penultimate sampling 
time (6hrs after inoculation), and the last sampling time (overnight, 23.5 hours after 
inoculation), the levels of SpA present (per mg m l'1 cells) dropped from 135.5 pg ml-* 
to 31.5 pg ml-*. Analysis of the growth medium from the 23.5 hour samples from all 
three JM83 [pPA] cultures showed no SpA present in that of cells carrying pPA16, SpA 
levels of 1 pg m l'1 in that of cells harbouring pPA31 and 120 pg m l'1 in that of cells 
containing pPA34. Whereas SpA was almost exclusively intracellular in cells 
containing pPA16 and pPA31, after 23.5 hours incubation under the growth conditions 
above, almost 80% of the SpA produced by cells carrying pPA34 was found to be 
extracellular.
4.2.1.4 SpA production and Cell Fragility
Further investigation to determine whether SpA produced by pPA34 containing cells 
was actively secreted from the cell or was present in the culture medium, solely through 
cell lysis, were performed. Repeat growth experiments, with conditions identical to the 
above excepting a reduction in shaking speed, revealed no decrease in cellular SpA 
levels during growth, and extracellular SpA levels of less than 5 pg ml"1 when shaken at 
speeds less than 120 rpm. As the shaking speed was increased above this level, so the 
extracellular levels of SpA increased. Determination of the molecular sizes of the IgG 
binding polypeptides produced showed an identical banding pattern for both 
intracellular and extracellular SpA. Analysis of the cells under a light microscope 
showed a high percentage to be lysed "ghosts" (Section 4.2.15). It was concluded that 
the SpA produced was intracellular in nature, but due to the fragile nature of the host 
cells, were easily released into the external medium.
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The fragile nature of JM83 when carrying an SpA plasmid appeared to correlate 
directly with the amount of SpA produced. Cell viability was a particular problem with 
JM83[pPA31) and JM83[pPA34], both during culture growth and during storage of 
cells (viability problems during large scale cultivation o f the latter clone will be 
discussed further in section 4.2.4). The maximum rpm at which a 500 ml JM83[pPA] 
culture could be shaken with less than 5% SpA released into the media, when grown 
under the conditions already stated, was 220 rpm for JM83 [pPA16], 170 rpm for 
JM83 [pPA31], and 160rpm for JM83 [pPA34]. This contrasts with JM83[pUC8], 
which could be shaken at 300 rpm with no apparent lysis of the cells. It was found that 
whereas JM83 {pPA16] remained viable on a 2xYT (ampicillin 50 pg ml'*) plate 
stored at 4°C for approximately 2 months, JM83 [pPA31] and JM83 [pPA34] were 
found to have lysed after 5 days and 3 days respectively. When incubated at 37°C for 
more than 14 hours both the latter developed a second smaller colony type, which was 
not resistant to ampicillin and did not produce SpA. No plasmid was detected in these 
cells. Storage at -70°C revealed a 25%, 30%, and 50% loss in viability for JM83 
[pPA16], JM83 [pPA31] and JM83 (pPA34) respectively, compared with a 10% loss in 
viability in JM83[pUC8J stored for the same length of time.
4.2.1.5 SpA Production and Cell Morphology
Examination by light microscopy of a 5 pi sample of SpA producing cells, from a 
10 ml culture shaken for 6 hours at 37°C, magnification 100, revealed a difference in 
the cell shape for each of the high producing SpA clones (Figure 4.3). JM83(pPA16] 
appeared almost identical to JM83 [pUC8], a 2-3 p rod, it was the same length but 
slightly ovoid in shape. The 5 pi sample of JM83[pPA31] contained 50% normal cells 
(Figure 4.3), the rest of the cells showed varying degrees of elongation and distortion of 
the cell wall. Many contained a denser region which is normally indicative of an 
inclusion body. The 5 pi sample of JM83[pPA34] also contains a mixed population; 
consisting of 10% normal cells, 90% slightly ovoid cells. The fact that the presence of
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r  igure 4.3 Cell-Morphology of JM 83 IpUCSJ, JM 83 [pPA16], JM 83 [pPA31] and JM 83
Gram stain of: A: JM 83 JpUCM . B: JM83 (pPA 16 |. C: JM 83 lpPA31J (to show  the 
frequency of elongated cells in the culture BG) D: JM83 |pPA311 (to  show the ex ten t of 
elongation of the cells) E: JM83 [pPA34J OI

pPA31 caused a far greater distortion of the cell structure than did the presence of 
pPA34, would seem to indicate that the SpA cell membrane binding region, present in 
pPA31, might be interacting with the E. coli outer membrane. This interaction may 
also explain the elongation of the cells, as the SpA may be interfering with membrane 
sites involved in the process of cell division.
That such an interaction occurs is corroborated by experimental evidence obtained from 
comparing the difference in SpA yields between cells that have been disrupted using a 
lysozyme/detergent method with those disrupted using sonication (Table 4.2). The 
former method involves centrifugation to separate the cell debris from the soluble cell 
fraction, allowing the latter fraction to be collected. Any SpA adhering to the cell 
membranes, or cell wall, would also be removed. Sonication will fractionate the cell- 
membranes and cell-wall to such a degree that far less cell debris is pelleted during 
centrifugation. Cellular disruption, using sonication rather than lysis, results in more 
than an 80% increase in the recovery of the full-length SpA coded for by pPA31; 
compared with an increase of only 30-40% in the recovery of the truncated SpA coded 
for by both pPA16 and pPA34. These results suggest that the proposed membrane 
binding region of SpA, coded for by pPA31, does associate with the E. coli cell- 
membrane or cell-wall.
4.2.1.6 Production in Different E. coli Hosts
The poor viability of the two high expression clones, JM83[pPA31] and JM83[pPA34] 
would make successful production of SpA in large scale cultures difficult. As E. coli 
strains are known to vary in their susceptibility to cell lysis, the use of a different E. 
coli host might result in greater plasmid and cell stability, without a significant 
reduction in SpA production. The two high SpA producing plasmids pPA31 and 
pPA34 were transformed into the E. coli strains JM101, MC1061 and GM242. The 
transformed strains were then cultured in 10 ml volumes in the standard manner, the 
SpA recovered using the lysozyme method (Section 2.2.13.2) and the levels of SpA 
compared by monorocket electrophoresis (2.2.14.2). Statistical analysis of the results,
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TABLE 4.2
Comparison of the SpA Levels Obtained When JM83 [SpA]
Cells are Disrupted Using Either Sonication or Lysozymc/Dctergent Lysis
Plasmid SpA levels pgmg** cells dry wt.
Lysozyme/
detergent
Sonication % increase in SpA 
obtained using 
sonication
pPA16 36.2 49.7 37.3
(0.57) (0.71) (3.6)
pPA31 58.6 107.6 83.6
02.1) (20.4) (5.6)
pPA34 148.8 196.2 31.9
(22.3) (27.4) (15)
sample size = 6
std deviation values in brackets (n-1)
summarized in table 4.3, showed that there was no significant difference at the 5% level 
between the amounts of SpA produced by each of the E. coli hosts carrying the same 
plasmid. The viability of the cells following storage was again found to be directly 
correlated to the amount of SpA produced; as SpA levels increased, so cell viability 
decreased.
4.1.2.7 Sizes of IgG binding Polypeptides Produced
The sizes of the IgG-binding polypeptides produced by the different SpA clones were 
determined by Western blotting. Cell-free extracts were prepared from cultures by lysis 
with lysozyme and detergent, heated with an SDS containing running dye to destroy 
secondary structure and fractionated on an SDS- polyacrylamide gel. The proteins 
were transferred electrophoretically to nitrocellulose niters, which were then washed 
with 5% BSA to prevent non-specific binding and probed with ^**I-labelled human 
IgG. After exposure to the probe, the filters were washed, dried and autoradiographed. 
(Details in Methods, sections 2.2.15, 2.2.16 and 2.2.17).
Analysis of the cell-free lysates from HB101[8G4] and JM83[pPA30], both of which 
contain an SpA fragment capable of coding for the entire gene, showed the presence of 
more than one IgG-binding polypeptide in both lysates. The number of IgG- binding 
bands present were found to vary between samples from three (Molecular weight bands 
47 kDa, 43 kDa and 14.5 kDa) up to six (tracks 4 and 5, Figure 4.4), though the position of 
the peptides remained constant relative to one another. The 14.5 kDa IgG-binding band 
was also shown to be present in the control samples (lysates from identical E. coli host 
[plasmid] system lacking only the SpA inserts). This band was found to be identical in 
size to the lysozyme band in the protein marker sample. A sample containing buffer 
and lysozyme, when analysed using the same Western blotting procedure, was found to 
produce a 14.5 kDa band. Therefore, the 14.5 kDa IgG-binding band in the E. coli [SpA] 
lysates was considered to be lysozyme and not an SpA polypeptide. The smaller 
molecular weight peptides are thought to be a result of degradation of the mature SpA,
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TABLE 4.3
Alternative E. coli Hosts
SpA Levels ligmg’* Dry Weight 
E. coli Strain
Plasmid JM83 JM101
■finducer (IPTG)
MC106I GM242
pPA31 63.6 51.4 57.3 72.4
(13.2) (8.7) (6.4) (15.6)
pPA34 123.7 86.4 86.2 106.6
(15.1) (21.6) (11.8) (17.2)
Results from 10 ml o/n cultures, 37°C, 200 rpm. ImM IPTG added to JM101 culture 
JM83 and MC1061; 11 samples 
JM101 and GM242; 6 samples 
std. deviation values in brackets (n-1)
1 2  3 4  5 6 7  8 9
Figure 4.4 Analysis of IgG Binding Polypeptide 
lpPA30]
Lanes contained:
(1) Sigma Protein A, 100 pg/ml. (2)
(3) JM83 lpUC8], (4)
(5) JM83 pPA30] & pmsf. (6)
(7) HB101 |pBR327] (8)
(9) HB101 [8G4] & pmsf
^ -6 9 K
•♦■46K
• ♦ - 3 0 K
14-3K
luced by  HB101 [8G4] and JM 83
Sigma Protein A 10 pg/ml 
JM83 IpPA30],
Lysozyme 
I IB 101 [8G4],
as their number is found to increase in proportion with the length of the cell growth 
period, (Figure 4.8, reported in greater detail at a later point). Degradation is possibly 
caused by one of the many proteases known to be located within the E. coli periplasm. 
Degradation was unlikely to be the result of E. coli serine protease activity 9s the 
inclusion of the serine protease inhibitor, phenylmethylsulphonyl fluoride (PMSF, 
0.1 mM final concentration), in cell suspensions prior to lysis caused no alteration to the 
banding pattern observed (Figure 4.6), though a few serine proteases are not sensitive to 
this reagent.
Analysis of the IgG-binding peptides produced by JM83[pPA31] produced an identical 
banding pattern to that seen for 8G4 and pPA30. A similar banding pattern was present 
in lysates from JM83[pPA16] and JM83[pPA34]; the only significant difference being 
a decrease in the size of the largest molecular weight band from 53 kDa to 48 kDa (Figure
4.5, Table 4.4). This difference in size is approximately 2 kDa less than would be 
expected for the deletion of the C-terminal region in the latter constructs, and is 
probably indicative of the limits of accuracy imposed upon the system through trying to 
cover a wide range of molecular weight polypeptides at inconsistent concentrations. 
The largest SpA polypeptide band (53 kDa) produced by cells carrying either pPA30 or 
pPA31 was indistinguishable from the native Cowan I SpA mature peptide, whereas 
the largest SpA polypeptide from cells containing pPA16 and pPA34 (immunoblot for 
pPA34 shown only. Figure 4.8) can be seen to have a higher relative mobility. This 
appears to indicate that the largest molecular weight polypeptide represented the 
processed (mature) SpA molecule, rather than preprotein form (before cleavage of the 
signal sequence).
N-terminal amino acid analysis of the IgG-binding polypeptides produced by pPA34, 
was undertaken by Mr Roy Hartwell, PHLS, CAMR, using an automated Edman 
degradation technique as detailed in Section 2.2.20 and showed that all the polypeptides 
possessed the same N-terminal sequence, that of the mature SpA. This information 
both confirms that the SpA signal sequence cleavage site is recognised and the
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Figure 4.5 Analysis of IgG-binding Polypeptides Produced by JM83 [pPA 16], JM83 [pPA31] and Jm83 [pPA34] 
Lanes contained
(1&2) JM83 [pPA31] (3 & 4) JM83[pPA34]
(5) Molecular weigh! marker (6&7) JM83 [pPA34]
(8) S. aureus, wood 46 (9) JM83 [pPA16]
(10) Molecular weight marker
TABLE 4.4
IgG-Binding Peptides Produced by 
the JM83 [SpA] Clones
M olecular weight of IgG -binding peptides present in lysates from the SpA 
plasmids
CowanI 8G4 pPA30 pPA16 pPA31 pPA34
56,000 54,000 54,000 48,000 53,000 48,000
46,000 45,000 45,000 45,000 45,000
43,000 43,000 42,000 42,000 43,000
42,000 42,000 14,000 14,000 32,000
14,000 28,000
14,000
Figur« 4.6 Effect o f (i) Lac Control on SpA expression and ii. the Presence o f (pmsf) on the Degradation o f the IgG- 
Binding Polypeptides of JM83 |pPA31 and pPA34] (I)
(I) JM83 [ pPA31] earlier sample positive control
(3) JM83(pPA3lj and pmsf
(5) JM83 lpPA31| and (pNM52] and IPTG
(7) JM83 [pPA34j earlier sample positive control 
(9) JM83 [pPA34 and pmsf
(II) JM83 |pPA34) and (pNM52] and IPTG.
(2) JM83 (pPA31),
(4) JM83 lpPA31) and [pNM52j 
(6) Molecular weight marker,
(8) JM83 |pPA34|
(10) JM83 |pPA34) and (pNM42]
preprotein correctly processed by E. coli enzymes, and also helps localise the SpA 
regions where proteolytic cleavage may occur. As the N-terminus has been shown to 
be intact in the smaller SpA polypeptides, and it is unlikely under the denaturing 
conditions of the running gel that the formation of a variable secondary structure could 
account for all the smaller SpA polypeptide bands, any truncated polypeptides are 
likely to have resulted from proteolytic cleavage occurring in the C-terminal region of 
the protein. As the banding patterns for the smaller IgG-binding polypeptides are 
identical for the lysates from both the full length and truncated SpA clones, this infers 
that proteolytic cleavage is occurring at the N-terminal side of the amino acids 
corresponding to the Pst 1 site in the nucleotide sequence. Comparison o f the 
molecular wts obtained for the degraded SpA polypeptides with the amino acids 
predicted from nucleotide sequencing of the gene, places the C-termini of the 45Kd, 
43Kd and 42Kd SpA polypeptides within the first 27 amino acids of the Xc region, and 
the C-terminus of the 32Kd polypeptide on the boundary between IgG-binding region, 
C, and the Xr region. This is corroborated by a personal communication from Rene 
Arenson, Dupont, reporting the presence of 26 lysines in the C-terminal region of 76% 
o f the SpA derived from pPA34, which indicates that the majority of the SpA 
polypeptides retain the Xr region.
4.2.1.8 Degradation of IgG-binding Polypeptides
Growth experiments on JM83[pPA31] and JM83[pPA34] were carried out to 
determine the rate of degradation of the IgG-binding polypeptides. One litre of 
prewarmed (37°C) 2xYT, ampicillin 50 ng ml"1, was inoculated with 7 ml of an 
overnight bacterial culture to give a starting OD450 of 0.1. The cultures were shaken at 
their optimum SpA production speed, at 37°C, and a 10 ml sample taken at hourly 
intervals. The SpA was recovered from the cells using the lysozyme/detergent 
procedure, detailed in methods Section 2.2.13.2, and the amount of SpA determined by 
monorocket electrophoresis, as detailed in Section 2.2.14.2. The cell-free lysates were 
then diluted to give a maximum concentration of 100 \ig ml-1 and the IgG-binding
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polypeptides determined using the Western blotting and radioimmunoassay procedure 
detailed in sections 2.2.15, 2.2.16 and 2.2.17.
Analysis of the gels, Figure 4.7 and 4.8, reveals that the rates of degradation for two 
different mature SpA polypeptides, produced by cells carrying pPA31 and pPA34 were 
different. The lysates from JM38 [pPA31] (Figure 4.7) show both the 53 kDa and 45 kDa 
polypeptide present in the 1 hour sample; in the 2 hour sample the 53Kd band appeared 
stronger, however, closer examination of the gel shows evidence for an air-bubble 
being present during the Western blotting procedure resulting in poor transfer of the 45 
kDa band in tracks 4 and 5. The 43 kDa band first appeared in the 3 hour sample, and 
evidence of further degraded polypeptides was seen in the 7 hour sample. The first 
IgG-binding polypeptide seen in the lysate from JM83 [pPA34] was the 45 kDa band, 
which was seen in the sample taken immediately after inoculation of the 1 litre culture. 
The 48 kDa band, thought to represent the mature form of the truncated SpA, was not 
visible until the 3 hour sample and was then seen to increase until, in the 6 hour sample, 
it had a similar intensity to the 45 kDa band (which appeared to have remained at a 
constant level since the 3 hour sample). This alteration in the proportions of the 48 kDa 
and 45 kDa bands may have resulted from further degradation of the 45 kDa band, as a 43 
kDa band first became apparent in the 4 hour sample, and was seen to increase in 
intensity, whilst the intensity of the 45 kDa band remained constant From the 6 hour 
and later samples, the number of small IgG-binding polypeptides increased 
dramatically. The 48 kDa band remained at a fairly constant level, taking into account 
the dilution factor, until the 16 hour sample, when its concentration decreased, along 
with the 28 kDa band.
During the course of the experiment the levels of SpA were found to decrease from a 
level of 324 pg ml" ^  in the 14 hour sample to a level of 246 pg ml" * in the 16 hour sample. 
This may be due to lysis of some of the cells, or alternatively, to continued degradation 
of SpA already present in the cells without the further synthesis of new SpA. The latter 
alternative may also explain the absence of the 48 kDa band in the 16 hour sample. The
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Figure 4.7 Time Course Experiment Showing Rate o f Production and Degradation o f the Different IgG-binding 
Polypeptides Produced by JM83 [pPA31]
Lanes contained:
(1 & 2) 1 hr post-inoculation,
(5 & 6) 3 hr post-inoculation.
(9) molecular weight marker.
(12 & 13) 6 hr post-inoculation,
(16 & 17) 8 hr post-inoculation.
(3 & 4) 2 hr post-inoculation,
(7 A 8) 4 hr post-inoculation,
(10 & 11) 5 hr post-inoculation,
(14 & 15) 7 hr post-inoculation.
1 2 3 4 5 6 7 8 ft K> 11 12 13 14 15 16 17 18
Figure 4.8 Tune Course Experiments Showing Rates o f Production and Degradation for 
the Different IgG Binding Polypeptides Produced by JM83 (pPA34)
Except where stated otherwise all lanes contained JM83 |pPA34| and times are post-inoculabon. 
Lanes contained (1) S. aureus Cowan I, (2) 30 minutes, (3) 1 hr, (4) 2 hr, (5) 3 hr, (6) 4 hr, 
(7) 5 hr, (8) 6 hr. (9) 7 hr, (10) 8 hr, (11) 9 hr, (12) 10 hr. (13) 13hr, (14) 14 hr, (15) 15 hr. 
(16) 16 hr. (17) 16 hr cell paste and (18) molecular weight marker.
fact that definite bands are present in the 16 hour sample; (45 kDa, 43 kDa, 42 kDa, 32 kDa 
and 28 kDa), rather than a even spread of material along the track, and that the 
proportions of the various polypeptides present within the cell differ according to the 
time of sampling was taken, suggested that some of the cleavage activity was specific 
in its action. Comparison of the overall degradation patterns produced by JM83 
lpPA31] and JM83 [pPA34] suggested that the full length SpA protein produced by 
pPA31 containing cells was slightly more resistant to degradation than the SpA protein 
lacking the C-terminal 69 amino acids. A similar analysis of the medium from the final 
sampling time for JM83 [pPA34], gave an identical banding pattern to that obtained 
from the cell-free lysate (Figure 4.8). Levels of SpA in the medium, prior to the 
decrease in SpA levels found in the cell lysates at time 15 hours, were insignificant. 
This suggested that the SpA present in the surrounding medium was due to cell lysis, 
rather than excretion.
4.2.1.9 Localisation of SpA Under Conditions of Low Expression 
Protein A has been shown to be a cell wall component of S. aureus, covalently linked 
to the peptidoglycan structure, (Sjoquist et al., 1972a & b), with the IgG binding 
regions exposed on the cell surface . As the natural host, S. aureus, is Gram-positive 
and the SpA gene has been cloned into E. coli, a Gram-negative organism which has a 
very different cell wall structure (Figure 1.2), it is not known whether the SpA would 
be exported to the surface of the E. coli cell (Chapter 1, Section 1.3). The results from 
the analysis of the SpA IgG-binding peptides in section 4.2.1.3 showed that the signal 
sequence had been correctly processed. This implied that the SpA had been transported 
across the cytoplasmic membrane. The apparent absence of a precursor form of the 
SpA molecule appeared to indicate that the processing occurs co-translationally. To 
clarify this situation experiments were undertaken to determine the cellular location of 
SpA in E. coli.
The localisation method used relied on a controlled disruption of the bacterial cell to 
yield fractions representative of a specific cellular compartment. In order to ascertain
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the degree of contamination of each fraction with the other, assays for the presence of 
marker enzymes were undertaken. These enzymes were, alkaline phosphatase 
(periplasmic), glycerol-3-phosphate dehydrogenase (cytoplasmic) and NADH-oxidase 
(membrane). The JM83 [SpA] cells were prepared and the localisation assays 
undertaken as described in Section 2.2.18. If the different cellular fractions were 
shown to be adequately separated, then a 10 pi sample from each of the cell fractions 
was analysed using the standard monorocket electrophoresis conditions (Section 
2.2.14.2) to quantitate the amount of SpA present, and a 200 pi sample from each of the 
cellular fractions examined using the Western blotting and labelled IgG method 
described in Sections 2.2.15, 2.2.16 and 2.2.17.
Localisation of SpA in JM83 [pPA30] showed SpA to be present in all the cellular 
fractions (Figure 4.9), however, different peptide forms were found to predominate in 
different cell fractions. The membrane fraction was seen to contain both the 53 kDa 
and 46 kDa IgG-binding peptides, with the 53 kDA peptide being the dominant form. 
The majority of the SpA found in the periplasmic fraction was either the 46 kDa or the 
43 kDa peptide, with a small amount of the 53 kDa form being detected. All o f the 
above three peptides were seen to be present in about the same concentration in the 
cytoplasmic fraction. However, the location of the marker enzymes (Table 4.5) revealed 
that the cytoplasmic fraction was contaminated with material from both the periplasmic 
fraction and the membrane fraction, to an extent that could account for the SpA levels 
present. As the 53 kDa SpA IgG-binding peptide is found predominantly in the 
membrane fraction, the smaller SpA IgG- binding peptides predominantly in the 
periplasm, and the N-terminus o f the protein has been shown to be present on the 
smaller peptides, it is likely that the full size SpA peptide’s association with the cell 
membrane is mainly due to the C-terminal section, which is deleted in the smaller IgG- 
binding peptides.
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TABLE 4.5
Localisation of spa, Marker Enzymes Separation Results
JM83I Plasmid | SpA level 
Hg/ml
GADPH
%
NADH
%
Alkaline
Phosphatase
%
pPA30
whole cells 2.5
sonicated cells 6.8
periplasmic fraction 5.2 1.3 0.9 87.7cytoplasmic fraction 0.9 98.4 16.2
membrane fraction 0.5 0.3 82.9 0.6
pPA16
whole cells 2.0
sonicated cells 8.5
periplasmic fraction 6.0 19.7 17.5 94.6cytoplasmic fraction 1.0 80.3 10.4 2.5membrane fraction 0.4 0.1 72.1 2.9
pPA34
whole cells <0.1
sonicated cells <0.1 .
periplasmic fraction <0.1 16.0 33.1 61.0cytoplasmic fraction <0.1 81.0 47.5 30.0membrane fraction <0.1 3.0 19.4 9.0
cytoplasmic fraction marker enzyme. NADH : membrane fraction marker. 
Alkaline phosphatase : periplasmic fraction marker enzyme.
Localisation results for pPA31 are not shown in the above table as they were virtually 
identical to those obtained from pPA34.
Figure 4 .9  A nalysis o f IgG -Binding Proteins Present in the D ifferen t C ellular 
C om partm ents o f  JM 83 (pPA 16]
Lanes contained (1) JM83 |pUC8] whole cell sonicate, (2) JM83 |pPA16] whole cell sonicate 
(3) JM83 [pUC8] periplasmic fraction (4) JM83 |pPA16] periplasmic fraction, (S) JM83 [pUC8] 
cytoplasmic fraction (6) JM83 |pPA16] cytoplasmic fraction, (7) JM 83 |pUC8] membrane 
fraction, (8) JM83 |pPA16] membrane fraction, (9) S. aureus Cowan I and (10) M olecular 
weight marker.
4.2.1.10 Localisation of SpA Under Conditions of High Expression 
Localisation studies were undertaken on JM83 [pPA16J, JM83 [pPA31J and JM38 
[pPA34] using identical techniques to those stated for JM83 [pPA30J. These proved 
unsatisfactory for the following reasons. It became apparent that under low phosphate 
growth conditions, necessary to induce the alkaline phosphatase used as the 
periplasmic marker, all three normally high producing SpA plasmids synthesized little 
or no SpA. Thus, JM83 |pPA16] produced only 3-5% of its average yield, the SpA 
levels in both JM83 [pPA31] and JM83 [pPA34] were not detectable using monorocket 
electrophoresis. As this reduction in SpA yields was only seen in those clones 
producing the greatest amount of SpA, it was thought more likely to be due to loss of 
the resident recombinant plasmid, rather than some form of phosphate related gene 
regulation mechanism, as the latter would be expected to operate in both the high and 
low SpA production plasmids. The retention of the various SpA plasmids by JM83, 
when grown in either 2xYT broth or LP broth for a period of 5 hours, was confirmed 
by testing for ampicillin resistance (the bla gene of pUC8 is present in all the above 
SpA plasmids) by means of a comparison of the viable count on 2xYT agar plates with 
and without ampicillin (50 jigml-1). From the results (Table 4.6) it can be seen that 
loss of ampicillin resistance, indicative of plasmid loss, when grown on LP broth, 
explains the lack of SpA production by JM83 [pPA31] and JM83 [pPA34]. It is also 
of interest to note that the general level of cell viability of the latter two containing the 
plasmid, compared with JM83 [pPA30 and pPA16] under all growth conditions 
examined, was almost 10-fold lower. A similar reduction in ampicillin resistant cells 
was not seen to occur with JM83 [pPA16] when grown on LP broth. Therefore 
something other than total loss of SpA plasmid must have been responsible for the low 
levels of SpA produced by JM83 [pPA16] when grown in LP broth.
As a low phosphate medium affected SpA production in the high producing clones, it 
was thought that the normal JM83 growth medium, 2xYT broth, together with an assay 
for an alternative periplasmic marker such as (1-lactamase, might be used. However, 
the levels of contamination between the different cellular compartment markers was
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TABLE 4.6
Comparison of Viable Counts from JM83 [SpA] Plasmids Grown on 2xYT Broth 
and LP Broth With and without Ampicillin
Medium JM83 [SpA plasmid]
pPA30 pPA16 pPA31 pPA34
No. of colonies present 10'**
2xYT 480 392 86 49
2xYT 457 407 60 25
(Ap
50 pg ml"1)
LP 320 220 69 49
LP 301 200 2 0
(Ap
50 pg m l'1)
found to increase considerably in the higher SpA expression clones JM83 [pPA31 and 
pPA34] (Table 4.5), probably due to the increased tendency to lyse when subjected to 
any external stress; as reported earlier. Therefore it was decided that a localisation 
procedure which involved less cellular disruption would be more appropriate.
4.2.1.11 The Use of Immunological Labelling to Localise SpA Within the Cell 
The recent development of immunoelectron microscopy using colloidal gold allows an 
alternative approach to localising SpA within the E. coli host. Classical cellular 
fractionation is not involved in the method and the need for the detection of host 
enzymes as markers of cross-compartmental contamination is eliminated. Therefore, 
the problems caused by the use of traditional studies on the JM83 [SpAJ clones, such as 
poor cellular fractionation resulting from the fragility of cells carrying the spa gene 
when grown on a restricted medium, and the low levels of SpA produced under the 
physiological growth conditions necessary to induce the synthesis o f alkaline 
phosphatase for use as the periplasmic marker) are avoided. However, immunoelectron 
microscopy does have its own limitations such as the need for large amounts of the 
protein to be present in the cell and for that protein to be in an antigenic state. The 
fixation and dehydration treatments necessary to prepare the cells for sectioning prior to 
electron microscopy (E.M) must be applied with care or they may result in an alteration 
of the antigenic site or in the appearance of the internal structure of the cell.
4.2.1.11.1 Analysis of E. coli Cell Structure Using Electron Microscopy 
Preparation of cells for E.M was carried out in collaboration with A. Wames and the 
Electron Microscopy undertaken by B. Dowsett.
Samples of culture for electron microscopy analysis were removed during the late 
exponential growth phase and prepared for E.M analysis according to Section 2.2.22. 
The results are shown in Figure 4.10 and 4.11. Electron lucent areas can be within seen 
the cells, these areas are present between the inner membrane and the outer membrane.
129
Figure 4.10 Structural analysis of E. coli JM83 [pPA16]
Magnification 46,750. Electron lucent areas are show n (L).

4.2.1.11.2 Probing for SpA Using Immunogold Labelling
In order to establish whether immunogold labelling followed by electron microscopy 
would allow the location of SpA to be determined the technique was evaluated by using 
gold labelled antibodies to probe the surface of whole S. aureus Cowan I and E. coli 
JM83 [pPA16] cells. A far higher amount of gold label could be seen bound to the 
surface of the S. aureus cells than was seen in the surrounding background, ratio of 
approximately 10:1 (Figure 4.12(A)). The level of binding seen on the surface of E. 
coli JM83 [pUC8] cells was no higher than background levels (Wames 1989).
The recombinant E. coli cells carry the plasmid pPA16 were also shown to have SpA 
on the surface with the gold label binding a level approximately 4-fold greater than 
background, but substantially lower than that seen for S. aureus whole cells (40% of S. 
aureus binding levels) Figure 4.12(B). Probing for SpA in JM83 [pPA16] cell sections 
clearly shows the immunogold localised to the electron translucent areas. Figure 4.13. 
The distortion of the cell walls and tears within the cell section (seen as white spots 
within the cells, Figure 4.13) are indicative of an increase in the section fragility caused 
by omitting the post-fixation osmium tetroxide step, this omission is necessary for the 
success of the gold immunolabelling of SpA.
4.2.2 Use of Site-Directed Mutagenesis to Specifically Alter spa
4.2.2.1 Rationale
A major aim of this study was to obtain enhanced expression of spa in E. coli. The 
measures taken to achieve this, with regards to genetic constructions, are described in 
detail in section 4.2.3. A number of the recombinant plasmids constructed, however, 
required the introduction of specific nucleotide base changes into the 3 ' end of the 
gene. Such an undertaking is most simply achieved by site-directed mutagenesis 
methodology. Two specific alterations were considered appropriate:-
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Figure 4.12 Imtnunogold Labelling of lhe Protein A on the Surface of S. onreur Corean I 
and  E. colt JM 83 [pPA16]
(A) S. aureus, magnification of 72,000 (B) E. cali JM83 |pPA161. magnification o f 37,400.


i) The principle mutation change deemed worthwhile was to substitute the 
translational initiation codon of spa TTG (very uncommon in E. coli genes, present in 
only 4.5%) to ATG (the most commonly occuring initiation codon in E. coli genes, 
91.2%). The presence of a TTG inititation codon in the spa gene (discussed in further 
detail in section 3.3.1.2) may well adversely effect its native translation intitiation 
frequency when expressed in E. coli.
ii) The experiments described in 4.2.1 did not allow any definite conclusions to 
be drawn as to the relative contribution o f  the lac and spa to the high level of 
expression directed by plasmid pPA34. To clarify the situation a plasmid was required 
which no longer carried the spa promoter. Removal or inactivation of the spa promoter 
would not only allow the effect of the lacZ promoter on spa production to be evaluated, 
it would also allow the possibility of control of SpA production during small scale 
fermentation (further discussed in Section 4.2.4, where continuous SpA production 
during fermentation can be seen to be detrimental to cell growth resulting in a 
decreased final yield) to be examined. The most effective way of ensuring that the spa 
promoter was non-functional was to remove the -35 and -10 transcriptional promoter 
sequences entirely, leaving the spa Shine-Dalgamo sequence intact. As there was no 
cleavage site for any of the commercially available restriction enzymes between the -10 
promoter sequence and the Shine-Dalgamo sequence site-directed mutagenesis was 
employed to create one.
Oligonucleotide-directed mutagenesis is a method of in vitro mutagenesis which allows 
the construction of cloned DNA bearing a specific alteration. The oligonucleotide- 
directed mutagenesis technique used was based on the single primer method detailed by 
Carter et al„ 1985 (further details are given in section 2.2.12). This technique involved 
the chemical synthesis of an oligonucleotide consisting of a mutant sequence, which is 
hybridised to its complementary wild-type DNA (prepared as a single-stranded 
template using an M13 derivived vector) forming a mutant-wildtype duplex. The
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oligonucleotide mutant once hybrdised serves as a primer for in vitro enzymatic DNA 
synthesis of the regions which are to remain genotypically wild-type. A double- 
stranded duplex is formed, which is subsequently segregated in  vivo into separate 
mutant and wild-type clones, which can be detected by screening with the radio- 
labelled mutagenic oligonucleotide.
4.2.2.2 Oligonucleotide Design
The longer the oligonucleotide is, the more likely that it will recognise only the target 
sequence within the spa gene. Although it is now easily possible to produce synthetic 
oligonucleotides of 50-100 bases in length, these are not particularly suitable for site- 
directed mutagenesis for two reasons : firstly the chances of an error in the synthesised 
sequence increases with length and secondly the screening method used for detecting 
the mutants relies on differential annealing procedure involving radiolabelled 
mutagenic oligonucleotide. This procedure is dependent on the difference in the 
dissociation temperature (Td) of a perfectly matched oligonucleotide duplex and that of 
a mismatched duplex. It is possible to calculate the Td of a duplex by using the values 
stated in the Wallace rule : G - C base pairing = 4 C and A - T base pairing = 2 C 
(Wallace et al, 1979). However the relationship between oligonucleotide length and Td 
is nonlinear, and it is generally accepted (Smith 1986) tha t this rule become 
progressively more invalid as oligonucleotides become greater in length than 20 bp. 
Therefore it was decided to design mutagenic oligonucleotides consisting of 20 
nucleotides.
The s tric tes t crite rion  regarding the placement o f  the m ism atch  w ithin the 
oligonucleotide is that it must not be placed within 4 nucleotides o f the 3' end, as this 
might result in repair of the mismatch by the 3 ' > 5' exonuclease activity present in 
the DNA polymerase Klenow fragment. The presence of 3 nucleotides following the 
mismatch has been shown to protect it from this exonuclease activity (Gillam and 
Smith, 1979). Placement of the mismatch close to the centre of the oligonucleotide, is 
also important if the oligonucleotide is to be used as a probe to screen for the mutant.
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Szostak et al (1980) have demonstrated that the central positioning of the mismatch 
yielded the greatest binding differential between a perfectly matched duplex and a 
mismatched duplex.
The final step in designing an oligonucleotide is to analyse the DNA sequence of both 
the vector, in this case M13mp8, and the rest of the cloned fragment for regions of 
partial complementarity and so identify any competing sites from which priming might 
also occur. There should be as little dyad symmetry as posssible in the oligonucleotide 
in order to advoid the possibility of self-hybridisation occurring.
Observing the above criteria and using the comparison programs supplied by 
DNASTAR Inc (Madison, USA) set to show regions of 50% or greater homology 
within a 20 nucleotide window; a range of possible mutagenic oligonucleotides 20bp in 
length (with the mismatch occupying a central position, at least 5bp from either the 5 ' 
or 3' end) were analysed.
The DNA sequence for the oligonucleotide designed to introduce an EcoRl site 
between the spa -10 promoter sequence and the S.D sequence by altering the sequence 
AAATAC to GAATTC, whilst consisting of a static 13 nucleotide core region could be 
extended by up to 7 nucleotide in either the 5 ' or 3 ' direction, as shown in Figure 
4.14. Computer analysis showed no homologies of 50% or greater existed between any 
of the potential mutagenic oligonucleotide sequences and the vector M13mp8. 
However all the potential mutagenic oligonucleotides showed many homologies of 
60% and higher when compared to the rest of the cloned spa fragment. Taking into 
account the fact that a predominance of matches at the 3 ' end of the oligonucleotide 
will make a more efficient priming site than the same degree of complementation at the 
5 ' end (Zoller et al, 1983) the nucleotide sequence indicated in Figure 4.14 was 
selected to be used as a mutagenic oligonucleotide. For, although it had one match of 
68% homology with a region further downstream in the spa gene only one of the 6
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Figure 4.14 spa DNA Sequences to which the complementary sequences for 
the two oligonucleotides for site directed mutagenesis were 
synthesized
A) Oligonucleotide to introduce an EcoRl between the -10 promoter and the 
Shine-Delgamo sequence.
A A
gatgactTT A CG A A TTCA TA caggggg
B) Oligonucleotide to alter the translation initiation codon from TTG to ATG. 
T
The oligonucleotide is complementary to the DNA sequence shown. The difference 
between the oligonucleotide sequences and the wild-type spa DNA sequence which 
will creat point mutations, are indicated: superscript letters represent the nucleotides in 
the original spa nucleotide sequence which were altered. Upper case letters indicate 
which nucleotides should be included in the synthetic oligonucleotide. Lower case 
letters indicate the range (in both the 3' and 5 ' direction) from which a 20 bp 
oligonucleotide could be selected (following the rules given on Section 4.2.2.2). 
Oligonucleotides synthesized for mutagenesis are indicated by underlining.
bases at the 3' end of the oligonucleotide was involved, thus the oligonucleotide was 
unlikely to hybridize to this competing region.
A similar analysis of the vector and spa DNA sequence for regions complementary to 
the possible designs of oligonucleotides to alter the spa translation initiation codon 
from TTG to ATG gave many matches of 65% homology and over against both 
M 13mp8 and the non-target region of the spa insert. The oligonucleotide with the 
lowest degree of homology to the latter two regions was selected for the mutagenic 
oligonucleotide, see Figure 4.14. This oligonucleotide gave 16 homologies of 60% and 
above with M13mp8, including 7 matches with the 5 bases at the 3' end having 100% 
homology. The oligonucleotide also showed 2 matches of over 65% homology with 
non-target regions of the spa gene, one of these exhibiting 100% homology for the 6 
bases at the 3 ' end of the oligonucleotide.
Several regions of the spa gene were shown to exhibit a high degree of homology to 
one or other of the two nucleotide probes. The specificity of the oligonucleotide for the 
correct target sequence was checked by using the oligonucleotide sequence as a 
dideoxy-sequencing primer for single-stranded M13 mp8 DNA containing the spa gene 
(Figure 4.15). Although both synthetic oligonucleotides bound to the target spa DNA 
sequence and initiated DNA synthesis, the resultant sequence "ladders" became 
unreadable approximately 21-26 nucleotides ustream of the Dra\ site. Comparison of 
the oligonucleotide sequence with the spa sequence at these points (Figure 4.16) showed 
that the appearance of multiple bands on the autoradiograph coincided with areas of 
strong homology. These extra bands are probably caused by multiple hybridisation 
resulting from the use of these particular synthetic oligonucleotides as primers, as no 
interference was seen on the original sequencing of the spa gene using M13 universal 
primer. The overall level of homology between the oligonucleotides and thse non­
specific regions was 50% over a distance of 20bp ( although at the point the extra 
banding occurs; X and Y (Figure 4.15 and 4.16) the level of homology was 83% over a 
distance of 12 nucleotides and 89% over a distance of 9 nucleotides); and as such
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Figure 4.15 D id e o x y -se q u e n c in g  S h o w in g  M u ltip le  B in d in g  o f  th e  M u ta g e n ic  
Oligonucleotides
Figure 4.16 Examination of Possible Hybridisation Between the Synthetic 
Oligonucleotide Sequences with Non-target DNA S’ to the spa 
Gene
Homology X
AC A AAATTTTT ATTTT ATAA
I I I I I I I | I I 50% homology over 20 bp
GACTTTACAAATACATACAG
Homology Y
ATCTTTGGACAAAATTTTTA
| | I I I  I I I I I 45% homology over 20 bp
GGGGTATTAATTTGAAAAAG
The upper sequence of each homology pair is native spa DNA, while the lower 
sequence is the synthetic oligonucleotide (with X = EcoRl mutation and Y = ATG 
initiation codon mutation). The position of spa DNA sequence with respect to the Dral 
site and target priming site are shown on Figure 4.15.
would not have been detected as significant within the limits of the homology search 
undertaken using the computer (homologies of 60% and greater over a window of 
20bp), therefore, a similar or more extensive effect may occur in the regions of greater 
homology shown to exist from the computer search.
During site-directed mutagenesis it is commonplace for additional mutations to those 
intended to be introduced into the target DNA. It is, therefore essential that the 
authenticity of mutated DNA be thoroughly checked prior to subsequent subcloning 
into a plasmid vector. To avoid having to resequence the entire spa gene after 
oligonucleotide mutagenesis only the part of the SpA gene containing the desired 
mutagenic changes was isolated, and an equivalent region in the wild-type, plasmid 
borne, spa was then replaced with this mutagenic subfragment. The spa gene was 
subjected to SDM and the mutated region subcloned as a 223 bp Dral/Mael restriction 
fragment (see Figure 4.17).
Mutagenesis was carried out as detailed in section 2.2.12. Detection o f the spa 
sequence containing the mutations was dependent on differentiation between the Td 
values for the hybridisation between the 7 ^2 p  ia5ene(j mutagenic probe and the single 
stranded template DNA, the latter being either the wild-type spa or the spa gene 
containing the mutagenic alterations. The Td values of the different mutations and 
wild-type regions are indicated below:
4.2.2.3 Site-Directed Mutagenesis
Td value °C
wild-type spa - 
mutagenic probe
mutant spa - 
mutagenic probe
EcoRl mutation 43 49
ATG start codon 45 47
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Identification of the mutant spa DNA was undertaken as follows. Excess ^2p 
oligonucleotide probe was removed from the filters by 3 washes in 6 x SSC at 37 C and 
the filters autoradiographed for an hour, Figure 4.18. The filters were then washed at 
45 C for 1 minute. The radioactivity from the filter containing EcoR 1 mutation was 
seen to drop from 200 counts/min to 50 counts/min whereas, no such fall in 
radioactivity was observed for the filter containing the ATG mutation, both filters were 
autoradiographed for 3 hours. The presence of the EcoRl mutation was easily 
identifiable, Figure 4.18(A), no differentiation between probe intensity was visible for 
the ATG mutation filter, therefore it was subjected to a set of 1 minute duration 6 x 
SSC washes at gradually increasing temperatures until a substantial drop in 
radioactivity levels was observed at 48°C. The filter was then autoradiographed for 3 
hours, Figure 4.18(A). Four "positive" colonies were then plaque purified and four 
templates prepared from each, Section 2.2.12.4. The mutagenic alteration was 
checked by dideoxy-sequencing using an oligonucleotide primer complementary to a 
region in the signal sequence 45 bp downstream of the Mael site, Figure 4.17. The 
entire DNA sequence of the Mael - Dral fragment, was resequenced using this primer 
to ensure that no other mutagenic alterations had occured. Although the plaques from 
the EcoRl mutation gave a higher percentage of mutants (60%) than the ATG mutation 
(40%), the use of the EcoRl oligonucleotide also resulted in more incorrect mutations 
than the use of the ATG oligonucleotide ( with 15% of the EcoRl mutant templates 
containing multiple copies of the oligonucleotide). However because the EcoRl 
mutation had been far easier to identify than the ATG mutation, the spa clone 
containing the both the EcoRl mutation and the ATG mutation was constructed by 
carrying out a further mutagenesis step with the EcoRl oligonucleotide on one of the 
successful ATG mutated templates. Detection of a successful mutant was carried out as 
previously decribed for the EcoRl mutation, Figure 4.18.
4.2.2.4 Incorporation of Mutagenic Changes into Recombinant Plasmids
In order to be able to carry out a direct comparison of the effect of the mutagenic
changes on the levels of SpA production in plasmids carrying either the full length spa
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100CAATTCACAATTCTACCTATTATCACTTCTCAAAATAAAAACATCGTTCTTCTTAAACATTTAATTGAAACAATCCACCATAAATACCCTCAAACTCTTA 
EcoRl Mael
CACCTCTCAATAATTTAAAAAAGCAAGGCTATCTAATAAAACAACCCCTCAACTGAACATCAAAGAAAAATTTTAATTCATATCAATCACGCCCAGCAAG 200 
Oral
ACCATCCTCAACAATTATTACCTCAACTCAATCAATTATTCCCACATAAAAATCATTTACATCTTGTTTTTGAATAATATCTCTATTACCCAAGTCTCCT 300
CTATTCTAAACTCCCATTCTCTTTTCTATTnTTAATAAAACCTCACCACATTATCAACAACTTTCTATTTTCTATATCTCTTAAAACCATTTCCCAAAT
TAAACCTCACCACATTCAAAATTCCATnTATTCTTAAAAATATTTTTTAACTCATATCTAATAAACCCCTTTCATTATAAAAAATATCTATATATTTTA
Oligo. A Oligo.B
400
300
TCTGTTTTTATTAATCCGAATAGCCTCATTTTCCGGTTTTAACCCTTTTACTTCCTCAATAAATCTTTGCACAAAATTTTTATnTATAACTTGTAAAAC 600r»
D ra jl -33  -1 0  G T S.D.
ttacctttaaatttaattataaatatacattttactaTtôcaatacataattccttatattatgatcactttacaaatacataêàccccctattaat 697
■TTC AAA AAC AAA AAC ATT TAT TCA ATT CCT AAA CtTA CCT CTA CCT ATT CCA TCT CTA ACT TTA CCT ACA TTA CTT
ATA TCT CCT CCC CTA ACA CCT CCT CCA AAT CCT'CCC CAA CAC CAT CAA CCT CAA CAA AAT CCT TTT TAT CAA CTC 
♦-sequencing primer
60 70
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TTA AAT ATC CCT AAC TTA AAC CCT CAT CAA CCT AAT CCT TTT ATC CAA ACC CTT AAA CAT CAT CCA ACC CAA ACT 922
Figure 4.17 Dral-Mael Fragment Used for Sub-cloning into Wild-type spa Following Oligonucleotide Mutagenesis
45*C
Figure 4.18 Detection o f Positive M utants Following the AcoRI and A T «  Oligonucleotide 
M utagenesis
A: EcoRl site mutagenesis
B: ATG start codon mutagenesis
C: EcoRl site mutagenesis carried out on earlier positive ATG mutagenic clone
gene (pPA30 and pPA31) or the truncated C-terminal version of the spa gene (pPA16 
and pPA34) it was decided to produce both the above versions with an identical series 
of mutagenic changes (Table 4.7).
Recombination of the mutated regions of the spa DNA with the "complementary" non 
mutated spa DNA to produce the complete spa gene required a series o f DNA 
manipulations. Non-mutated spa  DNA was isolated from a large scale plasmid 
preparation of pPA31. The mutated spa DNAs were isolated from large scale 
preparations of the replicative form o f  phage DNA, as described in Section 2.2.4.4. The 
series of manipulations necessary to construct spa plasmid pPA37, pPA38, pPA39, 
pPA40, pPA41 and pPA42 are detailed in Figure 4.19.
The transformation mixes were plated on to minimal agar containing Ap50 and BCIG 
(and IPTG for the JM101 transformants), to allow the detection of those carrying spa 
inserts. Twenty positive (white) colonies from each of the different plasmid types were 
selected and the DNA extracted for restriction enzyme mapping by the method of 
Bimboim and Doly (1979). Of the colonies examined for pPA37, pPA38, pPA41 and 
pPA42 63% contained the spa gene insert, and all but one gave the predicted restriction 
enzyme pattern. Only 35% of the pPA39 colonies and 10% of the pPA40 colonies 
contained an spa gene fragment, half o f  which had no Dra\ or Mael cleavage site.
Plasmid sequencing (as described in Section 4.2.2.11) was undertaken on 4 of the spa 
containing plasmids from each group. The DNA sequencing gels produced were of 
very poor quality, and despite alterations in both the concentrations of the sequencing 
chemicals and the use of different plasmid preparations, no improvement in the 
subsequent DNA sequencing was seen. Even though the nucleotide composition of all 
of the recombined regions of the plasmids could not be determined, it could be seen 
whether the spa fragments and pUC8 vector had recombined in the correct order. The 
pPA39 and pPA40 plasmids which had shown the aberrant restriction pattern were
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TABLE 4.7
Summary of the Difference Between the Six Mutagenic 
spa Plasmids
C-terminus Mutagenic alteration
comparable
to earlier £coRI site ATG initiation Eco RI site + ATG
plasmid no: codon initiation codon
pPA30/31 pPA37 pPA39 pPA41
pPA 16/34 pPA38 pPA40 pPA42
The mutagenic EcoKl cleavage recognition sequence was introduced between the 
predicted -10 promoter (Pribnow box) and the Shine-Dalgamo sequence, to produce a 
possible cleavage site between nucleotide positions 675 and 676.
The ATG translation initiation codon replaces the natural TTG translation initiation 
codon of the spa gene at amino acid position 1.
Nucleotide and amino acid numbering is according to Figure 3.2
Figure 4.19 Construction of plasmids pPA37, pl'A3X. pPA39, pPA40, pPA41 and pPA 42
A) SpA gene:
£coRI and EcoRI/ATG mutations
1 1 1
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l _ l
B) Original spa gene
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C) Recombination of the SpA fragments
I ,(A T G ) + I3 
I , (ATG) + 14
-  pPA37 
= pPA38 
»  pPA39
-  pPA40 
= pPA41
-  pPA42
Legend: Both M13mp7 and pUC8 contain multiple sites for the restriction enzymes 
Mae 1 and D ra\. Fragmentation of the vector and spa insert with these enzymes would 
resu lt in several vector DNA fragments o f  a similar size (indistinguishable using 
agarose gel isolation) to the required spa fragment Therefore the spa gene was initially 
isolated as an £coR 1 -BamH 1 fragment (A and B).
The following annotation for restriction endonuclease sites has been used; E: £coR l, 
M: Mae 1, H: «m dlll, P: F ill, D: O ral and B: Bamlll. Cleavage of a restriction site is 
indicated by the presence of an arrow ( | ) above the sites (A and B).
The spa  fragments (represented as Inserts. 1.1>4) were then recombined with one 
another as shown in C (above) and ligated into appropriately cleaved pUC8 vector, 
which was then transformed into E. coli strains JM83 and JM101.
found to lack the Dral-Mael spa fragment entirely.
4.2.3 Examination of Factors Effecting SpA Expression
The initial strategy adopted to obtain high expression of protein A in E. coli was to 
position the gene on a high copy number plasmid (pUC8) 3' to the promoter of the E. 
coli lac operon. The lac operon of E. coli consists of six different regions, which can 
be subdivided into two sections. One, which controls the level of expression of the rest 
of the operon, consists of three regulatory features; the sequence coding for the 
repressor gene I, the promoter region containing both the cAMP-CRP site and the 
Pribnow box, and the operator region containing the repressor protein binding region 
and the ribosome binding site. The second codes for the three structural genes: p- 
galactosidase (Z) which hydrolyses lactose to glucose plus galactose and is therefore 
essential for lactose catabolism, galactosidase permease (Y) which transports lactose 
and many related substances into the cell, and (i-galactosidase transacetylase (A) whose 
exact physiological roles has not yet been identified. The lac operon is subject to both 
repression control and activation control (Figure 4.20).
The plasmid pUC8 contains only a small region of the lac operon: the promoter region 
(P); the operator region (0), containing the repressor protein (I) binding site; and the 
first 59 codons of the lacZ structural gene, with the multiple cloning site (consisting of 
11 amino acids) inserted between the sixth and seventh codon of the lacZ structural 
gene. Although pUC8 does not code for the lac repressor protein (I), it does contain 
the repressor binding region. Therefore, the function of the lac promoter of pUC8 can 
be controlled by altering the amount o f repressor present in the host system in 
proportion to the number of copies of the lac gene present.
In thé case of the initial recombinant plasmids constructed, expression data described in 
section 4.2.1 appeared to indicate that the presence of the lac promoter 5 * to the spa 
structural gene (pPA16) had no beneficial effect on the level of SpA produced by E. 
coli, unless a region of DNA located between the lac promoter and the spa promoter
138
Figure 4.20 Control Mechanisms o f  the lac O peron
The lac operon has tw o control mechanisms that operate at the level o f transcription.
Repression control: The repressor protein (I) is an allosteric protein existing in tw o forms, only one of which binds to the 
operator region. In the absence of an inducer molecule it will favour the operator-binding conformation and blocks access of 
the RNA polymerase to  the promoter, thus preventing transcription of the lac  structural genes. In the presence o f  inducer, 
which will bind to the repressor and cause it to assume a operator-non-binding conformation, the RNA polymerase has access 
to the promoter and initiates transcription of the structural genes.
Activation control: This is dependent on the levels of cAMP which show an inverse correlation with the cell growth rate. 
The CRP gene (unlinked to the lac operon) codes for the cyclic 3 , 5  -AMP recep tor protein. The CRP protein is also 
allosteric in nature, in one conformation (caused by the presence of cAMP) it recognises the CRP DNA binding site, in the 
absence o f  cAM P it does not. The cAM P-CRP complex will bind to the CR P-binding site adjacent to that for RNA 
polymerase and in doing so enhances the affinity o f  the promoter for RNA polymerase and so increases transcription.
was first deleted (pPA34). It was, therefore of interest to determine whether the high 
level of spa expression directed by plasmid pPA34 was due either to the lac promoter 
and/or the spa promoter.
4.2.3.1 Repression of lac using lacfl at low gene dosage
The earlier expression work was carried out using E. coli JM83 as the host for the 
recombinant based on pUC8. This strain has the lac-proAB region of the chromosome 
deleted, and replaced by the lacZ A M15 mutation (which will produce a structural lacZ 
protein that complements that produced by pUC8). The absence of the lacl gene in 
JM83 results in the constitutive expression of the lac  promoter. The fact that 
transcription from lac cannot be repressed in JM83 meant that the extent to which lac 
and the spa promoter itself contributed to the expression of the spa gene, could not be 
ascertained. Use was therefore made of an E. coli strain which contained a lacl gene as 
a host for the SpA plasmids. JM101 was selected as this was very similar to JM83, and 
carried the same chromosomal (lac-proAB) deletion, however it differed from JM83 in 
that it carried a copy of lacfi and lacZ M15 on an F’ episome. The superscript ’q’ of 
lac fi indicates that this particular gene contains an "up" promoter mutation which 
causes a ten-fold increase in the expression of the repressor protein (Muller-Hill et al., 
1968, 1971). As the repressor is present the lac promoter of any pUC8-based any 
plasmid transformed in JM101 will be inducible rather than constitutive.
Cells of JM101 carrying either pPA16, pPA31 or pPA34 were cultured in 10 ml 2xYT 
(ampicillin 50 ng ml'*) at 37°C overnight, in the absence or presence of the lac inducer 
IPTG (final concentration 1 mM). The SpA was recovered from the cells and 
quantitated as detailed in Section 2.2.13.2 and 2.2.14.2. From the results presented in 
Table 4.8 for pPA31 and pPA34 the level of SpA increased substantially in the 
presence of the inducer IPTG, indicating that the lac promoter of pUC8 is apparently 
contributing to spa expression. The lack of a similar increase for pPA16 would appear
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TABLE 4.8
De-repression Of the lac Promoter Of The SpA Plasmids In 
JM101 Using IPTG
Plasmid SpA levels ugmg'1 cells dry wt.
-IPTG ♦IPTG % increase in SpA 
in presence of IPTG
pPA16 17.7 18.1 2.1
(1.9) (1.2)
pPA31 43.7 51.4 17.6
(9.7) (8.7)
pPA34 72.5 86.4 19.2
(16.1) (21.6)
Samples from 6 sets of experiments.
std. deviation values in brackets (n-1)
to be consistent with the hypothesis that the 609 S. aureus nucleotides prior to the spa 
promoter interfere with transcriptional readthrough from the lac promoter. It was also 
apparent that high levels of SpA were produced in the absence of inducer. There were 
two possible explanations for this. Firstly, the spa promoter itself could be responsible 
for the majority of spa expression. Or secondly, this "background" production of SpA 
can be accounted for by the fact that the equivalent number of operator sequences are 
present within the cell to the copy number of the plasmid. In the case of pUC8 the copy 
number has been shown to be between 500 and 600 copies per cell. In contrast, the 
lacfî gene is only present at 2 to 3 copies per cell i.e., the copy number of the F ' factor. 
Thus the excess of operator sequences could effectively titrate out all the available 
repressor protein molecules, with the result that expression from the lac promoter 
elements of a high percentage of the plasmid population would be constitutive.
4.2.3.2 Repression of lac using lacfl at high gene dosage
One way to overcome the inbalance between lac operator sites and repressor protein 
would be to increase the levels of the latter by locating the lacl^ gene to a plasmid with 
a higher copy number than F* . The plasmid pNM52 was especially constructed for 
this purpose (Gilbert et al., 1986). It was constructed by inserting the lacfi gene into 
pACYC184, and is therefore compatible with any plasmid derived from pUC8. It has a 
copy number of 20 copies per cell, and therefore is theoretically able to direct the 
expression of up to 10- fold higher levels of repressor protein than the F’ episome of 
JM101.
Plasmid pNM52 was transformed into JM83 [pPA16], JM83 [pPA31] and JM83 
[pPA34] and the cells were cultured either with or without ImM IPTG present. 
Contrary to what had been expected, not only did the addition of pNM52 fail to repress 
the production of SpA, it actually appeared to increase the levels, (Table 4.9). The 
addition of the inducer IPTG further increased the level of SpA recovered from the 
cells. To ascertain that the above anomaly was not restricted to the JM83 [SpA] 
system, pNM52 was then transformed into MC1061 [pPA31] and MC1061 [pPA34],
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TABLE 4.9
Controls O f The lac Promoter in the spa Plasmids by Use of 
loci** Expression From pNM52
Host (plasmid) SpA Levels pg ml"! Cells Dry Wt.
-pNM52 +pNM52 +pNM52 +IPTG
JM83 (pPA16J 32.2 36.0 42.61
(7.8) (7.6) (9.2)
JM83 [pPA31J 65.6 89.0 106.3
03.2) (20.0) (16.9)
MC1061 (pPA31J 57.3 80.2 90.7
(6.4) (14.9) (5.9)
JM83 [pPA34] 123.7 170.8 201.2
05.1) (29.0) (28.0)
MC1061 [pPA34] 86.2 95.6 112.9
(16.1) (29.0) 35.6)
SpA levels were not affected by adding IPTG to control cultures containing the SpA 
plasmid but not pNM52. std. deviation values are in brackets.
where exactly the same effect was seen to occur (Table 4.9). It was of interest to note 
that cells containing both an SpA plasmid and pNM52 were extremely fragile, cultures 
to be grown could only be inoculated from a -70°C stock as colonies on agar plates 
were found to lyse within 24 hours, when grown at 37°C.
4.2.3.3 Deletion of the spa promoter
Data obtained from the experiments utilising lac fi to regulate spa expression, described 
in two previous sections (4.2.3.1 and 4.2.3.2), did not allow any conclusions to be 
drawn as to the reason for the high level of SpA production in the absence of IPTG. As 
one possible source of transcription could be the spa promoter itself, recombinant 
plasmids were constructed which no longer carried the spa promoter. The construction 
of these plasmids (pPA37 and pPA38) enabled a direct comparison with the SpA levels 
produced by pPA31 and pPA34, as they are identical with regards to the spa encoding 
DNA, but lack the spa promoter region.
Cells of E. coli JM83 carrying pPA31, pPA34, pPA37 or pPA38 were cultured in 500 ml 
quantities, harvested and assayed for SpA production as detailed in section 4.2.1.2. The 
graph of growth against SpA production (Figure 4.21) for JM83 carrying the plasmid 
pPA38, closely resembled those of pPA34. In contrast, a similar comparison between 
pPA37 and pPA31 demonstrated that SpA production per mg of cells was higher during 
the early period of growth in cells possessing the former plasmid, though the final 
levels of SpA per mg of cells from an overnight culture of both clones were the same. 
Similar experiments were undertaken using JM101 in place of JM83 as the host strain. 
Cultures were grown in both the presence and absence of ImM IPTG and harvested at 9 
hours post-inoculation. SpA yields of both the JM83 and JM101 clones were 
determined and the results analysed as described for pPA16, pPA31 and pPA34 in 
section 4.2.1.2., the results are presented in Table 4.10.
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Figure 4.21 The effect on SPA production of removal of the spa
promoter from JM83[pPA31] Sc [pPA34] to give plasmids 
[pPA37] Sc [pPA38] respectively
TABLE 4.10
The Effect on SpA Production of the lac Promoter Under Repressed 
and Derepressed Growth Conditions in the Absence of the spa Promoter
Host Plasmid present 
pPA37 pPA38
JM83 118.3 244.5
(4.3) (31.6)
JM101 no IPTG 85.2 253.3
(9.1) (21.1)
JM101 + 1 mm IPTG 101.6 328.8
(6.7) (46.0)
JM101 % increase 19.2 29.8
in SpA yields in 
the presence of IPTG
std. deviation values are shown in brackets.
JM83 results are taken from 5 sets of experiments. 
JM101 results are taken from 3 sets of experiments.
Overall, ihe results with the host JM83 clearly demonstrate that removal of the spa 
promoter has no effect on the levels of SpA obtained. Thus the level of spa expression 
directed by pPA37 and pPA38 are the same as that directed by pPA31 and pPA34, 
respectively. The only significant difference in the SpA levels seen was between the 
plasmid possessing the entire spa gene (pPA37) and pPA38, which carries the spa gene 
truncated at the C-terminus. The latter plasmid directed the expression of twice the 
levels of SpA as the former. The same pattern was previously observed with the 
corresponding progenitor plasmids pPA31 and pPA34 (Table 4.1).
Similar expression data was obtained when JM101 was employed as the host organism, 
with the exception that cells carrying pPA38 produced significantly higher levels of 
SpA when grown in the presence of ImM IPTG. The high standard deviation value for 
this result does suggest that this may be a spurious observation. A direct comparison 
between the SpA levels of the mutagenic clones in JM101 with the SpA levels of 
pPA31 and pPA34 in JM101 was not possible, as the former were grown in 500 ml 
cultures and the latter in 10 ml cultures. The use of these two different culture volumes 
with JM83 clones has previously resulted in a two-fold difference in SpA production 
(Table 4.1). The percentage increase in SpA production by the mutagenic plasmids 
(Table 4.10) upon derepression of the lac promoter by the presence of IPTG in the 
growth media is consistent with that observed for pPA31 and pPA34 (Table 4.7), 
except for pPA38 which shows the higher increase in SpA production of 29.8%.
4.2.3.4 Removal of spa from the transcriptional control of the lac promoter.
The above results suggest that the lac promoter was solely responsible for the high 
expression of SpA in vectors such as pPA34. The fact that expression of spa was 
obtained in E. coli using pPA12 (4.2.1) demonstrates that the spa promoter can function 
in E. coli. To date, however, the efficiency of the spa  promoter on a high copy number 
plasmid could not be estimated due to the presence of the "upstream" lac promoter. 
The simplest way to ensure that the lac prom oter was not contributing to the
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transcription o f the spa gene, whilst retaining it in an otherwise identical multicopy 
plasmid, was to remove the lac promoter from the pPA plasmids. The region 
encompassing the lac promoter was removed from pPA16, pPA31 and pPA34 without 
altering the spa (J-galactosidase alignment to form plasmids pPA44, pPA45 and pPA46, 
equivalent to the pUC8 constructs pPA16, pPA31 and pPA34; respectively.
To remove the lac promoter, the spa plasmids were cleaved with £coRI and Seal, and 
the £coRI termini blunt-ended using T4 polymerase. The blunt-ended EcoRI-Scal 
fragment containing the spa gene was then isolated using agarose gel electrophoresis 
and the DNA recovered as detailed in sections 2.2.4.6 and 2.2.4.7, pUC8 DNA was 
cleaved with Seal and Pvull and the 5 ' termini of the fragments dephosphorylated to 
prevent any later self ligation of the blunt ends. The three pUC8 DNA fragments were 
separated on a 1% agarose gel and the 1.55 kb Scal-Pvall fragment recovered and 
ligated with the blunt ended EcoRI-Scal [spa/pUC8] fragment (Figure 4.22). E. coli 
JM83 was transformed with the ligation mix and plated onto a selective media 
containing 50pg ml'* ampicillin. The two fragments could ligate in either orientation 
but only the required ligation would result in the correct reconstruction of the bla gene. 
Ten colonies from each transformation were streaked out on 2xYT, ampicillin (50 
pgml'*) plates incubated at 38°C overnight and the DNA isolated using the STET 
procedure (Methods Section 2.2.4.2.1). The size of the spa insert was then checked by 
cleavage with Rsal.
JM83 cells containing either the above lac promoter-less plasmids or pPA16, pPA31 
and pPA34 (as controls) were grown overnight at 37°C in 10 ml of 2xYT ampicillin 
(50 pg ml'*). A 2.5 ml aliquot of these overnight cultures were used to inoculate 500 
ml of prewarmed 2xYT (50 pg ml'*) broth in a 2 litre flask, which were shaken at 200 
rpm at 37°C. Ten ml samples were taken at hourly intervals from 2 hours post 
inoculation to 9 hours post inoculation, a final sample of both cells and supernatant was 
taken at 24 hours post inoculation. The SpA content of the samples was determined as 
previously described in Section 2.2.14.2.
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IFigure 4.22 Construction of the lac'  Plasmids pPA44, pPA45 and pPA46
No SpA was detected in any of the 24 hour post inoculation sample supernatants. 
Growth curves showing pg m l'1 SpA against culture density were plotted for all the 
above cultures (Figure 4.23). The removal of the lac promoter’s contribution towards 
transcription resulted in a substantial reduction in the amount of SpA recovered from 
the cultures. Further 24 hour samples were taken in a series of repeat experiments and 
the average SpA yield determined for each plasmid type (Table 4.11). Those plasmids 
where SpA expression is entirely dependent on the spa promoter alone produced less 
than half (44 - 49%) of the amount of SpA obtained from the equivalent plasmid which 
carries both the spa promoter and the lac promoter in tandem.
4.2.3.S Alteration of the spa translational initiation codon
The site-directed mutagenesis experiments described in 4.2.2 had resulted in the 
replacement o f the spa TTG start codon with ATG. This mutation change was 
effectively introduced into the plasmids pPA30, pPA34, pPA37 and pPA38 to yield the 
plasmids pPA39, pPA40, pPA41 and pPA42, respectively. Cells carrying all 8 of these 
plasmids were separately cultivated and the level of SpA produced estimated as 
previously described.
Alteration of the translation initiation codon from TTG to ATG has no effect on the 
yields of SpA obtained from JM83 and JM101 or on their rate of growth (Figure 4.24). 
Removal of the DNA upstream of the spa SD sequence including the spa -10 and -35 
promoter region also appears to have little effect on the levels of SpA expressed, with the 
derepression of lac promoter in JM101 resulting in the same order of increase in SpA 
production regardless of the presence of the spa promoter (Table 4.12). Thus, the 
presence of the lac promoter in the SpA plasmids can account for all of the SpA 
produced and the additional presence of the spa promoter in some of the plasmids 
would seem to either not interfere with transcriptional readthrough from the lac 
promoter or alternatively compensates for any interference by its own activity.
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T A B L E 4 .il
Comparison of Maximum SPA Yields of the lac Promoter- 
Plasmids with the Comparable lac Promoter + Plasmids
pg SPA /  mg cells dry wt % difference
pUC8 [lac +J pUC8 [lac -1 A
pPA 16:55.7 pPA44:25.8 46.3
pPA31:124.0 pPA45:50.1 40.4
pPA34:293.9 pPA46:132.4 45.0
TABLE 4.12
Effect on SpA Production of i. Alteration of the spa Translational 
Initiation codon [pPA39] and (pPA40] ii as i plus the 
lac Promoter Under Repressed and Depressed Growth conditions in the Absence 
of the spa Promoter [pPA41] and [pPA42]
Plasmid Present
pPA39 pl'A40 pPA41 pPA42 
SpA pgmg'1 Cells Dry Weight
JM83 122.3
(10.4)
JM101 97.1
noIPTG (15.1)
JM101 177.7
+lmM IPTG (18.4)
JM101 21.2
% increase in SpA 
yields in the 
presence of IPTG
249.9 121.0 258.1
(33.2) (11.3) (40.1)
241.2 121.1 204.5
(10.2) (16.0) (30.1)
278.1 143.7 237.1
(29.2) (20.1) (36.3)
15.3 18.7 15.9
std. evaluation values are shown in brackets.
JM83 results are taken from 5 sets of experiments. 
JM101 results are taken from 3 sets of experiments.
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Figure 4.23 Comparative study to establish the effect of the vector—borne 
lac promoter upstream of the 5' terminus of the Spa gene
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Figure 4.24 Effect on SPA production of: i alteration of the spa 
translational initiation codon [pPA39] 8c [pPA40] and 
ii. as i. plus removal of the spa promoter [pPA41] 8c 
[pPA42]
4.2.4 Fermentation of E.coli JM83[pPA] for the production of commercially 
viable amounts of SpA
4.2.4.1 Introduction
The cloning and manipulation of the S.aureus protein A gene detailed in this thesis has 
allowed the development of the SpA producing clones pPA31 and pPA34. When these 
are expressed in an E.coli host, produced under small-scale laboratory growth 
conditions, a 3-to 5-fold increase in the levels of SpA recovered is seen compared to the 
level of SpA production by S.aureus Cowan I. Unfortunately, these two clones have 
proven susceptible to plasmid loss and cell lysis unless grown under stringent 
conditions. Therefore, before these constructs can be considered a success in terms of 
commercial exploitation, it must first be shown that they can withstand the more 
vigorous conditions encountered during large-scale culture (150 L and 400 L) 
fermentation and subsequent downstream processing. It was decided to scale up 
fermentation of both JM83 (pPA34) and JM83 (pPA31) for two reasons. Firstly, the 
truncated SpA clone pPA34 produces a greater amount of SpA than pPA31 (2 fold 
increase), however, the latter clone has been shown to withstand more rigorous culture 
conditions. Secondly, the two spa recombinant clones produce SpA o f different 
lengths, one with a hydrophobic cell wall binding C-terminus (pPA31) and one without 
this binding ability (pPA34), and so can be utilised for different purposes.
4.2.4.2 Experimental Procedures
The stability of the plasmid and viability of the host have been shown to be poor when 
maintained on antibiotic 2xYT or L-agar, with cell lysis occurring within a few days. 
Therefore, glycerinated cultures stored at -70°C were used to seed broth to provide an 
inoculum for the 20 litre fermenter. Glycerinated seed cultures were prepared by 
growing cells in 50 ml of L-broth with 50 pg ml'* ampicillin in 150 ml shake flasks, at 
160 rpm, 37°C, for 8 hours. Ten ml of the culture was removed and tested for SpA 
levels while the rest was preserved with 15% sterile glycerol in 1 ml aliquots. The
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aliquots were maintained for further use (providing the SpA assay showed an adequate 
level of SpA production). To prepare an inoculum for the 20 litre seed vessel, 50pl of a 
glycerol culture was inoculated into 10 ml of L-broth containing 50pg m l'1 ampicillin in 
a 25 ml universal, and shaken at 260 rpm, 37°C for 6 hours. This was then used to 
inoculate a litre of L-broth (50 |ig m l'1 ampicillin) in a 2 litre unbaffled flask, which was 
shaken at 160 rpm o/n. Two litres of such culture was supplied to the CAMR Pilot 
Plant section to inoculate a 20 litre seed fermenter, this in turn was used to inoculate the 
main 150L or 400L culture vessel (when an OD65Qnm o f 2 was reached or after 6 
hours incubation, whichever was sooner). The contents of the main culture vessel were 
harvested when the OD^SOnm (about an OD^5Qnm of 20).
Fermentation medium, and conditions for growth in the 20, 150 and 400 litre culture 
vessels are detailed in Appendix U.
During the fermentation procedures, 25 ml samples were taken and various parameters 
monitored. The pH and OD were monitored hourly and a cell purity and cell viability 
count performed every two hours. The SpA levels in the cells were also determined as 
follows. The monorocket SpA detection assay was performed on 10 ml volumes of 
culture, the cells were spun down and disrupted using lysozyme. The SpA assay was 
carried out on samples taken at the following points in the culture runs; on the 1 litre 
seed prior to inoculating the 20 litre vessel; on the 20 litre seed at hourly intervals from 
4 hours growth and just prior to inoculating the main vessel; on the 150 litre and 400 
litre main culture vessels at 4 hrs post inoculation and then at hourly intervals and just 
prior to harvesting and on a sample of the harvested paste. Ten ml culture samples 
from the 20 L, 150 L and 400 L culture vessels were spun down, the supernatant 
removed and reserved, the cells were then resuspended in 10 ml of growth medium and 
both supernatant and resuspended cells stored frozen for 48 hours until assayed. The 
growth medium in which the cells were resuspended (cell wash) was also assayed to 
determine how much SpA had been released from the cells during the freeze-thaw 
process.
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Preparation and maintenance of the seed stock; the growth of the 10 ml and 1 litre seed 
cultures; and quantification of SpA levels (using the monorocket assay described in 
section 2.2.14.2) in culture samples from the seed and main culture vessels and in the 
final harvested cell paste were undertaken by myself.
Fermentation and monitoring of the culture in the 20 litre seed vessel, 150L or 400 L main 
culture vessels and harvesting of the cells were undertaken by shift technicians at the 
fermentation P ilot Plant under the guidance o f Dr. S. Chambers, recovery and 
purification of the SpA to commercial standard was carried out by Dr. P. Hammond of 
the Diagnostic Reagents Group.
4.2.4.3 Results
Both JM83 [pPA31] and JM83 [pPA34] cultures were grown in identical 20 litre 
fermentation vessels, 10 ml culture samples taken at regular intervals, and the cells and 
supernatant assayed for SpA content. Results are presented in Table 4.13 and Figure 
4.25. JM83 [pPA34] produces 17.46g SpA in a 20 litre culture and JM83 [pPA31] 
produces only 35% of this amount, 6.1 g SpA in a 20 litre culture. Further examination 
of SpA levels, revealed that 76.5% of the SpA is cell associated in the JM83 [pPA34] 
culture whereas only 59% is cell associated in the JM83 [pPA31] culture. As it is only 
the cell paste that is harvested for recovery and purification of SpA for a commercial 
market, the use of JM83 [pPA31] would result in the discarding of 41% of the potential 
SpA yield, JM83 [pPA34] will limit the loss to 23.5% of that potential.
The freeze-thawing step involved in storage of the cells prior to assaying for SpA 
content was also seen to be highly detrimental to the cells, resulting in the release of 
SpA equivalent to 21.9% and 24.6% of that retained by pPA34 and pPA31 cell 
samples, respectively. Taking into account the above information JM83 [pPA34] was 
selected for large-scale fermentation in preference to JM83 [pPA31].
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TABLE 4.13
Comparison of SpA Levels Obtained From a 
20 Litre Fermentation Culture of JM83 [pPA31] and JM83 [pPA34]
JM83 [pPA34] JM83 lpPA31]
Incubation SpA |ig ml" 1 culture
Time
lysed Supn.
cells
Whole
culture
Lysed
cells
Supn. Whole
culture-«-
1 litre 
seed 
culture- 
transfer
110 18 128 0 0 0
4hr 118 18 136 0 45 45
5hr 176 18 194 0 60 60
6hr 242 32 274 21 100 121
7hr 412 80 492 45 125 170
8hr 444 104 548 128 115 243
9hr 484 148 632 134 121 255
lOhr 548 208 756 144 124 279
Total SpA 
♦present
10.96 g 4.16 g 2.88 g 2.5 g
%SpA in 
cell wash*
21.9% 24.6%
♦Potential 13.3 g 4.16 g 17.46 g 3.59 g 2.5 g 6.09g
SpA yield
Cell wash*: Medium in which cells were resuspended and stored at -20°C following 
harvesting and removal of the supernatant (supn.). Assayed to ascertain the amount of SpA 
lost from the cells through damage caused by the freeze-thawing step used in storage. 
The Final harvest of cells are stored as a frozen cell paste at.-20°Cf and thus have no 
wash step prior to the recovery of the SpA. The SpA |tg ml*1 level in the cell wash is 
presented as a % of the total SpA present in the lysed cells, as only every second hourly 
sample and the final sample were assayed for SpA (no % difference greater than 1.3 
was observed). The SpA cell wash in the figure is presented as % as only every second 
sample and the final sample were assayed, none varied from the calculated average by 
more than 1.3%.
SpA whole culture-«-: SpA in lysed cells plus SpA in supernatant (excludes cell wash 
figure).
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Figure 4.25 Graph comparing the amount of SPA present in
intact cell lysates and in whole cultures during 10 
hour, 20 litre fermentations of JM83[pPA31] and 
JM83[pPA34]
The samples of cell lysate and supernatant from JM83 [pPA34] were diluted to give a 
final concentration o f lOOpg ml"1 and were then examined, using the SDS gel 
fractionation and immunoblotting techniques described in section 4.1.2.3, to 
determine the size o f the IgG binding polypeptides produced during the 20 litre 
fermentation. Figure 4.26. In the 4 hour cell lysate the predominant bands consist of 
the 48 kDa and 45 kDa SpA polypeptides, though less distinct, the 43 kDa and 32 kDa 
and 28 kDa polypeptide are also visible. There is a faint band seen in both the 4hr and 
5hr cell lysates corresponding to 53 kDa in size, which is thought to represent the 
precursor form of the truncated protein coded for by pPA34. Degradation o f the IgG 
binding polypeptides is seen to increase in direct proportion to the length o f culture 
incubation, in particular, the 32 kDa and 28 kDa bands increase in intensity and there is 
also an increase in the amount o f "non-banded" binding seen throughout the 
electrophoresis lane between the 48 kDa and 28 kDa bands. The supernatant samples 
show a very similar pattern of IgG binding polypeptides to that present in the cell 
lysates from the same time period, except that, overall, less degradation of the major 
polypeptide (48 kDa) was observed and the general increase in "background staining" 
within the lanes (probably caused by non-specific degradation) is less.
A large-scale fermentation run (400 litres) was carried out using JM83 [pPA34]. The 
results are shown in Table 4.14. The total culture yield was 195.7g, however 60% of 
this appeared to be present in the supernatant. Therefore, the amount recovered from 
the entire cu ltu re run was only 7 8 .lg  SpA in a total cell paste o f 12,130g. 
Consequently, for a 20 fold increase in culture size, less than a 6 fold increase of 
recoverable SpA was seen. In the 20 litre seed culture, the amount of SpA in the cells 
was always considerably more than in the supernatant (Figure 4.27). Whereas, in the 
400 litre main culture there was always more SpA accumulating in the supernatant than 
present in the cells (Figure 4.28). As SpA production appeared to decline following 
transfer from the 20 litre to the 400 litre container it was decided to try and grow JM83 
[pPA34] in a smaller culture vessel (150 L) which did not have a 20 litre transfer stage.
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Figure 4.2« Analysis of IgG-binding Polypeptide* Produced by JM 83 [pPA34] Under 20 
Litre Culture Conditions
All sample JM83 [pPA34] unless stated otherwise. Lanes contained
(1) 1 Litre seed culture cell lysate (2) 20 cell culture 4 hr
(3) 20 L, cell culture 5 hr (4) 20 cell culture 5 hr
(5) 20 L, cell culture 7 hr (6) 20 L, cell culture 8 hr
(7) 20 L, cell culture 9 hr (8) 20 L, cell culture 10 hr
(9) 5. aureus Cowan I (10) Molecular weight marker
(ID 1 litre seed culture, supernatant 02) 20 L, supernatant 4 hr
03) 20 L, supernatant S hr (14) 20 L, supernatant 6 hr
05) 20 L, supernatant 7 hr 06) 20 L, supernatant 8 hr
(17) 20 L, supernatant 9 hr 08) 20 L, supernatant 10 hr
(19) 20 L, cell paste supernatant, 10 hr (20) washed cells, 10 hr.
TABLE 4.14
SpA Levels Obtained Using a 20 Litre Seed Culture Vessel and a 400 Litre Main 
Culture Vessel for the Fermentation of JM83 [pPA34]
Culture Time (hr) 
Vessel OD600L!'sed cells
SpA pg ml** culture 
Supernatant Whole
culture
20 litre 5 2.78 33 25 58
seed
6 3.71 157 52 209
7 5.50 171 59 228
8 5.59 274 71 345
9 7.09 368 96 464
10 7.20 508 128 636
Transfer 572 203 775
Total SpA present: 11.44g 4.06g
% SpA in cell wash: 21.2%
Potential SpA yield: 13.77g 4.06g 17.83g
400L main 4 3.08 44 86 130
culture
5 3.58 51 99 160
6 6.42 100 120 220
7 7.85 136 146 282
8 12.75 149 164 313
9 19.95 160 206 366
9.5 23.25 173 294 467
Total SpA present: 69.9g 117.6g
% SpA in cell wash:* 11.7%
Potential SpA yield: 78.lg 117.6g 195.7g
+ and * see Table 4.13
600
OD (600 nm)
Figure 4.27 SPA production levels obtained using a 20-litre  culture 
vessel for the growth of JM83[pPA34] seed culture for 
inoculation of a 400—litre culture vessel
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SPA production levels obtained using a 400—litre culture 
vessel for the growth of JM83[pPA34]
JM83 lpPA34] was grown in a 150 litre culture vessel for 13hrs (rather than the usual 
lOhrs) until an OD6QQnm of 7.52 was reached (an OD6QQnm of 7-8 gave optimum 
yields in the 20 litre cultures). Samples for SpA analysis were taken hourly from the 
5hr point and the results shown in Table 4.15. A total culture yield of 167g was 
observed with 60% (lOlg) of the SpA associated with the cellular fraction. The total 
yield SpA/litre of the 150 litre culture is higher than that seen for both the 400 litre and 
20 litre culture, with yields being l.lg/litre, 0.49g/litre and 0.87g/litre, respectively. 
The SpA yields from the cellular fraction of the 150 litre, 400 litre and 20 litre were 
0.67g/l, 0.2g/l and 0.67g/l, respectively. The amount of SpA in the supernatant can be 
seen to increase dramatically at the 12hr sample, OD^qq 7.28. In the 1 lh r sample 
(OD600 7.08) 81% of the total SpA was present in the cell (495|lg ml"* cell lysate 
(62.6%) and 18.4% more in the cell wash) whereas the 12hr sample (OD^qq 7.28) the 
amount of SpA in the cell lysate was seen to fall, while the amount of SpA in the cell 
supernatant increased dramatically; so that only 64% of the total culture SpA is present 
in the cells. The dramatic increase in SpA in the supernatant was seen to continue in 
the 13hr sample (Figure 4.29).
Viable counts on cells from the 150 litre culture were performed using L-agar plates 
and L-agar ampicillin (50pgml'*) plates. A comparison of the results allowed the 
percentage of the population with ampicillin resistance to be determined (Figure 4.30). 
As the coding capacity for ampicillin resistance and SpA production are carried on the 
same plasmid, the degree of ampicillin resistance of the culture will give a fair 
indication of the percentage of cells still capable of producing SpA.
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TABLE 4.15
SpA Levels Obtained Using a 150 Litre Culture Vessel for the 
Fermentation of JM83 [pPA34]
Incubation 
Time (hr) o d 600
Lysed
cells
SpA ng ml' *
Supernatant
cells
culture
Whole*
culture
5 1.66 28 0 28
6 2.39 77 0 77
7 3.05 138 14 152
8 4.82 302 36 338
9 5.52 387 60 447
10 6.4 437 110 547
11 7.08 498 136 634
12 7.28 491 328 819
13 7.52 564 440 1004
Total SpA present 84.6g 66g
% SpA in cell wash* 19.4%
Potential SpA yield 101g 66g 167g
and * see Table 4.13
OD (600 nm)
Figure 4.29 SPA production levels obtained using a 150-litre culture 
vessel for the growth of JM83[pPA34]
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Figure 4.30 Graph showing percentage of population resistant to 
Ampicilllin (50 /¿g/ml)
4.3 DISCUSSION
Protein A has been successfully expressed from plasmids carrying the spa gene in 
E. coli (Duggleby and Jones, 1983), the level achieved, however, was no higher than 
that attained using S. aureus Cowan I. The work discussed here details the assessment 
of SpA producing plasmids, which were designed to produce higher levels of SpA in 
E. coli than those occurring naturally in S. aureus Cowan I. This assessment has been 
made in terms of the levels o f  SpA production achieved both under small-scale 
laboratory culture conditions and large-scale "commercial" culture conditions; and the 
effect of these levels of SpA production on the host organism’s characteristics. Cellular 
localisation of the recombinant IgG-binding polypeptides have been examined in 
respect of the spa gene fragment utilised and expression levels in the cloned system 
have been compared with the naturally occurring SpA. Factors effecting SpA 
expression within the plasmid host system utilised have been investigated, and the 
results of each individual experiment discussed in Section 4.2; this section summarises 
those discussions and draws attention to the overall conclusions that can be made.
4.3.1 Background
Earlier work on SpA expression in E. coli carried out in this laboratory by Duggleby and 
Jones had utilised plasmid constructs which carried a truncated spa fragment, lacking 
the final 69 codons of the C-terminus. These constructs also carried 608 nucleotides of 
S. aureus DNA upstream from the spa gene. Duggleby and Jones (1983) indicated that 
the 608 bp region of S. aureus DNA, positioned between the N-terminus of the spa 
structural gene and the lacZ  promoter of the pUC8 host plasmid might prevent 
transcription from the lacZ promoter having a discernible effect on spa expression. 
This suggested the possibility that high levels of spa expression might be achieved 
using the multicopy plasmid pUC8, if transcription from its lacZ promoter could be 
ensured. Using this data, three preliminary SpA clones (pPA30, pPA31 and pPA34) 
were constructed, and expression levels compared with those for pPA16. Comparison 
of the levels of SpA produced in overnight (10 ml cultures) by these four constructs
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indicated that, not only did the removal of 608 bp between the plasmid lacZ promoter 
and the spa gene enhance the amount of SpA produced, there was also a 2-fold 
difference in SpA levels between those clones carrying the entire spa gene and those 
carrying the C-terminally truncated spa gene. Possible reasons for these differences in 
SpA production will be discussed later (4.3.3).
4.3.2 Protein A Production in E. coli
Comparison of the SpA levels produced by the four E. coli clones with that of the native 
S. aureus Cowan I, showed that both pPA31 and pPA34 produced substantially more: 
2-3 fold higher and 4-5 fold higher, respectively. Therefore pPA16 producing an equal 
amount of SpA to S. aureus Cowan I, pPA31 and pPA34 were considered as potentially 
suitable for commercial exploitation and were subject to further investigations. pPA30 
was included in many of these studies to allow a full comparison to be made.
Analysis of the IgG binding peptides produced by the SpA plasmids demonstrated a 
major difference between the SpA produced by S. aureus Cowan I and the E. coli 
recombinant clones. This was revealed by analysis of the IgG binding peptides isolated 
from samples derived after culturing the organisms for 16hrs. Whereas S. aureus 
Cowan I contained only one form of SpA, the E. coli clones were shown to contain up 
to 7 different sizes of IgG binding protein. The largest of these was found in clones 
carrying plasmids encoding the full length SpA and were only 2 kDa smaller than the 
S. aureus Cowan I SpA. The largest polypeptide from the plasmid encoding the 
truncated SpA is 7 kDa smaller than the Cowan I Spa, the size expected allowing for the 
lack of 69 a.a at the C-terminus. The rest of the small size IgG-binding polypeptides 
are thought to represent degraded forms of the largest polypeptide. The degradation 
appears to result from site specific proteolytic cleavage, rather than C-terminal "chew 
back", as discrete bands, rather than a general background smear are seen in the 
electrophoresis lanes and polypeptides of identical molecular weights are present in the 
lysates from the majority of clones. These peptide cleavage points do not appear to be
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located in the N-terminal, IgG-binding portion of the SpA molecule as N-terminal 
sequence analysis of the IgG-binding polypeptides produced by JM83 [pPA34] have 
shown all the polypeptides to possess the same N-terminal sequence; that of native 
SpA. Degradation is thought unlikely to be the result of E. coli serine protease activity, 
as the inclusion of the general serine protease inhibitor (phenylmethyl-sulphonyl 
fluoride) did not alter the binding pattern observed. However, not all serine proteases 
are sensitive to this reagent. Time course experiments showed that the levels of the 
various size IgG binding proteins varied at different times in the culture; in general, the 
larger IgG binding polypeptides was seen first with the smaller ’degraded’ forms 
appearing with increasing time after inoculation. Again, this indicated that these were 
degradation products of the larger forms. The full length SpA appeared to be resistant 
to degradation for longer than the truncated SpA. Towards the end of the culture run, 
about 16hrs post inoculation, the largest IgG-binding polypeptide form was seen to be 
absent from the cell lysates of JM83 [pPA34] whilst the level o f  the smaller IgG 
binding peptides remained constant, or was seen to increase further, this also 
corresponds to a decrease in the total amount of SpA in the cell lysate and an increase 
in the amount of SpA in the supernatant. This would indicate that de novo syntheses of 
SpA was decreasing prior to cell lysis when a culture was grown under optimum 
conditions. The strong correlation between the sudden decrease in cell lysate SpA 
levels with a sudden increase in SpA in the cell supernatant; would suggest that SpA is 
not actively secreted to an extracellular location but is probably in the supernatant as 
the result of cell lysis or increased cell permeability.
Scale up of the culture volumes involved in the time course experiments from 10 ml to 
500 mis, revealed a problem of cell fragility that had not been apparent in the small- 
scale samples. JM83 [pPA31] and [pPA34] which produced the highest levels of SpA 
were found to be extremely susceptible to cell lysis when subjected to stress. For 
instance, culture aeration had to be low, as anything more than modest agitation would 
cause lysis, and growth on a minimal media would result in early lysis. The use of 
alternative E. coli hosts for expression of the two high SpA producing plasmids, pPA31
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and pPA34, did not improve viability of the cells during culture or storage and the SpA 
yields between the different strains did not vary greatly from that of JM83. Scale up to 
Pilot Plant production levels of 20 litre, 150 litre and 400 litre cultures showed JM83 
[pPA31] to be move liable to cell lysis than JM83 [pPA34]. As the established practice 
for recovery of SpA from cell cultures involved only the harvesting of the cells, cell 
lysis prior to harvesting resulted in a significant loss of SpA. Therefore, it was 
important to prevent cell lysis prior to harvesting the large-scale cultures. JM83 
[pPA34] was successfully grown to produce large amounts of SpA in both the 20 litre 
and 150 litre fermentation vessels, with 78.1% from a total yield of 17.46 g SpA, and 
60% of 167 g SpA, being retained in the cells, respectively. JM83 [pPA34] produced 
195.7 g of SpA when grown in the 400 litre fermentation vessel, however only 40% of 
this was present in the cells, the remainder was in the supernatant. Thus, the overall 
amount of SpA recovered from the 400 litre fermentation run was less than from the 
150 litre fermentation run. It was noted that the percentage of SpA found in the cell 
wash for the 400 litre culture samples was approximately half that found in the 20 litre 
and 150 litre cultures. This seems to indicate that the surviving cells are less fragile, 
which suggests that a possible reason for the low amounts of SpA produced in the 
whole culture may be a result of constant level of cell lysis in cells containing a high 
level o f SpA. This would also explain the very high levels of the SpA in the 
supernatant compared with the lysed cells. It was also observed that SpA production 
appears to be at its maximum when the culture has an OD^qq of 7; after which an 
increase in cell lysis is observed.
It would appear that two separate factors are responsible for lysis. Firstly, the levels of 
SpA in the cell and secondly, the physical agitation the cell receives during growth. 
Under the gentle aeration conditions used in the small-scale cultures, JM83 [pPA34], 
the highest SpA producing plasmid, will lyse when the culture medium becomes 
depleted of nutrients. Under the more vigorous growth conditions of a large-scale 
culture, JM83 [pPA31] will lyse; even though cell growth is still exponential. This
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suggests that the possession of the hydrophobic membrane region of the SpA molecule 
is responsible for the fragility of JM83 [pPA31], It is proposed that this region of the 
SpA molecule may bind to the membranes in E. coli, and, in doing so, interfere with the 
sites normally concerned with septate formation and cell division. This is supported by 
the morphological appearance of cells examined using light microscopy, where JM83 
[pPA31] was seen to be up to 20 times the normal length, this extreme elongation of 
cells has often been reported to occur when the high levels of heterologous protein are 
produced (Schoner et al., 1985; Schoemaker et al., 1985; Georgiou et al., 1986). 
Although JM83 [pPA16] and JM83 [pPA34] were the same length as non-plasmid 
carrying JM83, they both appeared slightly more ovoid in shape than the normal JM83 
rod. This would appear to indicate that cellular elongation is a genuine result of the 
hydrophobic C-terminus rather than an effect of over-expression and the increase in the 
cellular SpA levels. The thesis is also supported by the fact that the detectable cellular 
SpA levels in JM83 [pPA31] increased when the cells were disrupted by sonication, 
rather than lysozyme/detergent lysis where there is a greater chance of membrane 
associated SpA being trapped by cell debris, pelleted and discarded. If the SpA 
produced in JM83 [pPA31] is more likely to be membrane associated than the SpA 
produced in JM83 [pPA34], this may also mean that the some of the apparent 2-fold 
difference in SpA levels first indicated may be a difference in the rate of recovery, 
rather that the rate of production.
Cellular localisation of the SpA to the different compartments of the cell using 
traditional fractionation techniques proved unsuccessful using JM83 [pPA31] and JM83 
[pPA34] as the degree of cell fractionation was poor, with contamination occurring 
between the cytoplasmic, periplasmic and membrane fractions. This was probably due 
to the fragile nature of both high SpA producing clones; particularly under phosphate 
limited conditions. In addition, both these clones failed to produce measurable levels of 
SpA when grown for 6 hours on a low phosphate broth. However, the JM83 [SpA] 
clones producing lower levels o f SpA, pPA16 and pPA30 were successfully 
fractionated using the above method and also produced a reasonable level of SpA.
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Both the full length SpA and the truncated SpA were found to be located mainly in the 
periplasm (78.8% and 81%, respectively), and the full length carrying the hydrophobic 
"membrane-binding" C-terminus was found in the membrane fraction at a level (7.6%) 
only slightly higher than the truncated SpA form (5.4%. Further examination of the cell 
fractions of JM83 [pPA30] to allow visualisation of the different molecular weight IgG 
binding peptides indicated that most of the proteolysis o f SpA occurred in the 
periplasm, with very little full size SpA being present. Most of the SpA associated with 
the cell membranes was full size Both full size and degraded IgG binding polypeptides 
seen in the cytoplasmic fraction can be accounted for by the levels of contamination 
seen in the localisation assay results (Table 4.5). A less disruptive method of localising 
the SpA within the cell, using immuno-gold labelling and electron microscopy, was 
also attempted.
Electron lucent areas were seen in E. coli expressing SpA. These areas could be seen to 
be present between the inner (cytoplasmic membrane) and the outer cell membrane 
(Figure 4.10 and 4.11), thus occupying the periplasmic space. They appear to increase 
the size of the periplasmic space considerably, as normally both membranes are seen to 
be in close opposition. The aim of trying this method was to assess its suitability for 
determining the location of SpA within the cell by probing cross sections of JM83 
[pPA16] with immunogold. Results showed the immunogold to be present almost 
exclusively in the electron lucent areas which would indicate that the truncated SpA 
protein coded for by pPA16 is transported to the periplasmic space. This result concurs 
with that reported using the traditional localisation studies (Section 4.2.1.9 and 
4.2.1.10). There appears to be no significant association with either the inner or outer 
membrane of the cell, although some gold particles are seen along the outer membrane 
and cell wall (Figure 4.13). This may be an artifact of cross sectioning of the cells. 
Whilst the electron lucent areas may represent accumulations of SpA, they could also 
represent an accumulation o f ^-lactamase, which has been shown to be highly 
expressed by the [SpA] progenitor plasmid [pUC8] (unaltered bla gene) under identical
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growth conditions to those used for JM83 [pPA16] (Warnes 1989). Georgiou et al 
(1986) also reported (5-lactamase to be localised in the form of electron dense inclusion 
bodies present in the periplasm rather than in the cytoplasm. Further experiments 
involving electron microscopy of E. coli JM83 and E. coli JM83 [pUC8] would help 
resolve this problem. The negative results of Wames for immunogold binding to SpA 
E. coli lacking the SpA plasmid, and the presence of the gold label bound to the surface 
of E. coli JM83 (pPA16] shown in 4.12, indicates that some antigenic portion of a small 
number of the SpA molecules protrude through the outer cell membrane and wall. 
Preliminary studies on pPA16 would appear to indicate that immuno gold electron 
microscopy can be used to determine the localisation of SpA within an E. coli host at 
low levels of expression. Further experimentation on JM83 [pPA31] and JM83 
[pPA34] using this method is necessary to determine if this method can be used 
successfully on the more fragile high expression SpA clones.
Subsequent studies by Wames (A. Wames personal communication) on JM83 [pPA31] 
have shown the SpA to be localised in the periplasmic space, both in the electron 
lucent areas and also around the outer membrane of the host. This may be due to the 
fact that pPA31 contains the hydrophobic membrane binding region of protein A which 
is not present in pPA16 or pPA34. Alternatively, it may be a result of higher levels of 
SpA present in the host cell carrying pPA31. Results from pPA34, which is identical to 
pPA31 except it lacks the hydrophobic C-terminal sequence, may explain this. If the 
hydrophobic C-terminus of pPA31 is binding to the membrane, this could well interfere 
with septate formation of the host cell and so prevent division. This would also explain 
the extremely elongated forms of JM83 associated with the presence of pPA31 but not 
pPA34 or pPA16. Analysis of the effect of the lower expression levels of full length 
SpA produced by pPA30 on the cell structure may well help resolve these results. 
However, the fact that it only produces a low level of SpA may well not interfere with 
septate formation. Wames showed electron lucent areas to be present in JM83 [pUC8] 
and that the levels of 0-lactamase activity found in the cell fell as the SpA levels 
increased. It is possible that both of these proteins may well compete for export to the
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periplasm. Thus P-lactamase may not be a good choice of selective marker for a high 
heterologous protein production strain secreting the protein.
As cell fragility appears to be an inherent characteristic of high levels of SpA 
production in E. coli, there would appear to be two options available for commercial 
exploitation of the SpA clones i) alter the fermentation procedure so that the cells 
survive longer and alter the harvesting procedure to allow recovery o f all the SpA 
produced; whether from intact cells, or the culture medium (or ii) alter the E. coli clone 
so that spa expression is under greater control and production of SpA can be limited to 
the point of the culture growth cycle where maximum SpA culture levels can be 
achieved.
4.3.3 Gene Factors Effecting spa Expression
This area of work was undertaken not only to try and control the production of SpA 
during a culture but also to investigate the efficiency of the Gram-positive spa promoter 
in a Gram-negative E. coli host and to establish factors which might effect this 
efficiency in E. coli.
Initial cloning of the S. aureus 2.012 bp fragment containing the spa gene into a 
multicopy (500 copies per cell) vector containing the strong E. coli lac promoter, 
appeared to show only a small increase in SpA production which could be accounted 
for solely by the increase in copy number. This suggested that either the spa gene 
could not be expressed using the lac promoter, or that transcriptional re ad through from 
the lac promoter was being prevented entirely or interrupted from reaching the spa 
gene. Examination of the nucleotide sequence of this region revealed one area of dyad 
symmetry of a reasonable length (Chapter 3, Section 3.3.2.3). This did not correspond 
to a transcriptional termination sequence. It is of interest to note the presence of two 
sequences within this region, that closely resemble the CRP - binding sites and other 
operator sites of E. coli (Ebright, 1982; de Crombrugghe et al., 1984, Studnicka, 1987)
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and the regulatory sites found in catabolite-repressed B. subtilis promoters (Weickert and 
Chambliss, 1990). Therefore, it was considered likely that this fragment of S. aureus 
might interact with the cAMP/CRP complex and so prevent readthrough of 
transcription from the lac promoter. Removal of this region did indeed result in a large 
increase in the levels of SpA produced; (a 12-fold increase between clones JM83 
[pPA30] and JM83 [pPA31] and a 4-fold increase between clones JM83 [pPA16] and 
JM83 (pPA34J.
Transformation of these plasmids into JM101, which was inducible for lac promoter 
expression and which could be induced using IPTG, showed that the lac promoter 
contributed to at least 17% of the SpA level seen in pPA31 and pPA34, but only 
contributed to 2.1% of the level seen in pPA16. This would be consistent with the 
proposed interference in transcription from the lac promoter. However, due to the well 
known "titration" effect seen when trying to control a multicopy plasmid promoter from 
a low copy expression system it was not possible to conclude whether the remaining 
SpA expression was due to the spa promoter activity or to lac promoter activity caused 
by a comparatively low amount of repression protein. Attempts to determine this by 
increasing the amount of repressor protein 10-fold, using the plasmid pNM52, were 
found to actually increase the amount of SpA when no inducer (IPTG) had been added 
to the growth medium. Levels of SpA increased still further when the lac promoter was 
derepressed. It would appear that either total repression of the lac promoter allowed 
increased expression from the spa promoter (as occurs with the CRP activated PII 
promoter of the lac operon in E. coli, where the CRP binding protein prevents the 
binding of RNA polymerase to the weak PI promoter (Munsen et al., 1984; Malan and 
McClure, 1984); or, that the lacl repressor protein in someway binds to the sequence 
upstream of the SpA promoter and increases expression; any binding site for the lad  
repressor protein must be located in the region 89 bp prior to a structural gene, as the 
same response was seen to occur in all three plasmids, and pPA34 and pPA31 only 
carry this 89 bp region of non-SpA S. aureus DNA, unlike pPA16 which carries 608 bp 
of S. aureus (including the two "CBS" homologous sequences) prior to spa standard
1S8
gene. Alternatively, pNM52 could have introduced an unknown factor into the system. 
It was clear that, whichever, if any, of the above might be happening, it was not 
possible to determine what level of spa expression could be attributed to each of the 
promoters whilst both were present on the same plasmid. Removal of the spa promoter 
had no discernible effect on the production of SpA, both in JM83 and JM101 (with or 
without IPTG), when compared to the levels of SpA o f the corresponding spa 
promoter+ plasmids, indicating that the lac promoter was capable of directing high 
expression of the spa gene. The spa promoter, however, was shown to be capable of 
directing only 50% of the spa expression compared with that seen using the lac 
promoter alone.
It was of interest to note that when the spa was removed from the transcriptional 
control of the lac promoter (thus effectively being expressed from the spa promoter 
alone), that the levels of SpA production for JM83 [pAP44] compared with those of 
JM83 |pPA46], although all reduced, retained the 4-fold difference previously seen 
between pPA16 and pPA34. As the result could no longer be attributed to interference 
with transcription from the lac promoter, and the only remaining difference between the 
two sets of clones was the presence of the 608 bp S. aureus DNA in the set (pPA16 and 
pPA44) producing lower levels of SpA, it would appear that this region must in some 
way decrease spa promoter efficiency. Examination of this region, as reported earlier, 
revealed several features that could possibly cause such an effect. Firstly, the presence 
of 2 regions with a high degree of homology to CRP binding site sequences and other 
reputed operator sites in E. coli (Studnicka, 1987) and to the proposed regulatory site of 
catabolite repressed B. subtilis promoters (Weickert and Chambliss, 1900). Binding of 
the CRP or another operator protein may produce a conformational change in the 
adjacent DNA lowering the efficiency of binding of RNA polymerase to the spa -35 
and -10 sequences. The affect that CRP binding sites have, if any, on spa expression 
could be investigated by using crp~ or cya~ mutant hosts. Abrahmsen et al., (1986) has 
suggested the presence of a stress-induced promoter located within this 608 bp region,
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(section 3.3.2.3) which is functional in E. coli. This again may interfere with the 
efficiency of the binding of RNA polymerase to the spa -35 and -10 sequences located 
immediately prior to the spa gene. However, the results of Abrahmsen et al., (1986) 
indicate an increase in SpA levels when this promoter is functioning, rather than a 
decrease. It is possible that the presence of an "CRP" binding site or operator sequence 
affects this promoter.
The spa gene is known to be subject to regulation by the agr locus and the associated 8- 
lysin gene (hid) in S. aureus (Recsei et al., 1986). Disruption of the hid transcript has 
been shown to enhance the expression of spa (Janzon and Arvidson, 1990). It is 
possible that the 608 bp region contains a sequence that acts as a regulatory site for spa, 
which if "activated" decreases spa expression, removal of this region may well result in 
the increase in SpA levels observed. More studies are needed to establish the 
regulatory function of the DNA sequence in this 608 bp region, both in E. coli and in 
the natural host S. aureus.
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5.1 INTRODUCTION
Alkaline phosphatase (orthophosphoric-monoester phosphohydrolase, EC 3.1.3.1) is a 
metalloenzyme specified by a single gene (phoA) in E. coli (Berg, 1981). The active 
form of the enzyme is secreted through the cytoplasmic membrane to its final location 
in the periplasmic space where it exists as a dimer of two identical 450 amino acid 
polypeptide chains. This secretory process involves the use of a signal peptide, as 
alkaline phosphatase is initially synthesised as a larger polypeptide chain with a mainly 
hydrophobic N-tcrminus which is cleaved after entry of the protein into the periplasm 
(Chang et al., 1980; Michaelis and Beckwith, 1982). Alkaline phosphatase occurs in 
three active forms. These forms, or isoenzymes, differ only in the presence of an N- 
terminal arginine residue on both subunits o f isoenzyme I, the absence of such a residue 
on both subunits of isoenzyme III, and in isoenzyme II by the possession of an arginine 
residue on one subunit but not on the other (Kelley etal., 1973; Schlesinger, 1975).
The expression of the phoA gene is controlled by a complex regulatory mechanism 
consisting of a series of non-contiguous genes, often referred to as the pho regulon, this 
includes both positive (phoR, phoB and phoM) and negative (phoR) regulatory genes 
(Wanner and Latterell, 1980; Tommassen and Lugtenberg, 1982). Transcription from 
the phoA gene is stimulated in response to the amount of phosphate available to the cell. 
When low levels of phosphate in the medium become the limiting factor of growth, the 
phoA gene is totally derepressed and results in alkaline phosphatase production to levels 
representing up to 6% of the total cell protein (Garen and Levinthal, 1960). Under 
conditions of high phosphate the amount of alkaline phosphatase synthesised is 
negligible.
The precise physiological function of alkaline phosphatase in E. coli is not clear. The 
enzyme is non-specific and hydrolyses all phosphates at similar rates, regardless of 
their size or chemical nature. Therefore, its role may be solely to supply phosphate 
from phosphate esters under conditions of phosphate deprivation. However, production
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of alkaline phosphatase in the majority of bacteria is constitutive, rather than inducible. 
This has led Reid and Wilson (1971) to suggest a possible additional role for the 
enzyme in phosphate transport, arguing that the provision of phosphate under 
conditions of deprivation is unlikely to be the enzymes only purpose.
Alkaline phosphatase has long been used as a marker enzyme due to the availability of 
a very simple and rapid colourimetric assay (p-nitrophenyl-phosphate is used as a 
substrate and the enzyme hydrolyses the bound phosphate to liberate yellow p- 
nitrophenolate). The main problem in the preparation of enzyme-labelled antigens or 
antibodies, for use in the detection and quantification of biological substances, is the 
reduction in enzyme activity often observed after the chemical procedures used to 
produce the conjugate. The construction of a spav.phoA gene fusion will result in the 
production of a defined bi-functional hybrid protein which has both the full enzymatic 
activity of alkaline phosphatase and the IgG binding ability of SpA. Such a bifunctional 
hybrid protein can be put to a wide range of immunological uses, as discussed in detail 
in section 1.1.5.
The production of a well defined gene fusion is considerably facilitated by the 
availability of the nucleotide sequences of the genes involved. These data allow the 
two genes to be precisely fused, translationally in phase, using either naturally 
occurring restriction sites, or sites created at the desired position(s) using site-directed 
mutagenesis. However, although the complete amino ac id  sequence of alkaline 
phosphatase isoenzyme III has been determined (Bradshaw et al., 1981), only a small 
portion of the phoA gene sequence is known. The sequence determined is from the 5' 
-end of the gene, and equates to the promoter region and codons specifying the signal 
peptide and first 56 amino acids of the mature protein (Kikuchi et al., 1981; Inouye et 
al., 1982). To facilitate future fusion of the phoA gene to spa, the gene was cloned 
from the E. coli strain JM83, and its entire nucleotide sequence determined.
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5.2 EXPERIMENTAL AND RESULTS
5.2.1 Detection of an active phoA gene in E. coli JM83
The E. coli K12 strain chosen as the source of the phoA gene was strain JM 83, a 
bacterial host in common use in this laboratory. Before commencing cloning 
experiments it was first necessary to establish the presence of a functional phoA gene. 
The nucleotide sequence of the 5 * end of the E. coli phoA gene has been determined 
by three independent research groups (Boidol et al., 1982; Inouye et al., 1982; Kikuchi 
et al, 1981). All report an identical nucleotide sequence for the region from  the 
Pribnow box (-10 region) to the 27th codon of the structural gene. This information 
was used to design a 17 base oligonucleotide probe which could be used to detect the 
phoA gene by DNA/DNA hybridisation methodologies (ie., Grunstein-Hogness colony 
hybridisations and Southern blots). The probe (5, -CTATTGCACTGGCACTC-3, ) 
corresponds to a region in the signal sequence 14 bp to 30 bp from the first nucleotide 
of the GTG initiation codon.
E. coli JM83 chromosomal DNA was cleaved with various restriction enzymes and the 
restriction fragments obtained transferred, following agarose gel electrophoresis, onto a 
nitrocellulose membrane. The nitrocellulose was then incubated with the ^P-labelled 
oligonucleotide probe at 45°C, using the conditions and buffers described in Section 
2.2.9. Consistent with the restriction map of the previously cloned phoA gene (Inouye 
et al., 1981), a 2.7 kb Xhol/HindlU fragment of the JM83 chromosome was shown to 
hybridise strongly to the oligonucleotide probe. In parallel, E. coli JM83 and E. coli 
AW 1046 (a negative control, lacking the phoA gene) were grown overnight on low 
phosphate (LP) indicator plates (see Section 2.1.4) and in LP broth. The latter was then 
subcultured and the cells grown until exponential phase and then assayed (see section 
2.2.18.2). The resulting colour change observed in assays of E. coli JM83 cell lysates 
were indicative of alkaline phosphatase production, whereas no colour change was 
observed using cell lysates derived from E. coli AW1046.
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5.2.2 Construction or an E. coli JM83 gene bank
Because the source of the gene being cloned was the same bacterial species as the 
intended recombinant host, it was considered prudent to employ a recA derivative, 
JLM85. The use of such a host should obviate any problems of recombination between 
cloned plasmid inserts and chromosomal DNA. A total of 450 pg of E. coli JM83 
chromosomal DNA (prepared as detailed in Section 2.2.4.1) was partially digested 
with Sau3A (see Section 2.2.3.8), the restricted DNA heat inactivated by a 10 min 
incubation at 70°C, and the restriction fragments produced size fractionated by 
electrophoresis on a 1% agarose gel. DNA fragments of between 10 kb —> 15 kb were 
recovered from the gel by electroelution (see section 2.2.4.6), ligated into BamHl- 
cleaved pUC8 and transformed E. coli JLM85 (rubidium chloride method, Section 
2.2.2). Transformed cells were plated onto L-agar ampicillin (50 pg ml"*) BCIG 
indicator plates and incubated overnight.
Presumptive recombinant clones (colourless colonies) were replica picked onto a L- 
agar ampicillin 50 (jig m l'1) master plate and onto a nitrocellulose grid placed on an 
surface of the L-agar ampicillin (50 pg ml*1) plate, and incubated overnight at 37°C. 
Each clone was also individually transferred into a microtitre tray well containing 
100 pi of L-broth, ampicillin (50 pg ml'*). The microtitre trays were incubated 
overnight at 37°C and then glycerol was added to each well, at a final concentration of 
20%. The trays were then frozen at -70°C, forming an E. coli JM83 gene bank for 
future use.
5.2.3 Detection of the phoA gene from an E. coli gene bank
Clones carrying the phoA gene were detected by in situ colony hybridisation using the 
•^P-labelled oligonucleotide as a probe. Hybridisation of the nitrocellulose filters was 
undertaken by the procedure of Grunstein and Hogness (1975), at a temperature of 
45°C. (see Section 2.2.7.2 for details). Following autoradiography of the processed 
filters, 7 presumptive positive clones were detected.
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All the putative positive clones were restreaked and their plasmid DNA extracted using 
the STET small-scale isolation procedure (Section 2.2.4.2.1). The DNA was cleaved 
with the restriction enzyme combinations Hindlll/Xhol and EcoRl/Pstl, and the 
restriction fragments generated analysed by agarose gel electrophoresis. Although all 
the recombinant plasmids released the expected pUC8-derived 2.7 kb fragment 
following digestion with EcoRl/Pstl, differences in the size and number of additional 
fragments suggested that no one clone was identical to another. Of the 7 clones, only 
two (2/47 and 9/27) released the expected 2.7 kb Hindlll/Xhol fragment (Figure 5.1a). 
Two other clones had a slightly smaller band of 2.4 kb present in the Hindlll/Xhol 
track. The DNA fragments were transferred to a genescreen membrane, and hybridised 
with the ^P-labelled oligonucleotide probe, using identical conditions to that described 
earlier. The 2.7 kb Xhol/Hindlll fragments of clones 2/47 and 9/27 were shown to 
hybridise strongly to the probe (Figure 5.1b).
5.2.4 Sub-cloning and Restriction Mapping of the phoA Gene
A large scale plasmid preparation was performed on clone 2/47, and the resultant 
plasmid cleaved with Hindlll/Xhol and the 2.7kb fragment isolated from a 1% agarose 
Tris/acetate gel by electroelution. This fragment was then ligated into the 
complementary Hindlll/Sall sites of pUC8 and the resulting clone transformed into 
competent JLM85. Thereafter, a restriction map of the phoA encoding insert was 
generated by comparison of the DNA fragment sizes obtained following digestion with 
various restriction enzymes, either singularly or in combination. These included; 
Bamlll, Pvull, EcoRl, BamHl/Pvull, BamHl/EcoRl, EcoRl/Hindlll and EcoRl/Pvull 
(Figure 5.2).
5.2.5 Site-Directed Sequencing of the phoA Gene
DNA from clone 2/47 was cleaved either with Pvull, or Hindlll and EcoRl, and 
electrophoresed on a 1% agarose gel. The 1.96 kb, 0.78 kb and 0.21 kb Pvull
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Figure 5.1 Detection of a Positive Alkaline Phosphatase Clone from a JM83 Gene
Hank in JI.M85
1% Tris/acetate gel showing restriction fragments produced for positive phoA clones: (a) 
9/43, (b) 9/27, (d) 5/16, and (e) 2/47. Tracks (from right to left) l-»3 of each digested 
clone represents; (1) uncut (2) EcoRUPstl and 3. HindiWXhoi. m = 2.7 kb pUC8 
marker. The putative 2.7 kb alkaline phosphatase containing fragment is arrowed.
B. Autoradiograph of gel shown in Figure 5.1 A. after probing for the presence of the phoA 
gene. Restriction enzyme digests are: U = uncut, E/P = EcoRl/Psil and X/H = 
Xhol/hindUl.
9 /2 7  2/47
P
 P
(A)
Figure 5.2 Restriction Map of the 2.7 kb H lnM l-X ho l Fragment Containing the PhoA Gene of E. coli JM83
restriction fragments used for site directed sequencing are indicated along with the amount of  sequence data generated 
- 300 bp) from each fragment
position of sequences complementary to the oligonucleotide primers are indicated a  . and their direction of synthesis 
. The sequence of the oligonucleotide primers were:
1. CACCCGGOGGTGCTC
2. TAA GAG AAT CAC GCA
3. TCA GCA ACC GCC TGG
4. CCCAGCGCGCCGTTA
5. TCC TGC AAG TTC AAG
6. ACT GAC CGA CCA GAC
7. GGG CGC GGT TTT ATT
8. CTA TTG CAC TGG CAC TC ( also used as the alkaline phosphatase gene probe)
(B)
Map of the alkaline phosphatase showing the regions of the gene covered by dideoxy-sequencing.
5-*3 strand sequencing >-«>) 86% nucleotide sequenced 
3*-5 strand sequencing 89% nucleotide sequenced
all regions indicated represented the consensus sequence derived from the sequencing of at least 4  different templates
for that region.
,0  »t,
fragments, the 0.3 kb and 1.3 kb EcoR\ fragment, and the 1.1 kb //indlll/ZfcoRI 
fragment (Figure 5.2) were gel purified by electroelution and cloned into appropriately 
cleaved M13 vectors. In the case of the three Pvull fragments, the vector employed 
was Smal cleaved, dephosphorylated M13mpl8 DNA. The isolated EcoRl fragment 
was cloned into EcoRl cleaved and dephosphorylated M13mpl8 DNA, while the 1.1 kb 
///ndlll/EcoRI fragment was inserted into dephosphorylated M13mpl8 and mpl9 
DNA, cut with Hindlll/EcoRl. The ligation mixes were transformed into competent E. 
coli TG2, plated out onto L-agar and covered with H-top agar containing BCIG.
Five positive (white) plaques were picked from each of the above transformations, 
template DNA prepared and their inserts sequenced (as described in Section 2.2.10.5) 
using universal primer. Thereafter, the sequence information obtained from individual 
tem plates was extended by using a sequence-specific, custom  synthesised, 
oligonucleotide primer. A total of 7 such primers were made, the data from which, in 
combination with that obtained using universal primer, allowed the derivation of the 
entire phoA sequence. The location of these oligonucleotide primers and their 
sequences are shown in Figure 5.2. All of the pho gene was sequenced on at least one 
strand and 85% o f the sequence on both strands (see Figure 5.2). The complete 
nucleotide sequence of the phoA structural gene, and its 5 '-  and 3' non-coding regions 
is illustrated in Figure 5.3. A revised version of the programme used to predict the 
secondary structure of staphylococcal SpA was used to predict the secondary structure 
of the encoded protein (Figure 5.4.)
5.3 DISCUSSION
Nucleotide sequence analysis has shown the £. coli JM83 phoA gene to be composed of 
1,413 bp, encoding for 471 amino acids. The translational initiation codon is preceded 
by a sequence motif (GGAG) typical of procaryotic ribosome binding (SD) sites. Thus, 
it is complementary to the nucleotide sequence of the 3 ' terminus of the E. coli 16S 
RNA (S'-ACCUCCU-S’) and there is a marked discrimination against the use of C
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nucleotides, and a preference for the use of A, in the immediate flanking regions 
(Stormo et a l., 1982). A hexanucleotide sequence (TATAGT), beginning 52 
nucleotides 5 ' to the translational initiation codon (position 198 to 203, Figure 5.3) 
corresponds closely to the recognised consensus sequence of the -10 (Pribnow box) E. 
coli promoter element, TATaaT (where the upper case letters represent the most 
conserved nucleotides of the promoter site). The distance of this -10 promoter from the 
start codon is 46 bp, which is similar to that of the E. coli lacZ gene (43 bp).
There are two hexanucleotide sequences that closely resemble the consensus E. coli "35 
promoter sequence (TTGaca). The first, CTGTCA, occurs at nucleotide position 170 
to 175, and the second, TTGTCA, at position 181-186 (see Figure 5.3). The first 
putative '35 promoter sequence differs from the E. coli consensus at 2 nucleotide 
positions, while the second deviates at only one nucleotide position. However, Stefano 
and Gralla (1982a and b) have shown the nucleotide spacing between the '35 and '10 
site of the lac promoter to be a crucial factor in promoter strength, with a spacing of 17 
nucleotides resulting in maximum promoter strength. Indeed, almost all of the 
procaryotic promoters examined to date (Rosenberg and Court, 1979; Siebenlist et al., 
1980) exhibit a spacing of 17+ 1 nucleotide. This would position the *35 site between 
the two sequences mentioned above at position 175 to 180 (Figure 5.3), the sequence of 
which, +l(C)-ATAAAG-(T)'l, exhibits little resemblance to the consensus '35. Other 
genes have been sequenced that appear not to contain a '35 consensus-like sequence 17 
bp 5 ' to their '10  motifs (eg., the cpg gene; Minton and Clarke, 1985), or have a '35 
consensus-like sequence positioned 20 to 23 bp upstream of their '10 sequences (eg., 
lacl, galPl and; Rosenberg and Court, 1979). Therefore, it is not possible from 
theoretical study to indicate which region of the phoA promoter is acting as the '35 
polymerase binding site. It is, however, unlikely to be the second consensus-like 
sequence, TTGTCA, as this would leave a spacing of only 11 bp between the '35 and 
'10 promoter regions, and no spacing less than 16 bp has been observed in those 
promoters examined to date.
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The phoA gene is immediately followed by a palindromic sequence, consisting of 38 
nucleotides, followed by a T-rich stretch of residues, indicative of a transcription 
terminating region. A possible mRNA hairpin structure for this region is schematically 
represented in Figure 5.5.
The deduced amino acid sequence of alkaline phosphatase differs from that obtained by 
protein sequencing (Bradshaw et al., 1981) at only three residues, viz, positions 16 and 
36 (Asp for Asn) and 177 (Glu for Gin). These differences are probably due to a 
misinterpretation of the results of amino acid analysis, as the particular amino acids 
involved are often difficult to distinguish from one another in the method used. The 
amino acid sequence deduced here from the nucleotide sequence is more likely to be 
correct as it is identical to that deduced from the partial nucleotide sequences of other 
investigators (Boidol et al., 1982; Inouye et al., 1982; Kikuchi et al., 1981), and to that 
more recently derived from the entire nucleotide sequence of E. coli strain 294 (Chang 
et al., 1986). It would also appear that the sequence of the phoA gene is highly 
conserved between the different E. coli strains analysed.
The amino acid sequence of the alkaline phosphatase protein consists of 471 residues. 
The first 21 amino acids of the N-terminus represent the signal peptide sequence, which 
is cleaved, following translocation across the cytoplasmic membrane, to leave a mature 
protein composed of 450 amino acids. The translational initiation codon is slightly 
unusual, being a GTG (coding for valine) rather than a ATG (coding for methionine). 
However, it has been shown that the 3 codons capable of initiating the translation of a 
gene, ATG, GTG and TTG, when positioned at the extreme 5' -end of a structural gene, 
encode an N-formyl-methionine residue. GTG functions as an initiation codon in 4% 
of E. coli genes, whereas ATG has that role in 91.2% of E. coli genes (GenBank, 1984). 
Between the codon encoding the N-terminal arginine of the native alkaline phosphatase 
protein and the SD sequence, there are only two codons capable of initiating translation 
in the correct reading frame. Both of these are GTG, the first at nucleotide position 283
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Figure 5.5 Hypothetical Secondary Structure for the Transcription Termination 
Sequence in the 3' Region Flanking the pho \ Coding Sequence
Numbered according to the deduced amino acid shown in Figure 5.3. The translation termination 
codon is denoted by an asterisk (•).
(amino acid -21, relative to the N-terminal Arg) and the second at position 334 (amino 
acid -4). The former of these is most likely to act as the initiation codon as it is in a 
suitable position downstream of the SD sequence (9 nucleotides), it is flanked by polyA 
tracts, a translational termination codon is present in both of the nonsense reading 
frames, and translation from this codon allows for a polypeptide, 21 amino acids in 
length, at the N-terminus of the native alkaline phosphatase protein that has the 
qualities normally attributed to a signal peptide. The properties of this putative signal 
peptide include: a positively charged N-terminal region (Lys at position  *20); a 
hydrophobic core region, 12 amino acids in length (consisting of 75% hydrophobic 
residues) and possessing a high helix forming potential which ends 4 amino acids prior 
to the peptidase cleavage site. The amino acids present from '5 to +5 are consistent 
with those reported by Perlman and Halvorson (1983) and von Heijne (1983, 1984a) to 
be common at a peptidase cleavage sites ie., Ala at '1 and Pro at '5  (m ore detailed 
preferences are given in Section 3.3.3). The second possible translational GTG start 
codon, at position 334, meets none of these requirements.
The most notable features of the amino acid composition per se are the high content of 
Ala (14%) and Gly (10%) residues, the low content of Trp (1%) and Cys (1%) amino 
acids, and the overall net negative charge of the protein (excess of 12 negative charges 
per subunit).
Examination of alkaline phosphatase both in solution and in crystal forms by a variety 
of methods (including X-ray crystallography, X-ray diffraction and NMR; (Wyckoff et 
al„ 1983), combined with knowledge of the amino acid sequence (Bradshaw et al., 
1981), has allowed models for a three dimensional structure to be presented (see Figure 
5.6). A revised version of the programme used to predict the secondary structure of 
staphylococcal SpA (Section 3.3.4.2) was used to predict the secondary structure of E. 
coli alkaline phosphatase (Figure 5.4). A comparison of the predicted secondary 
structure to that deduced by experimentation (Figure 5.6) showed that the computer
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Figure 5 .6  R ibbon D iagram  o f  the C om p lete  M onomer o f  E. coli A lkaline Phosphatase
Strands in the sheet are labelled A through J in order along the polypeptide, and their N-terminal 
amino acid is indicated. Helices are num bered according to their N-terminal amino acid. 
Adapted from Wyckoff et al., 1983.
accurately predicted 68% of the a-helix and fi-sheet regions. Correctly predicted 
regions included the position of 6 of the 10 (3-sheets and 11 of the 14 a-helix regions. 
Two of the regions not predicted (C and M Figure 5.6) were only 4 residues in length. 
Of the helical regions predicted using the computer programme, 6 were twice as long as 
those deduced by experimental methods. However, as Wyckoff et al. (1983) stated that 
the end points of the helical regions are not firmly defined, the computer prediction 
may be more accurate than it first appears. Such comparisons between a "known" 
(subject to continuous refinement, specifically in the active site, where substantial 
conformational flexibility has been observed) structure and that formed using computer 
predictions, allow the assessment of the value of such programmes for use with proteins 
for which a nucleotide or amino acid sequence is known, but no experimental data on 
secondary structure is available.
The active site of a single subunit of alkaline phosphatase consists of three distinct 
metal binding sites and one phosphorylatable serine (residue 103 which initiates 
phosphate ester hydrolysis). It has been suggested that the arginine residue at position 
167 is directly involved in phosphate hydrolysis (Wyckoff et al., 1983), its positive 
charge having a stabilising effect on the reaction. However, Butler-Ranshoff et al. 
(1988) have shown that the charge at residue 167 is not required for the hydrolysis of 
phosphate monoesters, and that its replacement with lysine or glutamine (which are 
capable of maintaining a hydrogen bond with aspartic acid 102, a bond thought likely 
to be necessary for the maintenance of serine 103 in a suitable orientation for 
nucleophilic attack on the phosphate), results in only a slight drop in catalytic activity. 
Amino acids thought to be involved in the active site, by virtue of close contact (12.5A) 
with the central metal group, and the probable bridging ligands are shown in Figure 5.4. 
These amino acids are in a non-contiguous arrangement with an isoleucine residue 
being nearest the N-terminus at position 50, and a glycine nearest the C-terminus at 
position 415. The N-terminal sequence prior to residue 50 has been shown to be 
important for alkaline phosphatase activity. Cleavage with trypsin removes the first 
eleven residues of the native protein, resulting in a change in the overall structure of the
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molecule concomitant with a 20% reduction in specific activity and an alteration in the 
affinity for metal ions (Roberts and Chlebowski, 1984, 1985). Cleavage using protease 
V-8 breaks the bond between the glutamine residue at position 9 and the asparagine 
residue at position 10. The removal of the first nine amino acids has no dramatic effect 
on the activity of alkaline phosphatase, whereas the loss of an additional dipeptide 
(asparagine-10, and arginine-11) results in the aforementioned loss of activity. As a 
consequence, if the metal ions are removed from the 11 amino acid-truncated form, the 
resultant monomeric subunits, upon addition of the essential metal ions, are unable to 
reconstitute to form an active enzyme. Thus, the asparagine-10 and arginine-11 
dipeptide appears to be crucial in the assembly of the native enzyme dimer (Tyler-Cross 
et al., 1989). Further studies by Olafsdottir and Chlebowski (1989), using hybrid 
dimers where only one of the alkaline phosphatase subunits has been cleaved by 
trypsin, suggests the presence of a strong sub-unit interaction within the alkaline 
phosphatase dimer, where an alteration at the arginine-11 and alanine-12 residues can 
effect the active site on both the truncated and native subunits.
In order to maintain a high degree of catalytic activity in the proposed alkaline 
phosphatase::SpA and SpA::alkaline phosphatase chimeric proteins, the protein regions 
forming the active sites, or known to effect the active site, should remain intact. 
Therefore, the preferred site for the N-terminal fusion of the alkaline phosphatase gene 
is located in the nucleotide region between nucleotide 346 (first base of triplet coding 
for arginine 1) and nucleotide 373 (first base of triplet coding for asparagine-10). The 
preferred site for the C-terminal fusion is in the nucleotide region downstream of the 
nucleotide triplet coding for glycine-415. The region of the spa gene to be used in a 
fusion must contain at least two of the five IgG binding domains (E, D, A,B, C) in 
order to maintain a reasonable degree of activity and the N-terminal half must also 
contain the region coding for the SpA signal peptide.
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Examination of the phoA and spa nucleotide sequences revealed a lack of naturally 
occurring suitable restriction enzyme cleavage sites in the aforementioned regions. 
Therefore, it was necessary to introduce suitable restriction enzyme cleavage sites using 
the technique of oligonucleotide site directed mutagenesis. These sites must fulfil two 
main criteria. Firstly, they must be compatible with restriction enzyme sites in a 
multiple site linker that will enable both the spa and phoA genes to be inserted in the 
correct order (as the N- or C-terminal half of the fusion) whilst ensuring that the gene 
forming the C-terminal portion of the fusion is in the same reading frame as the N- 
terminal gene. Secondly, any restriction enzyme cleavage site introduced should alter 
the gene sequence to be fused as little as possible. The overall strategy proposed is 
shown in detail in Figure 5.7. Oligonucleotide mutagenesis and construction of the 
phoAwspa gene fusion has been carried out by the Gene Expression Section of the 
Division of Biotechnology and is currently nearing completion.
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General Discussion
In recent years the applications of SpA in the field of biotechnology have increased 
dramatically. It was immediately apparent that such a versatile protein would be 
required in large quantities. Expression of the spa gene in E. coli had been achieved 
(Duggleby and Jones, 1983; Uhlen et al., 1983) though the levels of SpA produced did 
not appear to be higher than those seen in the natural host S. aureus Cowan I. As at this 
time no nucleotide sequence was available and only a partial amino acid sequence of 
the protein, encompassing the four IgG-binding domains and the repetitive region of the 
C-terminus had been determined (Sjodahl, 1976; 1977 a & b), it was necessary to 
determine the entire nucleotide sequence of the spa gene. This would allow further 
studies on the gene and its deduced a.a sequence in order to further enhance the 
expression of spa in E. coli and also to allow the construction of precisely defined gene 
fusions between spa and various enzyme genes for use as immunodiagnostic reagents.
The work undertaken in this thesis describes the determination and analysis of the 
nucleotide sequence and deduced a.a sequence of spa from S. aureus Cowan I 
(NCTC8530), the manipulation of the gene to achieve enhanced expression in E. coli 
and the characterisation of the SpA IgG-binding peptides produced.
Analysis of the nucleotide and the deduced amino acid sequence has shown;
i. spa encodes a protein, including a signal sequence of 36 a.a, of 508 a.a having 
a molecular weight of 55,426 D. This protein can be seen to consist of two separate 
functional regions; an IgG-binding region, and a cell-membrane-and cell-wall-binding 
region.
ii. A fifth N-terminal region (E), homologous to the four IgG-binding regions 
reported by Sjodahl (1976, 1977 a & b). This has subsequently been shown to have a 
weak IgG binding activity (Moks et al., 1986).
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iii The C-terminus can be divided into two structurally different regions. The Xr 
region consists of 10 octapeptide repeats, this region is shown to be hydrophilic and is 
proposed to act as the cell wall spanning domain of SpA. The Xc region coding for 88 
a.a, contains a 20 a.a. hydrophobic region at its C-terminus followed by five charged 
residues. This region is proposed to bind to the cell membrane and act as an anchor 
region for the protein A molecule, with the charged tail acting as a stop-transfer signal 
by binding to the cytoplasmic side of the inner membrane (von Heijne, 1981; Blobel, 
1980). This hydrophobic region and a pentapeptide sequence just prior to the 
hydrophobic sequence have been reported to occur in many Gram-positive proteins 
which have a membrane binding role (Fischetti, et al., 1990).
iv Studies on internal homologies within the spa sequence at both the nucleotide 
and a.a. level have shown the gene to be composed of a series of repeated sequences, 
that appear to be more highly conserved at the amino acid level than the nucleotide 
level, thus showing a strong evolutionary pressure to conserve particular protein 
sequences. Comparison of this spa gene with two other S. aureus spa genes suggest 
that the spa gene may have evolved by two independent stepwise gene region 
duplications. One to form the 5 IgG-binding domain repeat, indicating that 5 IgG- 
binding domains may represent the maximum number for optimum IgG binding. The 
other to form the octapeptide repeats of the cell wall binding region, Xr, here the 
number of octapeptide regions were seen to vary between the S. aureus strains (with the 
lowest number seen for NCTC8530, ten repeats).
v. Analysis of the codon usage of S. aureus appeared to indicate a difference in 
bias depending on whether the gene examined was derived from the chromosome, a 
plasmid or a transposon; surprisingly spa showed a greater similarity to the codon bias 
seen for plasmid derived genes rather than those from the chromosome. However, most 
of the other chromosomal genes examined are normally expressed at far lower levels 
than those seen for spa in S. aureus. As a difference in codon bias has been shown to 
exist in E. coli between strongly and weakly expressed genes, a similar system could 
exist in S. aureus. Until more of S. aureus genes have been analysed no firm
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conclusions can be made. A possible explanation (involving the presence in spa of a 
rarely used E. coli codon synonym for leu) for some of the differences in SpA levels 
produced between the C-terminally truncated SpA and the full length SpA has been 
proposed, Chapter 3, Section 3.3.12.
Expression studies of the cloned spa gene have revealed:
i. The spa promoter and Shine-Dalgamo sequence function efficiently in E. coli, 
achieving up to half the level o f SpA seen when expressed from the E. coli lac 
promoter.
ii A four-fold enhancement in SpA levels in E.coli was achieved by placing the 
E. coli lac promoter immediately upstream of the spa gene.
iii. Scale up o f SpA production to 150 and 400 litre batch fermenters has enabled 
yields of up to 1.5 g o f SpA per litre of culture to be achieved. However the 
recombinant clones are extremely fragile when expressing a high level of SpA. This 
has caused problems which hopefully should be overcome by using a vector system 
containing a fully repressible promoter.
iv. The Xc region of the SpA has been shown to affect the cell morphology 
dramatically when large amounts of SpA are present in the cell. Similar findings have 
been reported for the over expression of other of heterologous proteins (Schoner et al., 
1985; Schoemaker et al., 1985; Georgiou et al., 1986).
v. The lack of the Xc region of the SpA molecule has been shown to affect the 
membrane binding ability of the truncated protein.
vi. The existence of a possible regulatory control sequence for spa expression is 
proposed. Evidence presented in this thesis suggested this is located in the 608 bp 
region of S. aureus DNA prior to the spa structural gene (Chapter 4, Section 4.2.3.4). 
It was of interest to note the presence of two sequences within this region that possess a 
strong homology to both the proposed common regulatory site of catabolite repressed 
B. subtilis promoters (Weickert and Chambliss, 1990) and to the CRP binding site and
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other known operator sequences of E. coli promoters (Studnicka, 1987).
vii. SpA when produced in E. coli was shown to be localised to the periplasm of 
the cell, though traces of the precursor protein form were seen in the membrane fraction 
of the cell.
viii. Proteolytic degradation of the mature form of SpA was seen to occur when 
produced in an E. coli host. This degradation appeared to be occurring mainly at the C- 
terminal end of the protein, and appeared to occur at specific sites in the polypeptide 
rather than a general "chewback" of the end terminus of the protein. Such proteolysis is 
a common problem in the expression of heterologous proteins in bacteria (Uhlen and 
Moks, 1990). It has also recently been reported that the susceptibility of a recombinant 
protein to proteolysis can be affected by its neighbouring domains (Murby etal., 1991).
The results presented in this thesis provide a substantial basis for further work in 
several areas such as control of expression of spa either using an alternative E. coli 
vector system or perhaps eventually using its own regulatory controls. Stringent 
control of SpA production may obviate the problems of host cell fragility seen in this 
study and so increase the amount of SpA recovered from large-scale fermentations. 
The nucleotide sequence of the gene spa Cowan I (NCTC8350) and of the other spa 
genes published during the course of this thesis (Uhlen, et al., 1984a; Colbert and 
Anilonis (1984) have been used the construction of gene fusions between spa and the 
genes of many enzymes (see Appendix III).
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A p p e n d ix  I
Relationship Between Optical Density and Cell dry Weight
In order to accurately assess the level of expression of SpA from different E.coli [SpA] 
plasmid cultures it is necessary to know exactly how much SpA is produced per volume 
of cells. Determination of the SpA levels produced for a certain dry weight will enable 
the comparison of SpA levels between the cultures those optical density were measured 
at 450 nm (localisation experiments) with those measured at 600 nm (later 500 ml 
culture runs) and will also allow SpA to be expressed as pg SpA. mg' 1 cells. To 
construct a graph of dry weight against optical density a calibration curve of dry weight 
against % cell suspension must first be constructed. 
method
When measuring dry weights it is important to pre-dry the weighing bottles to prevent 
negative results. Bijou bottles were placed in a 150°C oven to dry. They were 
weighted beforehand and were left to dry until a constant weight was attained.
Stationary phase JM83 [pPA31] cells (100 ml volume) were harvested (centrifuged 
6000 r.p.m for 10 minutes using a SS24 Sorvall rotor) and resuspended in 35 mis of 
2xYT. This was deemed a 100% suspensions, 5 mis of the following suspension were 
prepared by dilution of this: 80%, 60%, 40% and 20%. 1 ml of each suspension was 
diluted in 9 ml of 2xYT and the optical density at 600 nm and 450 nm measured. 2 ml 
of each suspension was added to the pre-weighted bottles (4 duplicate samples) and 
allowed to dry at 115°C until a constant weight was achieved (four days), 2 mis of 
2xYT was also added to a pre-weighed bottle and dried down to determine the weight 
of the medium used.
A sample of stationary phase cells from JM83 [pPA163] and JM83 [pPA34] grown 
under identical conditions to JM83 [pPA31] was also diluted to the same OD^qq and 
OD450 as the 100% sample from JM83 [pPA31] and the dry weight determined. No 
significant difference was seen between the dry weights determined for each plasmid 
type.
The average dry weight of the cell culture was plotted against the percentage 
suspension (Figure A l.i). The true dry weight can be calculated from the plot by 
measuring the distance from the intercept of the slope with the Y axis (mg dry weight).
The resulting values of cell dry weight were calculated for 1 ml of cells and divided by 
10 to allow for the 1 in 10 dilution carried in obtaining the optical density of the 
culture.
lOxdil % Suspension Dry Weight 
mg ml'*
OD600 OD450
100 0.420 1.238 1.176
20 0.335 1.048 0.972
60 0.250 0.872 0.793
40 0.170 0.584 0.516
20 0.085 0.313 0.282
A graph of optical density versus dry weight for JM83 |pPA31] was plotted (Figure 
A l.ii). This showed a linear relationship to exist between dry weight and optical 
density for absorbance wavelength 450 nm and 600 nm until an optical density of 1.0
All small scale culture samples were dilated to give an OD of 1.0 or less and the 
dilution taken into account in the subsequent calculation of mg SpA mg' * cells.
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Figure AI.i Calibration curve of cell dry weight vs %  suspension to 
determine actual 100% level
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Figure Al.ii Optical density vs dry weight for JM83[pPA3l] grown in 
2 x YT broth
Appendix II
Matenals and Methods of Pilot Plant Fermentation of E.coli JM83 ISpAl of Strains 
Fermentation of JM83 [SpA] in the 20 litre seed vessel and the 150 litre and 400 litre 
main culture vessels followed by harvesting of the cells were undertaken by shift 
technicians at the CAMR Fermentation Pilot Plant under the guidance of Dr. S. 
Chambers. Standard protocols and quality control procedures, used at the Pilot Plant 
were followed throughout.
Medium
20, 150 and 400 litre culture medium was made up as follows:
Per Litre
K2HP04 4.0 g
k h 2p o 4 1.0 g
NH4CI 1.0 g
CaCl2.2HO 0.01 g
K2S04 2.6 g
♦Trace elements 10 mis
Cusamino acids 20.0 g
Yeast extract 3.0 g
Glycerol 46.0 g
♦Trace elements: 5 g of EDTA was dissolved in 300 ml of demineralised H20  then 
each of the following (dissolved separately in a small volume of demineralised H20 ) 
was added in the order shown.
FeCl3 0.5 g
ZnO 0.05 g
CuCl2.2H20  0.01 g
CoN03.6H20  0.01 g
(NH4)6 Mo.7O24.4H2) 0.01 g
these were made up to a final volume of 1 litre and added to give a 1% final 
concentration. The pH of the medium was brought to pH 7.0 using NaOH or H3PO4. 
The medium was sterilised by heating up to 121°C for 30 minutes at 20 PSI.
1 M Magnesium chloride -1 ml/litre and ampicillin to give final SO pg ml'* were added 
via a sterile filter first prior to inoculation.
Culture Conditions
The culture vessel and associated equipment used were of the design described by 
Melting and Scott (1972). The pH was monitored and controlled between present 
parameters by automatic additions of either 20% H3PO4 or 3.2N NaOH. Foaming was 
controlled by the addition of Mazu/8005 (3 mis in 20 litre cultures, 55 mis in 150 litre 
culture and 15 mis in 400 litre culture) to the growth medium prior to sterilisation. 
Temperature was monitored at 37°C by a thermostatically controlled water jacket. The 
C02 content of effluent gas from the culture was monitored using a Grubb Parsons 
model IRG-A-20 CO2 analyser. The culture was aerated with presterilised bottom air 
at a rate of 12 L min'* per 20 litre culture, 75 L min'* per 150 litre and 300 L min'* 
per 400 litre culture. The culture was stirred at 250 rpm. Samples were taken from the 
culture at hourly intervals for routine monitoring, purposes (100ml discard). The pH 
and OD^qq using a Pye Unicam SpB-100 spectrophotometer were monitored every 
hour. Cell growth was also monitored every 2 hours by lab dry weight (LDW) in 
conjunction with viable counts (made on nutrient agar plates (either L-agar or 2xYT 
agar). Plasmid loss could also be monitored by plating onto Ampicllin (50 pg ml'* 
containing nutrient agar plates and comparing the viable count to that of the non- 
ampicillin plates. Purity of culture was monitored every 2 hours by random selection of 
a few colonies from the viable count plate, these were then scanned under the light 
microscope and tested for known biochemical characteristics of the parent strain. The 
SpA levels within the cells and the culture supernatant were determined at 4 hours per
inoculation and then hourly, using the monorocket SpA assay described in section 
(2.2.14.2). All the above readings were also carried out on a final sample taken 
immediately prior to cell transfer to a larger fermenter or prior to harvesting.
Appendix III
S. aureus  Protein A Gene Fusions
The following protein A gene fusions have been constructed to date. The first protein 
of each fusion indicates the 5* end of the gene fusion and the second protein the 3 ' 
end of the gene fusion.
SpA - Protein A - (3-galactosidase (Uhlen, et al., 1983; Uhlen etal., 1984c; Nilsson et 
al., 1983a; Hellebust etal., 1987; Hellebust, et al., 1988).
SpA - Insulin like growth Factor I (Nilsson et al., 1985b)
SpA - antigenic peptide, SpA acts as an adjuvant (Lowenadler et al., 1986; Lowenadler 
etal., 1987, Valerie etal., 1987).
(3-glucuronidase - SpA (Anilonis and Palmer, 1987).
SpA - Ricin A (Kim and Weaver, 1988)
SpA - Carboxypeptidase G2 (Shuttleworth, unpublished results)
SpA - Alkaline phosphatase (Nilsson and Abrahmsen, 1990)
SpA - Bovine pancreatic trypsin inhibitor (Nilsson and Abrahmsen, 1990) 
Metapyrocatcchase - SpA (Kobatake, et al., 1990)
SpA - Aequorin (Zenno and Inouye, 1990)
SpA - Glutathione S-Transferase (Lew et al., 1991)
SpA - Luciferase (Lindbladh etal., 1991)
SpA - (3-lactamase (Georgiou and Baneyx 1990)

PUBLISHED PAPERS 
NOT FILMED FOR 
COPYRIGHT REASONS
TM
NUMEROUS ORIGINALS 
IN COLOUR
VARIABLE PRINT 
QUALITY
T H E  B R IT ISH  LIBRARY
BRITISH THESIS SERVICE
TITLE ....
S T U D IE S  O N  T H E  E X P R E S S IO N  O F  A  C L O N E D  
STAPHYLO CO CCUS A U R E U S  P R O TE IN  A  G E N E  IN 
ESCHERICHIA COLI
AUTHO R .............. Helen L. Shuttleworth, BSc
DEGREE..................
AWARDING BODY 
D A TE........................
University o f Warwick.
THESIS
NUMBER
T H IS  TH E S IS  H A S  BEEN M IC R O F IL M E D  E X A C T L Y  A S  R E C E IV E D
The qua lity  o f  th is re p ro d u c tio n  is dep e n d e n t upo n  the  qua lity  o f  th e  o rig in a l thesis 
subm itted  fo r  m ic ro film in g . Every e ffo r t has been m ade to  ensure th e  h ighest q u a lity  o f 
re p ro d u c tio n .
Some pages may have in d is tin c t p rin t, espec ia lly  i f  the  o rig ina l papers w e re  p o o r ly  
p roduced o r  i f  th e  aw ard ing  body sen t an in fe r io r  copy.
If pages are m issing, please con tac t th e  a w a rd in g  body w h ich  g ra n te d  th e  degree.
P rev ious ly  co p y rig h te d  m ateria ls  ( jo u rn a l a rt ic le s , published te x ts , e tc .)  a re  n o t 
f ilm e d .
This copy o f the  thesis has been supplied on condition th a t anyone who  
consults it is understood to recognise th a t  its copyright rests w ith  its a u thor  
and th a t no in fo rm atio n  derived fro m  i t  m ay be published w ith o u t the  
author's p rio r w r it te n  consent.
R e p roduc tion  o f  th is  thesis, o th e r than  as p e rm itte d  unde r th e  U n ite d  K ingdom  
C o p y rig h t Designs and Patents A c t 1988, o r  u n d e r specific ag re e m e n t w ith  the 
co p y rig h t ho ld e r, is p ro h ib ite d .
1 ' ' 1  je m s  1
l 2 | 1 3 1 U  151 U R E D U C T IO N  X a.o
C A M E R A __
N o . o f  pages
